{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Defaulting to user installation because normal site-packages is not writeable\n",
      "Collecting docling\n",
      "  Downloading docling-2.17.0-py3-none-any.whl.metadata (8.0 kB)\n",
      "Requirement already satisfied: beautifulsoup4<5.0.0,>=4.12.3 in /Users/gabrielmelmed/Library/Python/3.9/lib/python/site-packages (from docling) (4.12.3)\n",
      "Requirement already satisfied: certifi>=2024.7.4 in /Users/gabrielmelmed/Library/Python/3.9/lib/python/site-packages (from docling) (2024.8.30)\n",
      "Collecting deepsearch-glm<2.0.0,>=1.0.0 (from docling)\n",
      "  Downloading deepsearch_glm-1.0.0-cp39-cp39-macosx_13_0_x86_64.whl.metadata (11 kB)\n",
      "Collecting docling-core<3.0.0,>=2.15.1 (from docling-core[chunking]<3.0.0,>=2.15.1->docling)\n",
      "  Downloading docling_core-2.16.1-py3-none-any.whl.metadata (5.7 kB)\n",
      "Collecting docling-ibm-models<4.0.0,>=3.3.0 (from docling)\n",
      "  Downloading docling_ibm_models-3.3.0-py3-none-any.whl.metadata (7.3 kB)\n",
      "Collecting docling-parse<4.0.0,>=3.1.0 (from docling)\n",
      "  Downloading docling_parse-3.1.2-cp39-cp39-macosx_13_0_x86_64.whl.metadata (7.5 kB)\n",
      "Collecting easyocr<2.0,>=1.7 (from docling)\n",
      "  Downloading easyocr-1.7.2-py3-none-any.whl.metadata (10 kB)\n",
      "Collecting filetype<2.0.0,>=1.2.0 (from docling)\n",
      "  Downloading filetype-1.2.0-py2.py3-none-any.whl.metadata (6.5 kB)\n",
      "Collecting huggingface_hub<1,>=0.23 (from docling)\n",
      "  Downloading huggingface_hub-0.28.0-py3-none-any.whl.metadata (13 kB)\n",
      "Requirement already satisfied: lxml<6.0.0,>=4.0.0 in /Users/gabrielmelmed/Library/Python/3.9/lib/python/site-packages (from docling) (4.9.3)\n",
      "Collecting marko<3.0.0,>=2.1.2 (from docling)\n",
      "  Downloading marko-2.1.2-py3-none-any.whl.metadata (4.5 kB)\n",
      "Collecting openpyxl<4.0.0,>=3.1.5 (from docling)\n",
      "  Downloading openpyxl-3.1.5-py2.py3-none-any.whl.metadata (2.5 kB)\n",
      "Collecting pandas<3.0.0,>=2.1.4 (from docling)\n",
      "  Using cached pandas-2.2.3-cp39-cp39-macosx_10_9_x86_64.whl.metadata (89 kB)\n",
      "Requirement already satisfied: pillow<11.0.0,>=10.0.0 in /Users/gabrielmelmed/Library/Python/3.9/lib/python/site-packages (from docling) (10.0.1)\n",
      "Collecting pydantic<3.0.0,>=2.0.0 (from docling)\n",
      "  Downloading pydantic-2.10.6-py3-none-any.whl.metadata (30 kB)\n",
      "Collecting pydantic-settings<3.0.0,>=2.3.0 (from docling)\n",
      "  Downloading pydantic_settings-2.7.1-py3-none-any.whl.metadata (3.5 kB)\n",
      "Collecting pypdfium2<5.0.0,>=4.30.0 (from docling)\n",
      "  Downloading pypdfium2-4.30.1-py3-none-macosx_10_13_x86_64.whl.metadata (48 kB)\n",
      "Collecting python-docx<2.0.0,>=1.1.2 (from docling)\n",
      "  Downloading python_docx-1.1.2-py3-none-any.whl.metadata (2.0 kB)\n",
      "Collecting python-pptx<2.0.0,>=1.0.2 (from docling)\n",
      "  Downloading python_pptx-1.0.2-py3-none-any.whl.metadata (2.5 kB)\n",
      "Collecting requests<3.0.0,>=2.32.2 (from docling)\n",
      "  Downloading requests-2.32.3-py3-none-any.whl.metadata (4.6 kB)\n",
      "Collecting rtree<2.0.0,>=1.3.0 (from docling)\n",
      "  Downloading Rtree-1.3.0-py3-none-macosx_10_9_x86_64.whl.metadata (2.1 kB)\n",
      "Requirement already satisfied: scipy<2.0.0,>=1.6.0 in /Users/gabrielmelmed/Library/Python/3.9/lib/python/site-packages (from docling) (1.11.2)\n",
      "Collecting typer<0.13.0,>=0.12.5 (from docling)\n",
      "  Downloading typer-0.12.5-py3-none-any.whl.metadata (15 kB)\n",
      "Requirement already satisfied: soupsieve>1.2 in /Users/gabrielmelmed/Library/Python/3.9/lib/python/site-packages (from beautifulsoup4<5.0.0,>=4.12.3->docling) (2.5)\n",
      "Collecting jsonref<2.0.0,>=1.1.0 (from docling-core<3.0.0,>=2.15.1->docling-core[chunking]<3.0.0,>=2.15.1->docling)\n",
      "  Downloading jsonref-1.1.0-py3-none-any.whl.metadata (2.7 kB)\n",
      "Requirement already satisfied: jsonschema<5.0.0,>=4.16.0 in /Users/gabrielmelmed/Library/Python/3.9/lib/python/site-packages (from docling-core<3.0.0,>=2.15.1->docling-core[chunking]<3.0.0,>=2.15.1->docling) (4.21.1)\n",
      "Collecting pillow<11.0.0,>=10.0.0 (from docling)\n",
      "  Downloading pillow-10.4.0-cp39-cp39-macosx_10_10_x86_64.whl.metadata (9.2 kB)\n",
      "Requirement already satisfied: pyyaml<7.0.0,>=5.1 in /Users/gabrielmelmed/Library/Python/3.9/lib/python/site-packages (from docling-core<3.0.0,>=2.15.1->docling-core[chunking]<3.0.0,>=2.15.1->docling) (6.0.1)\n",
      "Collecting tabulate<0.10.0,>=0.9.0 (from docling-core<3.0.0,>=2.15.1->docling-core[chunking]<3.0.0,>=2.15.1->docling)\n",
      "  Downloading tabulate-0.9.0-py3-none-any.whl.metadata (34 kB)\n",
      "Requirement already satisfied: typing-extensions<5.0.0,>=4.12.2 in /Users/gabrielmelmed/Library/Python/3.9/lib/python/site-packages (from docling-core<3.0.0,>=2.15.1->docling-core[chunking]<3.0.0,>=2.15.1->docling) (4.12.2)\n",
      "Collecting semchunk<3.0.0,>=2.2.0 (from docling-core[chunking]<3.0.0,>=2.15.1->docling)\n",
      "  Downloading semchunk-2.2.2-py3-none-any.whl.metadata (10 kB)\n",
      "Collecting transformers<5.0.0,>=4.34.0 (from docling-core[chunking]<3.0.0,>=2.15.1->docling)\n",
      "  Downloading transformers-4.48.1-py3-none-any.whl.metadata (44 kB)\n",
      "Collecting jsonlines<4.0.0,>=3.1.0 (from docling-ibm-models<4.0.0,>=3.3.0->docling)\n",
      "  Downloading jsonlines-3.1.0-py3-none-any.whl.metadata (1.7 kB)\n",
      "Requirement already satisfied: numpy<2.0.0,>=1.24.4 in /Users/gabrielmelmed/Library/Python/3.9/lib/python/site-packages (from docling-ibm-models<4.0.0,>=3.3.0->docling) (1.26.0)\n",
      "Collecting opencv-python-headless<5.0.0.0,>=4.6.0.66 (from docling-ibm-models<4.0.0,>=3.3.0->docling)\n",
      "  Downloading opencv_python_headless-4.11.0.86-cp37-abi3-macosx_13_0_x86_64.whl.metadata (20 kB)\n",
      "Collecting safetensors<1,>=0.4.3 (from safetensors[torch]<1,>=0.4.3->docling-ibm-models<4.0.0,>=3.3.0->docling)\n",
      "  Downloading safetensors-0.5.2-cp38-abi3-macosx_10_12_x86_64.whl.metadata (3.8 kB)\n",
      "Requirement already satisfied: torch<3.0.0,>=2.2.2 in /Users/gabrielmelmed/Library/Python/3.9/lib/python/site-packages (from docling-ibm-models<4.0.0,>=3.3.0->docling) (2.2.2)\n",
      "Requirement already satisfied: torchvision<1,>=0 in /Users/gabrielmelmed/Library/Python/3.9/lib/python/site-packages (from docling-ibm-models<4.0.0,>=3.3.0->docling) (0.17.2)\n",
      "Requirement already satisfied: tqdm<5.0.0,>=4.64.0 in /Users/gabrielmelmed/Library/Python/3.9/lib/python/site-packages (from docling-ibm-models<4.0.0,>=3.3.0->docling) (4.67.1)\n",
      "Collecting transformers<5.0.0,>=4.34.0 (from docling-core[chunking]<3.0.0,>=2.15.1->docling)\n",
      "  Downloading transformers-4.42.4-py3-none-any.whl.metadata (43 kB)\n",
      "Requirement already satisfied: scikit-image in /Users/gabrielmelmed/Library/Python/3.9/lib/python/site-packages (from easyocr<2.0,>=1.7->docling) (0.22.0)\n",
      "Collecting python-bidi (from easyocr<2.0,>=1.7->docling)\n",
      "  Downloading python_bidi-0.6.3-cp39-cp39-macosx_10_12_x86_64.whl.metadata (4.9 kB)\n",
      "Requirement already satisfied: Shapely in /Users/gabrielmelmed/Library/Python/3.9/lib/python/site-packages (from easyocr<2.0,>=1.7->docling) (2.0.2)\n",
      "Collecting pyclipper (from easyocr<2.0,>=1.7->docling)\n",
      "  Downloading pyclipper-1.3.0.post6-cp39-cp39-macosx_10_9_x86_64.whl.metadata (9.0 kB)\n",
      "Collecting ninja (from easyocr<2.0,>=1.7->docling)\n",
      "  Downloading ninja-1.11.1.3-py3-none-macosx_10_9_universal2.whl.metadata (5.3 kB)\n",
      "Requirement already satisfied: filelock in /Users/gabrielmelmed/Library/Python/3.9/lib/python/site-packages (from huggingface_hub<1,>=0.23->docling) (3.15.4)\n",
      "Requirement already satisfied: fsspec>=2023.5.0 in /Users/gabrielmelmed/Library/Python/3.9/lib/python/site-packages (from huggingface_hub<1,>=0.23->docling) (2024.6.1)\n",
      "Requirement already satisfied: packaging>=20.9 in /Users/gabrielmelmed/Library/Python/3.9/lib/python/site-packages (from huggingface_hub<1,>=0.23->docling) (23.1)\n",
      "Requirement already satisfied: et-xmlfile in /Users/gabrielmelmed/Library/Python/3.9/lib/python/site-packages (from openpyxl<4.0.0,>=3.1.5->docling) (1.1.0)\n",
      "Requirement already satisfied: python-dateutil>=2.8.2 in /Users/gabrielmelmed/Library/Python/3.9/lib/python/site-packages (from pandas<3.0.0,>=2.1.4->docling) (2.8.2)\n",
      "Requirement already satisfied: pytz>=2020.1 in /Users/gabrielmelmed/Library/Python/3.9/lib/python/site-packages (from pandas<3.0.0,>=2.1.4->docling) (2023.3.post1)\n",
      "Requirement already satisfied: tzdata>=2022.7 in /Users/gabrielmelmed/Library/Python/3.9/lib/python/site-packages (from pandas<3.0.0,>=2.1.4->docling) (2023.3)\n",
      "Requirement already satisfied: annotated-types>=0.6.0 in /Users/gabrielmelmed/Library/Python/3.9/lib/python/site-packages (from pydantic<3.0.0,>=2.0.0->docling) (0.7.0)\n",
      "Collecting pydantic-core==2.27.2 (from pydantic<3.0.0,>=2.0.0->docling)\n",
      "  Downloading pydantic_core-2.27.2-cp39-cp39-macosx_10_12_x86_64.whl.metadata (6.6 kB)\n",
      "Collecting python-dotenv>=0.21.0 (from pydantic-settings<3.0.0,>=2.3.0->docling)\n",
      "  Downloading python_dotenv-1.0.1-py3-none-any.whl.metadata (23 kB)\n",
      "Collecting XlsxWriter>=0.5.7 (from python-pptx<2.0.0,>=1.0.2->docling)\n",
      "  Downloading XlsxWriter-3.2.2-py3-none-any.whl.metadata (2.8 kB)\n",
      "Requirement already satisfied: charset-normalizer<4,>=2 in /Users/gabrielmelmed/Library/Python/3.9/lib/python/site-packages (from requests<3.0.0,>=2.32.2->docling) (3.2.0)\n",
      "Requirement already satisfied: idna<4,>=2.5 in /Users/gabrielmelmed/Library/Python/3.9/lib/python/site-packages (from requests<3.0.0,>=2.32.2->docling) (3.10)\n",
      "Requirement already satisfied: urllib3<3,>=1.21.1 in /Users/gabrielmelmed/Library/Python/3.9/lib/python/site-packages (from requests<3.0.0,>=2.32.2->docling) (2.0.4)\n",
      "Requirement already satisfied: click>=8.0.0 in /Users/gabrielmelmed/Library/Python/3.9/lib/python/site-packages (from typer<0.13.0,>=0.12.5->docling) (8.1.7)\n",
      "Collecting shellingham>=1.3.0 (from typer<0.13.0,>=0.12.5->docling)\n",
      "  Downloading shellingham-1.5.4-py2.py3-none-any.whl.metadata (3.5 kB)\n",
      "Collecting rich>=10.11.0 (from typer<0.13.0,>=0.12.5->docling)\n",
      "  Downloading rich-13.9.4-py3-none-any.whl.metadata (18 kB)\n",
      "Requirement already satisfied: attrs>=19.2.0 in /Users/gabrielmelmed/Library/Python/3.9/lib/python/site-packages (from jsonlines<4.0.0,>=3.1.0->docling-ibm-models<4.0.0,>=3.3.0->docling) (23.2.0)\n",
      "Requirement already satisfied: jsonschema-specifications>=2023.03.6 in /Users/gabrielmelmed/Library/Python/3.9/lib/python/site-packages (from jsonschema<5.0.0,>=4.16.0->docling-core<3.0.0,>=2.15.1->docling-core[chunking]<3.0.0,>=2.15.1->docling) (2023.12.1)\n",
      "Requirement already satisfied: referencing>=0.28.4 in /Users/gabrielmelmed/Library/Python/3.9/lib/python/site-packages (from jsonschema<5.0.0,>=4.16.0->docling-core<3.0.0,>=2.15.1->docling-core[chunking]<3.0.0,>=2.15.1->docling) (0.33.0)\n",
      "Requirement already satisfied: rpds-py>=0.7.1 in /Users/gabrielmelmed/Library/Python/3.9/lib/python/site-packages (from jsonschema<5.0.0,>=4.16.0->docling-core<3.0.0,>=2.15.1->docling-core[chunking]<3.0.0,>=2.15.1->docling) (0.18.0)\n",
      "Requirement already satisfied: six>=1.5 in /Library/Developer/CommandLineTools/Library/Frameworks/Python3.framework/Versions/3.9/lib/python3.9/site-packages (from python-dateutil>=2.8.2->pandas<3.0.0,>=2.1.4->docling) (1.15.0)\n",
      "Collecting markdown-it-py>=2.2.0 (from rich>=10.11.0->typer<0.13.0,>=0.12.5->docling)\n",
      "  Downloading markdown_it_py-3.0.0-py3-none-any.whl.metadata (6.9 kB)\n",
      "Requirement already satisfied: pygments<3.0.0,>=2.13.0 in /Users/gabrielmelmed/Library/Python/3.9/lib/python/site-packages (from rich>=10.11.0->typer<0.13.0,>=0.12.5->docling) (2.16.1)\n",
      "Collecting mpire[dill] (from semchunk<3.0.0,>=2.2.0->docling-core[chunking]<3.0.0,>=2.15.1->docling)\n",
      "  Downloading mpire-2.10.2-py3-none-any.whl.metadata (14 kB)\n",
      "Requirement already satisfied: sympy in /Users/gabrielmelmed/Library/Python/3.9/lib/python/site-packages (from torch<3.0.0,>=2.2.2->docling-ibm-models<4.0.0,>=3.3.0->docling) (1.12)\n",
      "Requirement already satisfied: networkx in /Users/gabrielmelmed/Library/Python/3.9/lib/python/site-packages (from torch<3.0.0,>=2.2.2->docling-ibm-models<4.0.0,>=3.3.0->docling) (3.2.1)\n",
      "Requirement already satisfied: jinja2 in /Users/gabrielmelmed/Library/Python/3.9/lib/python/site-packages (from torch<3.0.0,>=2.2.2->docling-ibm-models<4.0.0,>=3.3.0->docling) (3.1.3)\n",
      "Requirement already satisfied: regex!=2019.12.17 in /Users/gabrielmelmed/Library/Python/3.9/lib/python/site-packages (from transformers<5.0.0,>=4.34.0->docling-core[chunking]<3.0.0,>=2.15.1->docling) (2023.12.25)\n",
      "Collecting tokenizers<0.20,>=0.19 (from transformers<5.0.0,>=4.34.0->docling-core[chunking]<3.0.0,>=2.15.1->docling)\n",
      "  Downloading tokenizers-0.19.1-cp39-cp39-macosx_10_12_x86_64.whl.metadata (6.7 kB)\n",
      "Requirement already satisfied: imageio>=2.27 in /Users/gabrielmelmed/Library/Python/3.9/lib/python/site-packages (from scikit-image->easyocr<2.0,>=1.7->docling) (2.31.6)\n",
      "Requirement already satisfied: tifffile>=2022.8.12 in /Users/gabrielmelmed/Library/Python/3.9/lib/python/site-packages (from scikit-image->easyocr<2.0,>=1.7->docling) (2023.9.26)\n",
      "Requirement already satisfied: lazy_loader>=0.3 in /Users/gabrielmelmed/Library/Python/3.9/lib/python/site-packages (from scikit-image->easyocr<2.0,>=1.7->docling) (0.3)\n",
      "INFO: pip is looking at multiple versions of imageio to determine which version is compatible with other requirements. This could take a while.\n",
      "Collecting imageio>=2.27 (from scikit-image->easyocr<2.0,>=1.7->docling)\n",
      "  Downloading imageio-2.37.0-py3-none-any.whl.metadata (5.2 kB)\n",
      "Collecting mdurl~=0.1 (from markdown-it-py>=2.2.0->rich>=10.11.0->typer<0.13.0,>=0.12.5->docling)\n",
      "  Downloading mdurl-0.1.2-py3-none-any.whl.metadata (1.6 kB)\n",
      "Requirement already satisfied: MarkupSafe>=2.0 in /Users/gabrielmelmed/Library/Python/3.9/lib/python/site-packages (from jinja2->torch<3.0.0,>=2.2.2->docling-ibm-models<4.0.0,>=3.3.0->docling) (2.1.5)\n",
      "Collecting multiprocess (from mpire[dill]->semchunk<3.0.0,>=2.2.0->docling-core[chunking]<3.0.0,>=2.15.1->docling)\n",
      "  Downloading multiprocess-0.70.17-py39-none-any.whl.metadata (7.2 kB)\n",
      "Requirement already satisfied: mpmath>=0.19 in /Users/gabrielmelmed/Library/Python/3.9/lib/python/site-packages (from sympy->torch<3.0.0,>=2.2.2->docling-ibm-models<4.0.0,>=3.3.0->docling) (1.3.0)\n",
      "Collecting dill>=0.3.9 (from multiprocess->mpire[dill]->semchunk<3.0.0,>=2.2.0->docling-core[chunking]<3.0.0,>=2.15.1->docling)\n",
      "  Downloading dill-0.3.9-py3-none-any.whl.metadata (10 kB)\n",
      "Downloading docling-2.17.0-py3-none-any.whl (121 kB)\n",
      "Downloading deepsearch_glm-1.0.0-cp39-cp39-macosx_13_0_x86_64.whl (6.3 MB)\n",
      "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m6.3/6.3 MB\u001b[0m \u001b[31m1.9 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0ma \u001b[36m0:00:01\u001b[0m\n",
      "\u001b[?25hDownloading docling_core-2.16.1-py3-none-any.whl (93 kB)\n",
      "Downloading docling_ibm_models-3.3.0-py3-none-any.whl (78 kB)\n",
      "Downloading docling_parse-3.1.2-cp39-cp39-macosx_13_0_x86_64.whl (22.0 MB)\n",
      "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m22.0/22.0 MB\u001b[0m \u001b[31m2.1 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m00:01\u001b[0m00:01\u001b[0m\n",
      "\u001b[?25hDownloading easyocr-1.7.2-py3-none-any.whl (2.9 MB)\n",
      "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m2.9/2.9 MB\u001b[0m \u001b[31m2.1 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0ma \u001b[36m0:00:01\u001b[0m\n",
      "\u001b[?25hDownloading filetype-1.2.0-py2.py3-none-any.whl (19 kB)\n",
      "Downloading huggingface_hub-0.28.0-py3-none-any.whl (464 kB)\n",
      "Downloading marko-2.1.2-py3-none-any.whl (42 kB)\n",
      "Downloading openpyxl-3.1.5-py2.py3-none-any.whl (250 kB)\n",
      "Using cached pandas-2.2.3-cp39-cp39-macosx_10_9_x86_64.whl (12.6 MB)\n",
      "Downloading pillow-10.4.0-cp39-cp39-macosx_10_10_x86_64.whl (3.5 MB)\n",
      "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m3.5/3.5 MB\u001b[0m \u001b[31m3.4 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0ma \u001b[36m0:00:01\u001b[0m\n",
      "\u001b[?25hDownloading pydantic-2.10.6-py3-none-any.whl (431 kB)\n",
      "Downloading pydantic_core-2.27.2-cp39-cp39-macosx_10_12_x86_64.whl (1.9 MB)\n",
      "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m1.9/1.9 MB\u001b[0m \u001b[31m2.4 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0ma \u001b[36m0:00:01\u001b[0m\n",
      "\u001b[?25hDownloading pydantic_settings-2.7.1-py3-none-any.whl (29 kB)\n",
      "Downloading pypdfium2-4.30.1-py3-none-macosx_10_13_x86_64.whl (2.9 MB)\n",
      "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m2.9/2.9 MB\u001b[0m \u001b[31m3.4 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0ma \u001b[36m0:00:01\u001b[0m\n",
      "\u001b[?25hDownloading python_docx-1.1.2-py3-none-any.whl (244 kB)\n",
      "Downloading python_pptx-1.0.2-py3-none-any.whl (472 kB)\n",
      "Downloading requests-2.32.3-py3-none-any.whl (64 kB)\n",
      "Downloading Rtree-1.3.0-py3-none-macosx_10_9_x86_64.whl (475 kB)\n",
      "Downloading typer-0.12.5-py3-none-any.whl (47 kB)\n",
      "Downloading jsonlines-3.1.0-py3-none-any.whl (8.6 kB)\n",
      "Downloading jsonref-1.1.0-py3-none-any.whl (9.4 kB)\n",
      "Downloading opencv_python_headless-4.11.0.86-cp37-abi3-macosx_13_0_x86_64.whl (56.7 MB)\n",
      "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m56.7/56.7 MB\u001b[0m \u001b[31m2.7 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m00:01\u001b[0m00:01\u001b[0m\n",
      "\u001b[?25hDownloading python_dotenv-1.0.1-py3-none-any.whl (19 kB)\n",
      "Downloading rich-13.9.4-py3-none-any.whl (242 kB)\n",
      "Downloading safetensors-0.5.2-cp38-abi3-macosx_10_12_x86_64.whl (427 kB)\n",
      "Downloading semchunk-2.2.2-py3-none-any.whl (10 kB)\n",
      "Downloading shellingham-1.5.4-py2.py3-none-any.whl (9.8 kB)\n",
      "Downloading tabulate-0.9.0-py3-none-any.whl (35 kB)\n",
      "Downloading transformers-4.42.4-py3-none-any.whl (9.3 MB)\n",
      "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m9.3/9.3 MB\u001b[0m \u001b[31m3.1 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m00:01\u001b[0m00:01\u001b[0m\n",
      "\u001b[?25hDownloading XlsxWriter-3.2.2-py3-none-any.whl (165 kB)\n",
      "Downloading ninja-1.11.1.3-py3-none-macosx_10_9_universal2.whl (279 kB)\n",
      "Downloading pyclipper-1.3.0.post6-cp39-cp39-macosx_10_9_x86_64.whl (143 kB)\n",
      "Downloading python_bidi-0.6.3-cp39-cp39-macosx_10_12_x86_64.whl (257 kB)\n",
      "Downloading imageio-2.37.0-py3-none-any.whl (315 kB)\n",
      "Downloading markdown_it_py-3.0.0-py3-none-any.whl (87 kB)\n",
      "Downloading tokenizers-0.19.1-cp39-cp39-macosx_10_12_x86_64.whl (2.5 MB)\n",
      "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m2.5/2.5 MB\u001b[0m \u001b[31m3.4 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0ma \u001b[36m0:00:01\u001b[0m\n",
      "\u001b[?25hDownloading mdurl-0.1.2-py3-none-any.whl (10.0 kB)\n",
      "Downloading mpire-2.10.2-py3-none-any.whl (272 kB)\n",
      "Downloading multiprocess-0.70.17-py39-none-any.whl (133 kB)\n",
      "Downloading dill-0.3.9-py3-none-any.whl (119 kB)\n",
      "Installing collected packages: python-bidi, pyclipper, filetype, XlsxWriter, tabulate, shellingham, safetensors, rtree, requests, python-dotenv, python-docx, pypdfium2, pydantic-core, pillow, openpyxl, opencv-python-headless, ninja, mpire, mdurl, marko, jsonref, jsonlines, dill, deepsearch-glm, python-pptx, pydantic, pandas, multiprocess, markdown-it-py, imageio, huggingface_hub, tokenizers, rich, pydantic-settings, typer, transformers, semchunk, easyocr, docling-ibm-models, docling-core, docling-parse, docling\n",
      "  Attempting uninstall: tabulate\n",
      "    Found existing installation: tabulate 0.8.10\n",
      "    Uninstalling tabulate-0.8.10:\n",
      "      Successfully uninstalled tabulate-0.8.10\n",
      "  Attempting uninstall: requests\n",
      "    Found existing installation: requests 2.31.0\n",
      "    Uninstalling requests-2.31.0:\n",
      "      Successfully uninstalled requests-2.31.0\n",
      "  Attempting uninstall: python-docx\n",
      "    Found existing installation: python-docx 1.1.0\n",
      "    Uninstalling python-docx-1.1.0:\n",
      "      Successfully uninstalled python-docx-1.1.0\n",
      "  Attempting uninstall: pydantic-core\n",
      "    Found existing installation: pydantic_core 2.27.1\n",
      "    Uninstalling pydantic_core-2.27.1:\n",
      "      Successfully uninstalled pydantic_core-2.27.1\n",
      "  Attempting uninstall: pillow\n",
      "    Found existing installation: Pillow 10.0.1\n",
      "    Uninstalling Pillow-10.0.1:\n",
      "      Successfully uninstalled Pillow-10.0.1\n",
      "  Attempting uninstall: openpyxl\n",
      "    Found existing installation: openpyxl 3.1.2\n",
      "    Uninstalling openpyxl-3.1.2:\n",
      "      Successfully uninstalled openpyxl-3.1.2\n",
      "  Attempting uninstall: pydantic\n",
      "    Found existing installation: pydantic 1.10.19\n",
      "    Uninstalling pydantic-1.10.19:\n",
      "      Successfully uninstalled pydantic-1.10.19\n",
      "  Attempting uninstall: pandas\n",
      "    Found existing installation: pandas 1.5.3\n",
      "    Uninstalling pandas-1.5.3:\n",
      "      Successfully uninstalled pandas-1.5.3\n",
      "  Attempting uninstall: imageio\n",
      "    Found existing installation: imageio 2.31.6\n",
      "    Uninstalling imageio-2.31.6:\n",
      "      Successfully uninstalled imageio-2.31.6\n",
      "\u001b[31mERROR: pip's dependency resolver does not currently take into account all the packages that are installed. This behaviour is the source of the following dependency conflicts.\n",
      "pandasdmx 1.10.0 requires pydantic<2.0,>=1.9.2, but you have pydantic 2.10.6 which is incompatible.\n",
      "vega 4.0.0 requires pandas<2.0.0,>=1.5.0, but you have pandas 2.2.3 which is incompatible.\n",
      "wbdata 1.0.0 requires tabulate<0.9.0,>=0.8.5, but you have tabulate 0.9.0 which is incompatible.\u001b[0m\u001b[31m\n",
      "\u001b[0mSuccessfully installed XlsxWriter-3.2.2 deepsearch-glm-1.0.0 dill-0.3.9 docling-2.17.0 docling-core-2.16.1 docling-ibm-models-3.3.0 docling-parse-3.1.2 easyocr-1.7.2 filetype-1.2.0 huggingface_hub-0.28.0 imageio-2.37.0 jsonlines-3.1.0 jsonref-1.1.0 markdown-it-py-3.0.0 marko-2.1.2 mdurl-0.1.2 mpire-2.10.2 multiprocess-0.70.17 ninja-1.11.1.3 opencv-python-headless-4.11.0.86 openpyxl-3.1.5 pandas-2.2.3 pillow-10.4.0 pyclipper-1.3.0.post6 pydantic-2.10.6 pydantic-core-2.27.2 pydantic-settings-2.7.1 pypdfium2-4.30.1 python-bidi-0.6.3 python-docx-1.1.2 python-dotenv-1.0.1 python-pptx-1.0.2 requests-2.32.3 rich-13.9.4 rtree-1.3.0 safetensors-0.5.2 semchunk-2.2.2 shellingham-1.5.4 tabulate-0.9.0 tokenizers-0.19.1 transformers-4.42.4 typer-0.12.5\n",
      "Note: you may need to restart the kernel to use updated packages.\n"
     ]
    }
   ],
   "source": [
    "pip install docling"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [],
   "source": [
    "from docling.document_converter import DocumentConverter\n",
    "converter = DocumentConverter()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Downloading detection model, please wait. This may take several minutes depending upon your network connection.\n",
      "Downloading recognition model, please wait. This may take several minutes depending upon your network connection.\n"
     ]
    }
   ],
   "source": [
    "source = \"ethiopia_nap.pdf\"\n",
    "\n",
    "result = converter.convert(source)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "## for ETHIOPIA\n",
      "\n",
      "Second Edition; 2015 to 2020 Addis Ababa October 2015\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "Ethiopian Food, Medicine and Healthcare Administration and Control Authority\n",
      "\n",
      "## STRATEGY for the PREVENTION and CONTAINMENT of ANTIMICROBIAL RESISTANCE for ETHIOPIA\n",
      "\n",
      "Second Edition, 2015 to 2020 Addis Ababa\n",
      "\n",
      "October 2015\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "Ethiopian Food, Medicine and Healthcare Administration and Control Authority\n",
      "\n",
      "## CONTENTS\n",
      "\n",
      "Acknowledgments ....................................................................................................................................... iii\n",
      "\n",
      "| Foreword ......................................................................................................................................................iv                                                                                                                                                                                |\n",
      "|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|\n",
      "| Abbreviations and Acronyms ........................................................................................................................ v                                                                                                                                                                                            |\n",
      "| Vision and Scope ........................................................................................................................................... 2                                                                                                                                                                                   |\n",
      "| Introduction ................................................................................................................................................... 3                                                                                                                                                                               |\n",
      "| Background .............................................................................................................................................. 3                                                                                                                                                                                      |\n",
      "| Situational Analysis of Antimicrobials Use and Resistance in Ethiopia ................................................. 4                                                                                                                                                                                                                        |\n",
      "| Rationale for Revision of the Strategy ..................................................................................................... 6                                                                                                                                                                                                   |\n",
      "| Guiding Principles ......................................................................................................................................... 7                                                                                                                                                                                   |\n",
      "| Goal and Strategic Objectives ....................................................................................................................... 8                                                                                                                                                                                          |\n",
      "| Strategic Objective One ................................................................................................................................. 9                                                                                                                                                                                      |\n",
      "| Raise awareness and understanding and improve education on antimicrobial use, resistance prevention,  and containment through effective communication, education, and training. ......................................... 9                                                                                                                      |\n",
      "| Priority  Actions ...................................................................................................................................... 10                                                                                                                                                                                      |\n",
      "| Strategic Objective Two .............................................................................................................................. 12                                                                                                                                                                                        |\n",
      "| Priority  Actions ...................................................................................................................................... 12                                                                                                                                                                                      |\n",
      "| Strategic Objective Three ............................................................................................................................ 15                                                                                                                                                                                        |\n",
      "| Improve infection prevention and contain the spread of resistant microorganisms across                                                                                                                                                                                                                                                           |\n",
      "| human and animal communities and health care settings through individual and   environmental sanitation, hygiene, and infection prevention measures. ................................................ 15                                                                                                                                         |\n",
      "| Strategic Objective Four .............................................................................................................................. 17                                                                                                                                                                                       |\n",
      "| Optimize the use of antimicrobials in human and animal health through effective stewardship   practices. ................................................................................................................................................ 17                                                                                     |\n",
      "| Priority  Actions ...................................................................................................................................... 18                                                                                                                                                                                      |\n",
      "| Strategic Objective Five .............................................................................................................................. 21                                                                                                                                                                                       |\n",
      "| Strengthen and establish national alliances and partnerships, management and governance arrangements,  and resource mobilizations for the prevention and containment of AMR at   all levels. ................................................................................................................................................ 21 |\n",
      "| Priority  Actions ...................................................................................................................................... 21                                                                                                                                                                                      |\n",
      "| Implementation, Monitoring, and Evaluation .............................................................................................. 23                                                                                                                                                                                                     |\n",
      "| Measures  of  Success .................................................................................................................................... 24                                                                                                                                                                                    |\n",
      "| Bibliography ................................................................................................................................................ 25                                                                                                                                                                                 |\n",
      "| Annex 1: National Advisory Committee for Antimicrobial Resistance Prevention and   Containment ................................................................................................................................................ 27                                                                                               |\n",
      "| Annex 2: Participants of the Workshop to Revise the Strategy for the Prevention and Containment of AMR  in Ethiopia ................................................................................................................................................... 28                                                                       |\n",
      "\n",
      "## ACKNOWLEDGMENTS\n",
      "\n",
      "The Food, Medicines, and Healthcare Administration and Control Authority (FMHACA) of Ethiopian appreciates the efforts of the Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program, funded by the US Agency for International Development under the terms of cooperative agreement number AID-OAA-A-11-00021, in the prevention and containment of antimicrobial resistance in general and in the revision and printing of this strategy in particular.\n",
      "\n",
      "FMHACA gratefully acknowledges Tenaw Andualem for his continued commitment to AMR containment and the drafting and finalizing for printing of this revised strategy. We would like to thank Teshita Shute and Asnakech Alemu for reviewing the draft and compiling the views from workshop participants.\n",
      "\n",
      "We would like to acknowledge the AMR Advisory Committee members (annex 1) and reviewworkshop participants (annex 2) for their time and feedback on the draft strategy. Heran Gerba, Hailu Tadeg, Edmealem Ejigu, Mark Moris, Mohan Joshi, Stephanie Berrada, and Shiou-Chu Wang have been supportive in facilitating, reviewing, editing, and formatting the revised strategy.\n",
      "\n",
      "Thank you all!\n",
      "\n",
      "## FOREWORD\n",
      "\n",
      "Antimicrobials are a scarce resource that is used every day to treat infectious diseases in humans and animals. Unfortunately, the actions (and inactions!) by human beings have resulted in antimicrobial resistance (AMR). AMR has been recognized as a global threat to society in terms of its impact on public health and risk to the economy. Infectious diseases and AMR have been spreading fast from one part of the globe to the other due to travel, globalization, and changes in the environment. AMR is becoming a growing threat to the effective prevention and treatment of a wide range of infectious diseases caused by bacteria, parasites, viruses, and fungi. It is feared that even simple and treatable infections and injuries in humans and animals may kill and the world will return to the pre-antibiotic era. This calls for action and coordination of efforts at the local, national, regional, and global levels and for multi-institutional and multidisciplinary approaches to the prevention and containment of not only infectious diseases but also AMR. Although we cannot eradicate AMR, we can contain it to a manageable level.\n",
      "\n",
      "To understand the national situation, Ethiopia did a situation assessment, launched its first strategy in 2011, and took action to contain AMR, as detailed in the blue boxes found throughout this strategy. This updated version of the strategy was in response to the revised health and medicines policies, health sector transformation plan, and the resolutions of the 68th World Health Assembly of May 2015 and so that Ethiopia's efforts could be coordinated with global initiatives in the prevention and containment of AMR. actions\n",
      "\n",
      "In this strategy, only priority and urgent actions are indicated. Implementation of these priorities requires involvement and commitment of multiple stakeholders across sectors at local and national levels. These priorities must be linked to global efforts since the challenges posed by AMR involve more than one sector and are more than one country can tackle.\n",
      "\n",
      "We would like to acknowledge the institutions and experts who have contributed, not only in bringing this strategy to this level, but also for their continued multifaceted interventions to contain AMR.\n",
      "\n",
      "The Ethiopian Government is confident that this strategy will help respond to the threats of AMR. The Government supports and urges all stakeholders to develop their specific plans of action in their respective institutions and sectors and also coordinates with national efforts to prevent, slow down, and contain AMR, so that our people can enjoy the benefits and contributions of effective antimicrobials in containing infectious diseases.\n",
      "\n",
      "Yehulu Denekew, Director General Ethiopian Food, Medicines, and Healthcare Administration and Control Authority\n",
      "\n",
      "iv\n",
      "\n",
      "## ABBREVIATIONS AND ACRONYMS\n",
      "\n",
      "AMR\n",
      "\n",
      "antimicrobial resistance\n",
      "\n",
      "BCC\n",
      "\n",
      "behavior change communication\n",
      "\n",
      "C&S\n",
      "\n",
      "culture and sensitivity\n",
      "\n",
      "FMHACA\n",
      "\n",
      "Food, Medicines, Healthcare Administration and Control Authority\n",
      "\n",
      "HIV\n",
      "\n",
      "human immunodeficiency virus\n",
      "\n",
      "IPC\n",
      "\n",
      "infection prevention and control\n",
      "\n",
      "MSH\n",
      "\n",
      "Management Sciences for Health\n",
      "\n",
      "NACARC\n",
      "\n",
      "National Advisory Committee on Antimicrobial Resistance Prevention and Containment\n",
      "\n",
      "SIAPS\n",
      "\n",
      "Systems for Improved Access to Pharmaceuticals and Services standard treatment guideline\n",
      "\n",
      "STG\n",
      "\n",
      "TB\n",
      "\n",
      "Tuberculosis\n",
      "\n",
      "USAID\n",
      "\n",
      "United States Agency for International Development\n",
      "\n",
      "WHA\n",
      "\n",
      "World Health Assembly\n",
      "\n",
      "WHO\n",
      "\n",
      "World Health Organization\n",
      "\n",
      "v\n",
      "\n",
      "v\n",
      "\n",
      "## VISION AND SCOPE\n",
      "\n",
      "## Vision\n",
      "\n",
      "The vision is a society where antimicrobials are recognized and managed as a valuable and shared resource, maintaining their efficacy so that infections in humans and animals remain treatable and communities continue to benefit from the advances that antimicrobials enable.\n",
      "\n",
      "## Scope\n",
      "\n",
      "This strategy includes effective antimicrobial resistance (AMR) prevention and containment of the ever-increasing range of infectious threats caused by bacteria, parasites, viruses, and fungi in humans, animals, agriculture, and the environment. The multiple stakeholders across sectors and the whole of society will be coordinated for the prevention and containment of AMR.\n",
      "\n",
      "## INTRODUCTION\n",
      "\n",
      "## Background\n",
      "\n",
      "During the past seven decades, antimicrobial medicines have saved millions of lives, substantially reduced the burden of diseases that were previously widespread, improved the quality of life, and helped increase life expectancy. However, in the recent past, the emergence and spread of AMR in several microorganisms has rendered the management of many infectious diseases difficult. The development of resistance to antimicrobials commonly used to treat malaria, TB, HIV, and others is of particular concern and is an impediment in achieving Millennium and Sustainable Development Goals.\n",
      "\n",
      "- '… Drugs that were once lifesavers are now worthless. Hospitals have become hotbeds for the transmission of highly resistant superbugs, increasing the risk that hospitals kill rather than heal. AMR is not a future threat looming on the horizon. It is here, right now, and the consequences are devastating.' (Dr. Margaret Chan, Director General of WHO, June 25, 2014, at the Ministerial Conference on AMR).\n",
      "- '… more and more first- and second-line antimicrobials failed … post-antibiotic era in which common infections will once again kill...' (Dr. Margaret Chan, Director General of WHO, May 18, 2015, 68th WHA opening speech)\n",
      "\n",
      "AMR is a natural biological phenomenon that can be amplified or accelerated by actions and inactions of human practices and a variety of other factors. The use of an antimicrobial for any infection, real or feared, in any dose and over any time period, forces microbes to either adapt or die in a phenomenon known as 'selective pressure.' The microbes that adapt and survive carry genes for resistance, which can be passed on. When antimicrobials are used incorrectly, such as for tooshort a time, at too-low a dose, or for the wrong disease; the likelihood that bacteria and other microbes will adapt and replicate rather than be killed is greatly enhanced. Much evidence supports the view that the total consumption of antimicrobials is the critical factor in selecting resistance. Paradoxically, underuse through lack of access, inadequate dosing, poor adherence, and substandard antimicrobials may play as important a role as overuse. The emergence of resistance is a result of use, overuse, and misuse in humans, animals, and the environment.\n",
      "\n",
      "In Ethiopia, there are indications of misuse of antimicrobials by health care providers, unskilled practitioners, and animal husbandry and drug users. These, coupled with the rapid spread of resistant microbes and inadequate surveillance, have exacerbated the problem.\n",
      "\n",
      "The prevention and containment of AMR has a common approach and requires integrated and wellcoordinated efforts at the global, national, institutional, and individual levels. AMR is a biological, behavioral, technical, economic, regulatory, and educational problem and requires a comprehensive response strategy developed on the basis of evidence.\n",
      "\n",
      "As AMR is a global and cross-border issue, the World Health Organization (WHO) published its first Global Strategy for Containment of Antimicrobial Resistance in 2001. This key document\n",
      "\n",
      "3\n",
      "\n",
      "provided an operational framework and a comprehensive set of AMR containment-related interventions that reflect AMR's multi-factorial nature. The 68th World Health Assembly (WHA) passed a resolution in May 2015 on the global action plan to contain AMR with five strategic objectives that member states can adapt and use. Some countries have also developed and revised their AMR containment strategies. Accordingly, relevant documents have been reviewed and used in the revision of this national strategy.\n",
      "\n",
      "The five strategic objectives are:\n",
      "\n",
      "-  Raise awareness and understanding and improve education on antimicrobial use, resistance prevention, and containment through effective communication and training.\n",
      "-  Strengthen the knowledge and evidence on antimicrobial use and resistance through onehealth surveillance and research.\n",
      "-  Improve infection prevention and contain the spread of resistant microorganisms across human and animal communities and health care settings through individual and environmental sanitation, hygiene, and infection prevention measures.\n",
      "-  Optimize the use of antimicrobials in human and animal health through effective stewardship practices.\n",
      "-  Strengthen and establish national alliances and partnerships, management and governance arrangements, and resource mobilizations for the prevention and containment of AMR at all levels.\n",
      "\n",
      "## Situational Analysis of Antimicrobials Use and Resistance in Ethiopia\n",
      "\n",
      "The 2009 national AMR baseline situation assessment (DACA 2009) documented the review of 10,000 culture and sensitivity (C&S) tests from across the country over a five-year period; about one-third of the tests contained one or more microorganisms. The assessment also documented that most microorganisms (bacteria) that are commonly involved in causing infections in human beings and animals showed a considerable degree of resistance to commonly used first-line antimicrobials (antibacterials) over the five-year period. Multiple AMR organisms were commonly identified.\n",
      "\n",
      "The AMR baseline survey (DACA 2009) used 10 different tools to look into the curriculum of health professionals; reviewed research; assessed the knowledge, attitudes, and practices of health care providers and clients; and looked into service records. Following identification of gaps, the national strategy for AMR prevention and containment was developed (EFMHACA 2011), followed by a national plan of action that has cascaded to stakeholder institutions and interventions targeted at the identified gaps. This has helped streamline subsequent interventions.\n",
      "\n",
      "4\n",
      "\n",
      "There are diseases that are transmitted from animals to humans and vice versa. Humans acquire infection from animals during husbandry, health service delivery, leather manufacturing, food processing, and vaccine production; laboratories, from zoo keeping; and from consumption of foods of animal origin (milk and meat from cattle, sheep, goats, poultry, pigs, and fish) and eggs. In zoonosis, susceptible and resistant microorganisms are transmitted from animals to man and sometimes from man to animals. Antimicrobials used in both humans and animals are similar and can be overprescribed for therapeutic, prophylactic purposes and as feed additives. The emergence and prevalence of Salmonella and S. aureus with multiple resistances in food animals can seriously compromise public health.\n",
      "\n",
      "Review of the course content at health training institutes (for both humans and animals) has shown that some improvement in education has occurred, including much more emphasis on the local context of antimicrobial use, resistance, and containment; counselling patients on and adherence to treatment with antimicrobials; adherence to treatment guidelines to prevent and contain AMR; and prophylaxis use. However, areas still lacking include rational prescribing and dispensing, standard treatment guidelines (STGs), principles and concepts of choosing antimicrobials and essential medicines (these are covered adequately in medicine and pharmacy classes); theory and practice in microbiology courses (less time is allowed); and key microbial resistance, nosocomial infections, and AMR mechanisms and containment.\n",
      "\n",
      "Average availability of key antimicrobials in health facilities was 73%. Availability of treatment guidelines in health facilities was 61%. Medicines use education was given in only 27% of health facilities, but no education on the proper use of antimicrobials was given to clients in the health facilities.\n",
      "\n",
      "Although the level and training type differs in aggregate, prescribers' knowledge of antimicrobials was, in certain categories, seriously compounded with the often empirical practices used during treatment. They had also reported that certain microorganisms did not respond to first-line antimicrobials.\n",
      "\n",
      "Even if there was some awareness of nosocomial infections, little is done by facilities to prevent and contain it. In addition, the availability and utilization of C&S tests and awareness of the factors contributing to AMR and containment strategies was low, and key infection prevention supplies and materials were not readily available.\n",
      "\n",
      "Clients' knowledge of prescribed antimicrobials, including routes, dosages, frequency of administration, duration of use, and the importance of continuing treatment even if they feel better, were less than the standard. Clients also believe that antimicrobials are used for illnesses like during watery diarrhoea and the common cold. Moreover, it was revealed that self-medication with antimicrobials was common. The sources of information for their self-medication were the pharmacy, leftover antimicrobials at home, and friends and relatives.\n",
      "\n",
      "Antimicrobial prophylaxis was used in the majority of surgical procedures, including clean surgical procedures and in more doses and duration than is recommended. A number of wide spectrum and combination antimicrobials and those with a potential resistance and toxicity problems were also used.\n",
      "\n",
      "5\n",
      "\n",
      "Prescribing antimicrobials to inpatients was widespread. More than two-thirds had 1 or more antimicrobials prescribed with a maximum of 6 (with an average of 1.5). Average duration of stay in a hospital for medical inpatients with antimicrobials prescribed was 7.4 days. Rational prescribing as measured by the extent of adherence to the Ethiopian STG 2004 was strikingly low. For example, the antimicrobials chosen and the duration of therapy for pneumonia conformed with the STG was only 20%, meningitis 33%, typhoid 25%, urinary tract infection about 20%, and relapsing fever 14.8% only.\n",
      "\n",
      "Reviews of outpatient prescription paper records showed that 23.0% of health facilities had not used standard prescription paper, often with incomplete information as regards the date of prescription, diagnosis, and prescriber's details. The outpatient prescriptions contained one or more antimicrobials in 62% of patient encounters.\n",
      "\n",
      "## Rationale for Revision of the Strategy\n",
      "\n",
      "The 2009 AMR baseline survey helped identify gaps and target interventions which were used as input to develop the first National Strategic Framework for the Prevention and Containment of Antimicrobials Resistance (EFMHACA 2011), which has been used for five years. These documents have helped to implement multifaceted interventions to prevent and contain AMR. Some of the results are described in boxes in this strategy.\n",
      "\n",
      "The revised health policy and the 2015-2020 Health Sector Transformation Plan has drawn attention to the prevention and containment of AMR. However, the growing public health and economic threats and the global nature of AMR have necessitated the updating and revision of the 2011 strategic framework. The review process has involved the National Advisory Committee on Antimicrobial Resistance Prevention and Containment (NACARC) members and other multiple stakeholders' institutions. This strategy contained here is formulated to have five inter-related and inter-dependent objectives which will harness efforts in the fight against AMR.\n",
      "\n",
      "Despite the Ethiopian Government's commitment and efforts to prevent and contain AMR, the challenge continues to escalate at the national and global levels, leaving limited choices to prevent and control not only infectious diseases, but also manage some non-communicable and chronic diseases and procedures, such as organ transplants, cancer treatment, rheumatoid arthritis, dialysis, and surgery. AMR also may threaten hard-won health development goals and risk the economy. Success in the prevention and containment of AMR necessitates the involvement of public and private bodies to coordinate their efforts in an integrated manner in human and animal health and the environment.\n",
      "\n",
      "6\n",
      "\n",
      "## GUIDING PRINCIPLES\n",
      "\n",
      "These guiding principles describe the role of all stakeholders to follow a common approach that requires integrated and well-coordinated efforts at the national, institutional, and individual levels and that links with regional and global efforts. The principles, based on the approach of the 68th WHA, are as follows:\n",
      "\n",
      "-  Whole-of-society engagement, including a one-health approach. AMR affects everybody, regardless of where they live, their health, economic circumstances, lifestyle, or behavior. It will affect sectors beyond human health, such as animal health, agriculture, food security, environment, and economic development. Therefore, everybody-in all sectors and disciplines-should strive to preserve the effectiveness of antimicrobial medicines.\n",
      "-  Prevention first. Every infection prevented is one that needs no treatment. Prevention of infection can be cost-effective and implemented in all settings and sectors. This can slow the development and contain the spread of AMR infections.\n",
      "-  Ensure access and improve rational use of antimicrobials and infection prevention supplies.\n",
      "-  Understand the emergence and spread of AMR.\n",
      "-  Invest resources that will provide a return over time. Resources are required for the prevention of infection, surveillance, stewardship, operations and interventions research, and capacity building in the laboratory, human resources and systems, regulatory areas, and education and training.\n",
      "-  Institutionalize ownership. The core principle of stakeholders' and health institutions' ownership is that it empowers them to manage the AMR issue and problems that are specific to their institutions and enable them to take actions to combat AMR.\n",
      "-  Information sharing and networking to establish and strengthen global, national, and regional platforms to facilitate information sharing and networking against AMR.\n",
      "\n",
      "The one-health approach and one-health response are coordinated, collaborative, multidisciplinary, and cross-sectoral actions to develop strategies for human and animal health and the environment, which are inextricably linked. Synergistic efforts of all the sectors involved are required.\n",
      "\n",
      "7\n",
      "\n",
      "## GOAL AND STRATEGIC OBJECTIVES\n",
      "\n",
      "## Goal\n",
      "\n",
      "The goal is to prevent, slow down, and contain the spread of AMR through the continuous availability of safe, effective, and quality-assured antimicrobials and their effective use thereof. This can only be achieved through the collaborative actions among partners in human health, agriculture, the food industry, teaching and research institutes, civil societies and associations, the pharmaceutical industry, and global stakeholders to synergize efforts and resources.\n",
      "\n",
      "## Strategic Objectives\n",
      "\n",
      "## Strategic Objective One\n",
      "\n",
      "Raise awareness and understanding and improve education on antimicrobial use, resistance prevention, and containment through effective communication and training.\n",
      "\n",
      "## Strategic Objective Two\n",
      "\n",
      "Strengthen the knowledge and evidence on antimicrobial use and resistance through one-health surveillance and research.\n",
      "\n",
      "## Strategic Objective Three\n",
      "\n",
      "Improve infection prevention and contain the spread of resistant microorganisms across human and animal communities and health care settings through individual and environmental sanitation, hygiene, and infection prevention measures.\n",
      "\n",
      "## Strategic Objective Four\n",
      "\n",
      "Optimize the use of antimicrobials in human and animal health through effective stewardship practices.\n",
      "\n",
      "## Strategic Objective Five\n",
      "\n",
      "Strengthen and establish national alliances and partnerships, management and governance arrangements, and resource mobilizations for the prevention and containment of AMR at all levels.\n",
      "\n",
      "8\n",
      "\n",
      "## STRATEGIC OBJECTIVE ONE\n",
      "\n",
      "Raise awareness and understanding and improve education on antimicrobial use, resistance prevention, and containment through effective communication, education, and training.\n",
      "\n",
      "Education and empowerment of the whole society on antimicrobial use and resistance containment\n",
      "\n",
      "are needed to alleviate the standard practices (boxes below) observed in the use of antimicrobials. Pre- and in-service education of health professionals and continuing professional development are also focus areas. Mass media education and empowerment of the public and the whole society on antimicrobial use and resistance has been provided. However, there are still gaps in addressing the threats AMR has posed and continued scale-up of interventions needed to prevent and contain it. Education and empowerment still remains a key strategy to prevent and contain AMR.\n",
      "\n",
      "Clients frequently believe that antibiotics will help them recover from all respiratory tract infections faster, although the most common pathogens are viral. And a significant percentage of clients did not finish their prescribed antibiotics or kept them for later use, all practices that encourage AMR. Clients also expect antibiotics for self-limiting infections (DACA 2009). Evidence on the benefits of educating clients about unnecessary antibiotic use is available. There have been efforts to increase awareness of the society on AMR prevention and containment through mass media and education of clients at healthfacility waiting areas.\n",
      "\n",
      "Number of Antimicrobial and Medicine Use Broadcasts by Year\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "9\n",
      "\n",
      "## Priority Actions\n",
      "\n",
      "## Improve Awareness and Understanding, Education, and Empowerment of Clients and the Community\n",
      "\n",
      "-  Promote strong and sustainable whole-of-society engagement, awareness raising, education, and empowerment about antimicrobial use and resistance containment though effective use of the media\n",
      "-  Incorporate hygiene, sanitation, infection prevention, and antimicrobial use and resistance into school curricula to promote better understanding and awareness\n",
      "-  Educate clients and the public to not self-medicate, share, discontinue, or hoard antimicrobials and to not demand them from health care providers for self-limiting illnesses\n",
      "-  Support the media to accurately report relevant information and reinforce key messages about antimicrobial use and resistance\n",
      "-  Support the develop of core communication materials and tools\n",
      "-  Advocate AMR as a national and global priority across all government ministries\n",
      "-  Promote and support the establishment of a one-health coalition to combat AMR\n",
      "-  Increase public engagement to promote key messages about antimicrobial use, with responsibility for appropriate use\n",
      "-  Promote open public discussion in the society and raise awareness about antimicrobials and ways to limit their use for low-risk and self-limiting infections to influence behavior change\n",
      "-  Ensure proper disposal of unfit-for-use antimicrobials to protect the environment\n",
      "\n",
      "## Support Education and Training of Human and Animal Health Care Professionals\n",
      "\n",
      "-  Support the incorporation and revision of course content for undergraduate and postgraduate health professionals (human and animal) to accommodate topics and allocate sufficient time to AMR prevention and containment\n",
      "-  Encourage AMR awareness and education on responsible prescribing, dispensing, and administration practices\n",
      "-  Strengthen effective prevention, management, and control of infection in undergraduate and postgraduate curricula for human medicine, nursing, pharmacy, dentistry, veterinary. and other professionals courses\n",
      "\n",
      "10\n",
      "\n",
      "-  Facilitate the development of sector-specific prescribing guidelines and promote responsibleuse practices, including effective dissemination of guidance\n",
      "-  Support health professionals in reinforcing adherence counseling and key messages and in providing resources for informed decision-making during patient counseling on AMR prevention and containment\n",
      "-  Encourage improved/targeted continuing professional education and development programs for human and animal health care professionals on antimicrobials and AMR\n",
      "-  Ensure that antimicrobial stewardship competencies are included in professional curricula and continuing professional development\n",
      "\n",
      "The AMR baseline survey has shown that there are gaps in training and research of public health importance. Instructors of microbiology, pharmacology, and pharmacotherapy participated during the baseline survey, strategy, and plan of action preparation. They were also involved in the training of trainers programs and encouraged to review the course content and time allocation for AMR containment in their respective courses. Some of the faculties have made significant strides to include content and allocate time to AMR prevention and containment.\n",
      "\n",
      "11\n",
      "\n",
      "## STRATEGIC OBJECTIVE TWO\n",
      "\n",
      "## Strengthen the knowledge and evidence on antimicrobial use and resistance through one-health surveillance and research.\n",
      "\n",
      "Surveillance and research are essential in guiding management of infectious diseases and updating infection control policies and practices, antimicrobial use, medicines lists, and STGs. It is also critical to provide early warning of emerging and reemerging infectious diseases, monitoring changing patterns of resistance, and targeting and evaluating AMR prevention and containment measures. Inadequate surveillance and research means that resistance prevalence and trends are not known and that baseline data for evaluating potential interventions are unavailable.\n",
      "\n",
      "The antimicrobial use, resistance, and containment baseline survey (DACA 2009) showed that empiric treatment with antimicrobials is widely practiced. Therefore, establishing and strengthening microbiology laboratories, encouraging microorganism culture and susceptibility testing, analyzing and periodic reporting, and sharing with health care providers and others are important. Standardizing methods and procedures for surveillance of antimicrobial use and AMR and ensuring data quality should also be given emphasis. Therefore, an effective network that generates and collates data on use, resistance, and use/ consumption of antimicrobial medicines needs to be established or strengthened. There are experiences in the collection, analysis, interpretation, and use of such data in Ethiopia.\n",
      "\n",
      "## Priority Actions\n",
      "\n",
      "## Support Surveillance of AMR Microorganisms\n",
      "\n",
      "-  Establish/strengthen national, regional, and health facilities' surveillance systems to detect and report AMR and disseminate information to facilitate decision making on diagnoses and treatments in public health, veterinary practice, and food laboratories\n",
      "-  Ensure the establishment of networks to develop surveillance linkages, testing methods, and data sharing between human and veterinary sectors at national and regional levels\n",
      "-  Support C&S tests on targeted microorganisms\n",
      "-  Support the quality assurance and standardization of routine antimicrobial testing and interpretation of results to improve diagnoses and treatment of infections\n",
      "-  Support and conduct population-based, real-time surveillance to monitor AMR patterns to demonstrate the extent of the problem in both human and animal health\n",
      "-  Disseminate data to users, national and regional focal points, and stakeholders\n",
      "\n",
      "12\n",
      "\n",
      "-  Encourage health care providers to utilize antimicrobial sensitivity tests and data in humans and animals health\n",
      "-  Extend alerts about new and emerging antibiotic resistance issues to a wide range of professionals\n",
      "-  Use the generated information to monitor trends, as an early warning system, and to determine risk factors and drivers of resistance\n",
      "-  Assess the magnitude of AMR microorganisms and infectious disease burden through networks of laboratories equipped with the capacity to perform quality assured antimicrobial susceptibility testing and estimate the impacts on public health and the economy\n",
      "-  Use the data generated to compare outcomes of interventions\n",
      "\n",
      "## Support Surveillance of Antimicrobial Use\n",
      "\n",
      "-  Support accessibility of the right antimicrobials\n",
      "-  Monitor prescribing, dispensing practices, client/community use, and consumption patterns in health care settings and in the community\n",
      "-  Support the assessment of non-therapeutic use of antimicrobials in veterinary and agriculture settings\n",
      "-  Support the identification of factors that influence prescribing, dispensing, and use by clients\n",
      "-  Strengthen the collection, consolidation, and publication of antimicrobials use to disseminate data and information to users, national and regional focal points, and stakeholders to facilitate decision making\n",
      "-  Support a series of population-based, real-time surveillance systems to monitor antimicrobial use to demonstrate the extent of the problem in both human and animal health\n",
      "-  Support studies on behavioral aspects about self-medication and adherence, and develop interventions to bring about behavior change\n",
      "-  Strengthen the premarket testing and post-marketing quality surveillance of antimicrobials and infection prevention supplies\n",
      "-  Monitor and evaluate the impact of pharmaceutical promotion on antimicrobial use\n",
      "-  Support generation of evidence in the promotion of antimicrobial use and containment of resistance\n",
      "\n",
      "13\n",
      "\n",
      "## Establish or Strengthen Capacity of National, Regional, and Health Facility Laboratories\n",
      "\n",
      "-  Support standardization of laboratory methodologies and quality assurance techniques and improve availability and reliability of microbiology laboratory facilities and tests\n",
      "-  Support and conduct C&S tests on targeted microorganisms and antimicrobials that will help assess the impact of interventions in humans and animals\n",
      "\n",
      "## Support Basic and Operational/Intervention Research\n",
      "\n",
      "Research on AMR provides knowledge necessary to develop appropriate responses for tackling the emergence and spread of AMR. The types of research needed in Ethiopian settings are those that show the extent and trend in resistance, practices causing resistance, and the driving factors, antimicrobial use pattern, and strategies that can be applied to prevent and contain resistance. Initiating and encouraging research in these areas should be considered seriously, and the capacity of research institutes and academia should be boosted. Work is also needed to translate research findings and recommendations into useful practices.\n",
      "\n",
      "-  Identify and prioritize antimicrobial use and resistance research needs\n",
      "-  Encourage research to understand the factors that facilitate development of resistance and transmission pathways between the environment, humans, animals, and the food supply\n",
      "-  Encourage the development of alternative treatments for infections that do not rely on antimicrobials; this has to be complemented with combination therapy and optimal dosing\n",
      "-  Promote research to identify high-risk strains, their resistance mechanisms, and their spread\n",
      "-  Promote the biopharmaceutical incubator consortium to promote innovation for new antimicrobials, vaccines, and therapies development\n",
      "-  Support genomic technologies and sequencing that have the potential to improve appropriate, prompt, early, tailored treatment, benefitting patients and conserving antimicrobials\n",
      "-  Explore the possibility of developing an 'AMR index' to communicate gaps in antimicrobial effectiveness and help aggregate data on resistance to assess trends over time and across locations\n",
      "-  Support research on the economic impact of AMR and its interventions\n",
      "\n",
      "14\n",
      "\n",
      "## STRATEGIC OBJECTIVE THREE\n",
      "\n",
      "Improve infection prevention and contain the spread of resistant microorganisms across human and animal communities and health care settings through individual and environmental sanitation, hygiene, and infection prevention measures.\n",
      "\n",
      "Infection prevention and control (IPC) measures in health facilities and the community reduces the risk of transmission of infections and minimizes the need for and use of antimicrobials. This prevents subsequent emergence of resistant strains. Furthermore, IPC measures contain the spread of resistant microbes once resistance has emerged. These measures include individual and environmental hygiene; promoting vaccination; use of personal protective equipment; maintaining a clean environment; appropriate use of appropriate antiseptics and disinfectants; decontamination, cleansing, and sterilization (or high-level disinfection) of instruments; improving safety in risky areas of the health facilities for humans and animals; safe use and disposal of sharps; appropriate waste disposal; and isolation of patients infected by highly contagious microorganisms, when required. Partners in many sectors of society and the general public will need to be involved in these efforts.\n",
      "\n",
      "Infection prevention and patient safety (IPPS) measures have been emphasized in Ethiopia; training manuals for health care providers and managers have been prepared, training on IPPS given, quantities of infection prevention commodities and supplies required per level of care have been listed, and infection prevention IEC/BCC materials developed and put to use. IPPS has also been given high priority by highlevel government authorities in the follow-up of referral hospitals in Addis Ababa. However, there remains a lot to be done on IPPS.\n",
      "\n",
      "## Priority Actions\n",
      "\n",
      "## Strengthen Infection Prevention and Control Programs\n",
      "\n",
      "-  Expand IPC systems at national, regional, health facility, and community levels both for humans and animals\n",
      "-  Strengthen vaccination programs in human and animal health to prevent infections\n",
      "-  Establish/enhance infection prevention standards\n",
      "-  Develop/revise, disseminate/implement, monitor, and evaluate infection prevention guidelines and codes of professional practice; set minimum accreditation standards (e.g., infrastructure of health facilities) and other relevant resources to promote IPC\n",
      "-  Launch IPC need-based education and training programs to target audiences in human and animal health\n",
      "\n",
      "15\n",
      "\n",
      "-  Limit the emergence and spread of multidrug resistant organisms in humans and animals through multi-sectoral and international collaboration\n",
      "-  Encourage dissemination, implementation, and monitoring of best practices\n",
      "-  Support better use of data and diagnostics\n",
      "-  Ensure the availability and adopt the use of evidence-based IPC practices and tools in human and animal health care settings\n",
      "-  Support initiatives and mobilize adequate human and material resources and supplies for IPC\n",
      "\n",
      "## Strengthen Infection Prevention and Control Practices in Health Facilities\n",
      "\n",
      "-  Establish IPC practices and create an enabling environment\n",
      "-  Develop and avail IPC guidelines to develop relevant standard operating procedures and monitor their implementation\n",
      "-  Standardize and promote the proper use of antiseptics and disinfectants\n",
      "-  Ensure availability and proper use of infection prevention materials and supplies\n",
      "-  Establish/strengthen a functional Infection Prevention and Control Committee in each health facility\n",
      "-  Conduct regular pre-service and in-service trainings on IPC\n",
      "-  Monitor and evaluate all IPC practices in health facilities\n",
      "-  Expand availability and use of diagnostics to improve treatment of AMR infections, enhance infection control, and facilitate outbreak detection and response in health care and community settings\n",
      "-  Encourage timely diagnosis and treatment of drug-resistant microorganisms\n",
      "\n",
      "## Promote Infection Prevention and Control Practices in Communities\n",
      "\n",
      "-  Develop tools for information, education, and communication/behavior change communication (IEC/BCC) on IPC in communities, including schools and public gathering areas\n",
      "-  Conduct need-based health education on IPC and AMR\n",
      "-  Implement, monitor, and evaluate sustainable infection prevention, health/antimicrobial use education\n",
      "-  Promote hygiene, sanitation, and infection prevention\n",
      "\n",
      "16\n",
      "\n",
      "## STRATEGIC OBJECTIVE FOUR\n",
      "\n",
      "## Optimize the use of antimicrobials in human and animal health through effective stewardship practices.\n",
      "\n",
      "When microbes are exposed to antimicrobials, susceptible organisms are eradicated while resistant ones persist, passing on their resistant genes to off-spring by replication or to other species through horizontal gene transfer. There is sufficient evidence that the higher the use of antimicrobials, the greater is the resistance to them and vice versa. Countries, regions, or health care facilities with higher antimicrobial use are associated with higher incidence of resistance. Poor infection prevention and control practices; inadequate training and capacity to diagnose and manage infectious diseases; overuse and misuse of antimicrobials; poor prescribing and dispensing practices; demand by uninformed patients and lack of adherence to treatments; substandard medicines and not up-to-date and biased medicine information; poor access to antimicrobials, leading to inadequate dosage regimens; and insufficient duration of therapy are important contributors to AMR. Therefore, judicious use of antimicrobials in human and veterinary settings is an important strategy to reduce the emergence of resistance. Achieving this strategy involves strengthening technical and regulatory requirements and bringing about a change in the behavior of prescribers, dispensers, and clients. Policies and regulations that encourage more appropriate and rational use of antimicrobials are key long-term interventions for the containment of AMR.\n",
      "\n",
      "There are indications for the existence of highlevel antimicrobial use (Andualem 1995, MOH 2003, FMHACA 2006, DACA 2009, FMHACA 2010. To overcome these practices, there have been many initiatives, such as the establishment of functioning infection prevention, drug and therapeutic, and antimicrobials stewardship committees in health facilities. These multidisciplinary teams are involved in the review of infection prevention practices, medicines use reviews and evaluations, and providing feedback to their respective staffs for improved health outcomes. Exemplary health facilities are engaged in such practices, but they must be scaled up at other facilities. To facilitate these practices, STGs, formularies, and medicine prescribing and dispensing manuals have been put into use.\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "17\n",
      "\n",
      "## Priority Actions\n",
      "\n",
      "## Promote Optimal Prescribing and Dispensing of Antimicrobials\n",
      "\n",
      "-  Ensure accessibility of essential antimicrobials at all health facilities\n",
      "-  Ensure the availability and monitor the use of and adherence to evidence-based guidelines and job aids, such as STGs, antimicrobial use policies, lists of essential or formulary medicines, good prescribing and dispensing manuals, and standard prescription forms\n",
      "-  Ensure and support the availability of evidence-based best approaches for responsible prescribing, dispensing, and administering principles for antimicrobials\n",
      "-  Strengthen or establish microbiologic diagnostic facilities and conduct regular antimicrobial sensitivity tests\n",
      "-  Promote proper prescribing and dispensing practices and minimize empiric treatment of infectious diseases\n",
      "-  Develop and disseminate guidelines for proper prophylactic use of antimicrobials\n",
      "-  Design and utilize locally feasible labeling, dispensing, and adherence aids\n",
      "-  Promote sustainable communication among prescribers, dispensers, and other health care providers\n",
      "-  Establish or strengthen proper functioning of drug and therapeutics and/or antimicrobial stewardship committees\n",
      "-  Support the development of antimicrobial stewardship working manuals and procedures\n",
      "-  Provide up-to-date and unbiased medicine information services to health providers, clients, and the community\n",
      "-  Assure that information provided by pharmaceutical companies is based on evidence and is in line with the policy and guidelines of the country\n",
      "-  Organize and conduct regular, need-based, pre-service and in-service continuing education and training to prescribers, dispensers, and other health care providers\n",
      "-  Work collaboratively to strengthen the available evidence base to benchmark current levels of resistance and antimicrobial consumption and develop or improve early warning systems\n",
      "\n",
      "18\n",
      "\n",
      "## Promote Adherence to Treatment and Proper Use by Clients and the Public\n",
      "\n",
      "-  Support empowerment of the public and organizations on appropriate use of antimicrobials, as they are shared resources\n",
      "-  Support and provide simple, targeted information to clients and the public\n",
      "-  Support the design and the implementation of antimicrobial use and resistance containment education programs to clients and the public\n",
      "-  Empower clients to provide information to and get information from health care providers about their health, diseases they have had, and their antimicrobial use (prescribed and self-medicated) history\n",
      "-  Encourage and support antimicrobial use adherence by clients and the public\n",
      "-  Regulate over-the-counter availability of and self-medication with antimicrobial medicines\n",
      "\n",
      "Clients and the public's empowerment and knowledge about health and disease in general and of the medicines they are using in particular are of vital importance, not only in the prevention of medicinerelated problems and AMR, but are also major factors that influence treatment adherence and good health outcomes. Patients who were provided the right information and counseling knew more about their medicines and how to use them. Evaluation of patients' knowledge may be used to educate the clients themselves and providers about problem areas to influence behavior change.\n",
      "\n",
      "## Rational Antimicrobial Use in Animal Health and Food Production\n",
      "\n",
      "-  Ensure access to essential antimicrobials for therapeutic use and vaccines to prevent diseases and minimize the use of antimicrobials\n",
      "-  Work closely with industries involved in animal husbandry and restrict non-therapeutic use of antimicrobials\n",
      "-  Eliminate the use of human health care antimicrobials as growth promoters and feed additives in animals\n",
      "-  Strengthen regulations for the food industry, including reviewing standards for animal products and setting clear specifications\n",
      "-  Ensure the availability and monitoring the use of and adherence to evidence-based guidelines and job aids, such as STGs, antimicrobial use policies, lists of veterinary medicines, and standard prescription forms\n",
      "\n",
      "19\n",
      "\n",
      "-  Ensure and support the availability of evidence-based approaches to adherence for responsible prescribing, dispensing, and administration principles\n",
      "-  Conduct regular pre-service and in-service trainings for practitioners in animal health and production on the proper use of antimicrobials, resistance prevention, and containment\n",
      "-  Prevent over-the-counter availability of and discourage self-medication with antimicrobials\n",
      "-  Conduct regular antimicrobial C&S tests for prescribing and dispensing decisions\n",
      "-  Empower those involved in animal husbandry to get information about antimicrobials from veterinary professionals\n",
      "-  Foster antimicrobial stewardship programs in animal health care settings\n",
      "-  Support collaborative work to strengthen the available evidence base, benchmark current levels of resistance and antimicrobial consumption, and improve early warning systems\n",
      "-  Encourage exploration of options for the collection and analysis of veterinary medicine prescription and use data, including local audit information\n",
      "-  Explore the possibility of developing an 'AMR index' to communicate gaps in antibiotic effectiveness and help aggregate data on resistance to assess trends over time and across locations.\n",
      "-  Initiate the inclusion of AMR prevention and containment in the respective plans of stakeholders\n",
      "\n",
      "Evidence from the field and published reports indicates the irrational use of antimicrobials in livestock production, either for treatment or prevention of animal diseases. Also, published and unpublished reports indicate that microorganisms isolated from animals are resistant to common antimicrobials in use. The Ethiopian Veterinary Drugs and Feed Additives Control Authority has tried to provide information, guidelines, and training on rational use of antimicrobials in agricultural practices and livestock production, including product quality and proper use, hoping to strengthen partnerships in AMR prevention and\n",
      "\n",
      "t\n",
      "\n",
      "i\n",
      "\n",
      "t\n",
      "\n",
      "20\n",
      "\n",
      "## STRATEGIC OBJECTIVE FIVE\n",
      "\n",
      "Strengthen and establish national alliances and partnerships, management and governance arrangements, and resource mobilizations for the prevention and containment of AMR at all levels.\n",
      "\n",
      "AMR is a global threat, with limited tools to deal with it. The increasing movements of people, animals, food and other products, and medical tourism have facilitated transmission of resistant microorganisms. Local action alone will not be sufficient to bring about desired change. Concerted and coordinated national and international efforts are needed to bring together various stakeholders to influence opinion, obtain support, mobilize action, harness expertise and resources available in different sectors, and improve governance. These efforts have to be complemented with international partnerships and collaborations. Resistant strains in one part of the globe have to be rapidly detected, diagnosed, and contained. All sectors must collaborate on innovations; enhance stewardship practices; address the threats of AMR, and move the issue of AMR to the political level.\n",
      "\n",
      "## Priority Actions\n",
      "\n",
      "## Strengthen or Establish a National Alliance for the Prevention and Containment of AMR\n",
      "\n",
      "-  Establish a team or focal points at different levels of the health care system for coordinating national activities and sharing information with all stakeholders\n",
      "-  Establish or strengthen a multi-institution and multidisciplinary advisory committee at different levels to advise, advocate, and educate on national efforts and to take assignments in their own institutions\n",
      "-  Promote public and private partnerships\n",
      "-  Develop networks and platforms for regular and formal interactions to facilitate experience and information exchange\n",
      "\n",
      "A multidisciplinary and multi-institution NACARC was established to advise, guide, and harness the fight against the challenges of AMR in Ethiopia. The advisory committee has also participated in reviewing the baseline survey and the AMR containment strategy, co-organized symposiums and workshops, and advocated and catalyzed AMR containment in their respective institutions.\n",
      "\n",
      "21\n",
      "\n",
      "## Resource Mobilization\n",
      "\n",
      "-  Mobilize or secure adequate resources to implement the strategy for the prevention and containment of AMR in all respective sectors and institutions\n",
      "\n",
      "## Strengthen National and International Networks and Collaborations\n",
      "\n",
      "-  Support and coordinate national and international activities related to AMR\n",
      "-  Strengthen the capacity to implement effective AMR containment and prevention strategies\n",
      "-  Develop linkages with all stakeholders\n",
      "-  Promote regular and formal interactions\n",
      "-  Encourage development partners in capacity building\n",
      "-  Collaborate with mass media to create awareness and empower the public\n",
      "-  Collaborate with professional associations to enhance information sharing and incorporate AMR as an important element of continuing education\n",
      "\n",
      "## Governance and Partnerships\n",
      "\n",
      "-  Develop a mechanism for international communication of critical events that may signify new resistance trends with global public and animal health implications\n",
      "-  Collaborate in the development and consistent use of international standards for determining resistance, identify evidence-based interventions, adapt these strategies to new settings, and evaluate their effectiveness in the prevention and containment of AMR\n",
      "-  Partner with other nations to promote quality, safety, and efficacy of antimicrobials and strengthen country pharmaceutical supply chains\n",
      "-  Form sustainable coalitions, management, and governance arrangements at all levels to bring together different sectors and stakeholders and own the implementation of this strategy\n",
      "-  Strengthen international collaborations to improve knowledge and understanding and gather information on drivers of AMR\n",
      "-  Strengthen conservation and stewardship of existing antimicrobials\n",
      "-  Encourage and facilitate development of new antimicrobials, vaccines, diagnostics, and novel therapies\n",
      "-  Demonstrate leadership in building political support for action\n",
      "-  Coordinate regulatory approaches by collaborating with regional and international organizations, such as Africa Union and WHO, to harmonize international data submission and risk assessment and guidelines related to the licensure and/or approval of antimicrobial products, including vaccines and diagnostics\n",
      "\n",
      "\n",
      "\n",
      "22\n",
      "\n",
      "## IMPLEMENTATION, MONITORING, AND EVALUATION\n",
      "\n",
      "This second Strategy for the Prevention and Containment of Antimicrobials Resistance in Ethiopia provides direction to guide actions and coordinate efforts across stakeholders. It will be implemented in accordance with the forthcoming and revised detailed plan of action and milestones for achieving the strategy's goals and objectives, along with metrics for measuring progress. An implementation action plan that provides details of activities, responsibilities of stakeholders, time frames, and budgets will follow and will be printed as a separate document. This strategy recognizes the need for a wide range of activities and a wide variety of players to support the prevention and containment of AMR. The strategy also recognizes the need for action by many organizations and individuals. The implementation may address the following issues:\n",
      "\n",
      "-  Obtaining national commitments to prevent and contain AMR\n",
      "-  Establishing a focal point in Ethiopia with the responsibility for coordinating the national alliance for implementation of evidence-based decisions of AMR and IPC programs and activities\n",
      "-  Strengthening the NACARC\n",
      "-  Strengthening antimicrobial stewardship programs\n",
      "-  Developing public IEC/BCC empowerment campaigns or activities and programs\n",
      "-  Establishing a national surveillance with mandatory reporting through efficient and quality laboratory networks and existing surveillance systems\n",
      "-  Developing and making available various national standards and guidelines for surveillance and strengthening regulatory support for their implementation\n",
      "-  Organizing continuing education that includes AMR containment and IPC courses for professionals and all health care workers through health-related institutions and professional bodies\n",
      "-  Collating research findings to develop actions\n",
      "-  Collaborating with international agencies for coordinated technical support and sharing current information and resources\n",
      "-  Identifying or consolidating AMR containment indicators\n",
      "-  Pool required data and information in one place to support policy making\n",
      "-  Using the surveillance system to feed into the monitoring and evaluation system and determining what resources are required to support it\n",
      "-  Reviewing, assessing, and modifying action plans with stakeholders on a regular basis\n",
      "-  Establishing a strong monitoring and evaluation mechanism\n",
      "-  Reviewing data generated on a regular basis to assess the performance and effects of interventions\n",
      "-  Assessing performance at different levels and organizing a review meeting for this purpose as one monitoring mechanism\n",
      "\n",
      "23\n",
      "\n",
      "## MEASURES OF SUCCESS\n",
      "\n",
      "Given the complexity of the AMR threat and the response, it is essential that every stakeholder is clear about its contribution in combating AMR, both within its own mandate as well as others that have a bearing on activities of other sectors. Ownership of the strategy by all stakeholders is critical to move forward and yield the desired results. This strategic document is important in presenting what needs to be done in Ethiopia to prevent the emergence, re-emergence, and contain the spread of AMR and how Ethiopia fits into regional and global efforts to combat resistance.\n",
      "\n",
      "The strategy considers the following are some of the measures as potential indicators of success:\n",
      "\n",
      "-  Political commitment and strong leadership, governance, and stewardship to support implementation of this strategy\n",
      "-  Strengthened and full commitment of the multi-institutional and multidisciplinary NACARC\n",
      "-  Establishment of a functional taskforce on the one-health approach\n",
      "-  Stakeholders that have developed, revised, and implemented their action plans and contributed to the overall implementation of the strategy\n",
      "-  Functional surveillance that collects, reports, interprets, and monitors changes in antimicrobial use and resistance trends in humans, animals, the food industry, and the environment and that is shared with those involved in these areas; this information should be used to compare the outcomes of interventions with the baseline\n",
      "-  Achievement of desired changes in infection prevention and antimicrobial use practices and behaviors\n",
      "-  Collection of antimicrobial use data by specific categories, such as human health, animal health, and the food industry, and the data is used for decision making\n",
      "-  Collection of data on resistant and re-emerging microorganisms of public health importance; data are generated and disseminated and appropriate actions are taken\n",
      "-  Generation of target indicators of progress and data sources for measuring success\n",
      "-  Regular follow-up and report by high-level government bodies\n",
      "-  Evaluation of the outcomes of the interventions for each strategic objective and generation of evidence for success (or lack of success)\n",
      "-  Use successful interventions as a basis for scaling up other interventions\n",
      "\n",
      "\n",
      "\n",
      "24\n",
      "\n",
      "## BIBLIOGRAPHY\n",
      "\n",
      "Andualem T, Kafel Z. Retrospective Drug Use Study Using Prescribing Indicators in 32 Health Facilities, Eth Pharm J. 1995. vol. 13\n",
      "\n",
      "Andualem T. Containing AMR in Ethiopia: What Role do the Media Play? 2015; http://siapsprogram.org/2015/06/11/containing-amr-in-ethiopia-what-part-do-the-media-play/\n",
      "\n",
      "Andualem T. Outcomes of Mass Media Intervention on Containment of Antimicrobials Resistance in Ethiopia. 2015; http://siapsprogram.org/publication/outcomes-of-the-journalists-capacitybuilding-intervention-in-the-prevention-and-containment-of-antimicrobial-resistance-in-ethiopia2012-to-2014/\n",
      "\n",
      "Australian Government, Department of Health, Department of Agriculture. Responding to the Threat of Antimicrobial Resistance: Australia's First National Antimicrobial Resistance Strategy 2015-2019;\n",
      "\n",
      "http://www.health.gov.au/internet/main/publishing.nsf/content/1803C433C71415CACA257C84001 21B1F/$File/amr-strategy-2015-2019.pdf\n",
      "\n",
      "Centers for Disease Control. Antibiotic Resistance Threats in the United States, 2013; www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf\n",
      "\n",
      "Dowell SF, Levitt AM. Protecting the Nation's Health in an Era of Globalization: CDC's Global Infectious Disease Strategy. 2002; http://stacks.cdc.gov/view/cdc/13371\n",
      "\n",
      "Drug Administration and Control Authority (DACA), Strengthening Pharmaceutical Systems. Antimicrobial Use, Resistance, and Containment Baseline Survey Syntheses of Findings. August 2009, Addis Ababa, Ethiopia\n",
      "\n",
      "Food, Medicines, Healthcare Administration and Control Authority (FMHACA). Assessment of the Pharmaceutical Sector in Ethiopia. October, 2006, Addis Ababa, Ethiopia\n",
      "\n",
      "FMHACA. Assessment of the Pharmaceutical Sector in Ethiopia. September 2010, Addis Ababa, Ethiopia\n",
      "\n",
      "FMHACA. National Strategic Framework for the Prevention and Containment of Antimicrobials Resistance. August 2011\n",
      "\n",
      "Government of Canada. Antimicrobial Resistance and Use in Canada: A Federal Framework for Action. October 2014; http://healthycanadians.gc.ca/alt/pdf/drugs-products-medicamentsproduits/buying-using-achat-utilisation/antibiotic-resistance-antibiotique/antimicrobial-frameworkcadre-antimicrobiens-eng.pdf\n",
      "\n",
      "Ministry of Health (MOH). Assessment of the Pharmaceutical Sector in Ethiopia. October 2003, Addis Ababa, Ethiopia\n",
      "\n",
      "25\n",
      "\n",
      "Review on Antimicrobial Resistance (United Kingdom). Antimicrobial Resistance: Tackling a Crisis for the Health and Wealth of Nations, 2014; http://amrreview.org/sites/default/files/AMR%20Review%20Paper%20%20Tackling%20a%20crisis%20for%20the%20health%20and%20wealth%20of%20nations\\_1.pdf\n",
      "\n",
      "United Kingdom. UK Five-Year Antimicrobial Resistance Strategy: 2013-2018. https://www.gov.uk/government/uploads/system/uploads/attachment\\_data/file/244058/20130902\\_U K\\_5\\_year\\_AMR\\_strategy.pdf\n",
      "\n",
      "The White House. National Strategy for Combating Antibiotic Resistant Bacteria. September 2014; https://www.whitehouse.gov/sites/default/files/docs/carb\\_national\\_strategy.pdf\n",
      "\n",
      "World Economic Forum. Global Risks 2013, Eight Edition; www3.weforum.org/docs/WEF\\_GlobalRisks\\_Report\\_2013.pdf\n",
      "\n",
      "World Health Organization (WHO). Antimicrobial Resistance: Global Report on Surveillance. 2014; www.who.int/drugresistance/documents/AMR\\_report\\_Web\\_slide\\_set.pdf\n",
      "\n",
      "WHO. Global Action Plan on Antimicrobial Resistance. 2015;\n",
      "\n",
      "www.who.int/drugresistance/AMR\\_DRAFT\\_GAP\\_1\\_Oct\\_2014\\_for\\_MS\n",
      "\n",
      "WHO. Global Strategy for Containment of Antimicrobial Resistance; 2001; www.who.int/drugresistance/WHO\\_Global\\_Strategy\\_English.pdf\n",
      "\n",
      "WHO. Regional Strategy on Prevention and Containment of Antimicrobial Resistance, 2010-2015. WHO Regional Office for South-East Asia, 2010; www.searo.who.int/entity/antimicrobial\\_resistance/BCT\\_hlm-407.pdf\n",
      "\n",
      "WHO. Worldwide Country Situation Analysis: Response to Antimicrobial Resistance. April 2015; www.who.int/drugresistance/documents/situationanalysis/en/\n",
      "\n",
      "26\n",
      "\n",
      "## ANNEX 1: NATIONAL ADVISORY COMMITTEE FOR ANTIMICROBIAL RESISTANCE PREVENTION AND CONTAINMENT\n",
      "\n",
      "All served as members of the committee unless otherwise noted.\n",
      "\n",
      "|   # | Institution                                                                 | Name                 |\n",
      "|-----|-----------------------------------------------------------------------------|----------------------|\n",
      "|   1 | Food, Medicines, Healthcare Administration and Control  Authority - Chair   | Heran Gerba          |\n",
      "|   2 | Ethiopian Veterinary Drugs and Feed Additives Control  Authority - Co-chair | Dr. Hassen Kebede    |\n",
      "|   3 | Federal Ministry of Health                                                  | Nigatu Taddese       |\n",
      "|   4 | Federal Ministry of Agriculture                                             | Dr. Elias Walelign   |\n",
      "|   5 | Ethiopian Health and Nutrition Research Institute                           | Surafel Fentaw       |\n",
      "|   6 | National Animal Health Diagnostic and Investigation  Centre                 | Dr. Solomon Gebre    |\n",
      "|   7 | Addis Ababa University - School of Medicine                                 |                      |\n",
      "|   8 | Addis Ababa University - School of Pharmacy                                 | Dr. Teshome Nedie    |\n",
      "|   9 | School of Veterinary Medicine                                               |                      |\n",
      "|  10 | World Health Organization Ethiopia country office                           | Abraham G. Giorgis   |\n",
      "|  11 | US Centers for Disease Control Ethiopia                                     | Dr. Yared Tedla      |\n",
      "|  12 | US Agency for International Development                                     | Dessalegn Tesfaye    |\n",
      "|  13 | Management Sciences for Health                                              | Dr. Negussu Mekonnen |\n",
      "|  14 | Ethiopian Pharmaceuticals Association                                       | Dr. Teferi Gedif     |\n",
      "|  15 | Ethiopian Medical Association                                               |                      |\n",
      "|  16 | Ethiopian Veterinary Association                                            | Dr. Nega Tewolde     |\n",
      "|  17 | Ethiopian Public Health Association                                         | Dr. Aster Tsegaye    |\n",
      "|  18 | Ethiopian Medical/Clinical Laboratory Association                           | Teklil Biza          |\n",
      "|  19 | Representative of the US Government universities in  Ethiopia               |                      |\n",
      "|  20 | Ethiopia Nurses Association                                                 |                      |\n",
      "|  21 | Armour Hansen Research Institute                                            | Dr. Mekonnen Teferi  |\n",
      "|  22 | Food, Medicines, Healthcare Administration and Control  Authority           | Asnakech Alemu       |\n",
      "|  23 | SIAPS - Member and Secretary                                                | Tenaw Andualem       |\n",
      "\n",
      "27\n",
      "\n",
      "## ANNEX 2: PARTICIPANTS OF THE WORKSHOP TO REVISE THE STRATEGY FOR THE PREVENTION AND CONTAINMENT OF AMR IN ETHIOPIA\n",
      "\n",
      "| S. no   | Name of participant                | Occupation/title                 | Organization                                                 |\n",
      "|---------|------------------------------------|----------------------------------|--------------------------------------------------------------|\n",
      "| 1       | Dr Hassen Kebede                   | Pharmacist/veterinarian          | Veterinary Drugs and                                         |\n",
      "| 2       | Dr. Yohannes Tsegaye               | Veterinarian                     | Feed Additives Control  Authority                            |\n",
      "| 3       | Kassu Desta                        | Microbiologist                   | Ethiopian  Medical/Clinical  Laboratory  Association/AAU     |\n",
      "| 4       | Rajiha Abubeker                    | Researcher                       | Ethiopian Public Health  institute                           |\n",
      "| 5       | Dr. Teshome Nedi                   | Pharmacologist                   | Addis Ababa University,  School of Pharmacy  (AAU/SOP)       |\n",
      "| 6       | Dawit Dikaso                       | Policy Advisor                   | FMHACA/UNFPA                                                 |\n",
      "| 7       | Abrehet Ghidey                     | Lawyer                           | FMHACA                                                       |\n",
      "| 8       | Baharu Zewdie                      | Pharmacist                       |                                                              |\n",
      "| 9       | Mahlet Dejene                      |                                  |                                                              |\n",
      "| 10      | Teshita Shute                      |                                  |                                                              |\n",
      "| 11      | Asnakech Alemu   Abraham G/Giorgis |                                  | WHO                                                          |\n",
      "| 12  13  | Amanuel Abebe                      | Medical Laboratory  Technologist | St. Paul Hospital                                            |\n",
      "| 14      | Gebremedhin B/Mariam               | Pharmacist                       | Ethiopian Pharmaceutical  Association                        |\n",
      "| 15      | Derese Tefera                      | HALS                             | Centers for Disease  Control                                 |\n",
      "| 16      | Kefylaw Chirkem                    | Veterinarian                     | Ministry of Agriculture                                      |\n",
      "| 17      | Dr.Mulugeta Tsegaye                | General Practitioner             | Alert Hospital                                               |\n",
      "| 18      | Dr. Solomon Gebre                  | Senior Researcher                | National Animal Health  Diagnostic and  Investigation Centre |\n",
      "| 19      | Dr.Nega Tewolde                    | Vet Epidemiologist               | Ethiopian Veterinary  Association                            |\n",
      "| 20      | Biruk Yeshitela                    | Microbiologist                   | Armour Hansen  Research Institute                            |\n",
      "| 21      | Nigatu Taddese                     | Pharmacist                       | Ministry of Health                                           |\n",
      "| 22      | Heran Gerba                        | Pharmaceutical Analyst           | FMHACA                                                       |\n",
      "| 23      | Edmealem Ejiegu                    | Pharmacist                       | SIAPS                                                        |\n",
      "| 24      | Tenaw Andualem                     | Pharmacologist                   |                                                              |\n",
      "|         |                                    |                                  | SIAPS                                                        |\n",
      "\n",
      "28\n",
      "\n",
      "5. Strengthen and establish national alliances and partnerships, governance arrangements, and resource mobilizations for the prevention and containment of AMR at all levels\n",
      "\n",
      "2. Strengthen the knowledge and evidence on antimicrobial use and resistance through onehealth surveillance and research\n",
      "\n",
      "1. Raise awareness and understanding and improve education on antimicrobial use, resistance prevention, and containment through effective communication and training\n",
      "\n",
      "STRATEGY for the PREVENTION and CONTAINMENT of ANTIMICROBIAL RESISTANCE for ETHIOPIA\n",
      "\n",
      "4. Optimize the use of antimicrobials in human and animal health through effective stewardship practices\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "Ethiopian Food, Medicine and Healthcare Administration and Control Authority\n",
      "\n",
      "3. Improve infection prevention and contain the spread of resistant microorganisms across human and animal communities and health care settings through individual and environmental sanitation, hygiene, and infection prevention measures\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "<!-- image -->\n"
     ]
    }
   ],
   "source": [
    "print(result.document.export_to_markdown())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [],
   "source": [
    "argentina_nap = \"argentina_nap.pdf\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [],
   "source": [
    "result = converter.convert(argentina_nap)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<!-- image -->\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "https://www.boletinoficial.gob.ar/pdf/linkQR/YzB6b2o4Qy9ZRDFycmZ0RFhoUThyQT09\n",
      "\n",
      "## MINISTERIO DE SALUD y MINISTERIO DE AGRICULTURA, GANADER\"A Y PESCA\n",
      "\n",
      "Resolución Conjunta 834/2015 y 391/2015\n",
      "\n",
      "Bs. As., 22/06/2015\n",
      "\n",
      "VISTO el Expediente N° 1-2002-28070/14-6 del registro del MINISTERIO DE SALUD; y\n",
      "\n",
      "CONSIDERANDO:\n",
      "\n",
      "Que los antimicrobianos son medicamentos esenciales para la salud humana y animal, y su aplicación ha permitido salvar millones de vidas.\n",
      "\n",
      "Que su uso masivo ha traído como consecuencia la aparición del fenómeno de la resistencia a los antimicrobianos, uno de los mecanismos que tienen los microorganismos para defenderse en un medio hostil o desfavorable, como lo es la presencia de los antibióticos.\n",
      "\n",
      "Que si bien cualquier tipo de microorganismo puede desarrollar resistencia, el impacto sobre las posibilidades terapØuticas actuales es especialmente grave y preocupante en las bacterias.\n",
      "\n",
      "Que es cada vez mayor la evidencia que demuestra que la resistencia simultÆnea a mœltiples antimicrobianos constituye un factor independiente de mal pronóstico (mayor mortalidad) por fracaso terapØutico, y se asocia a un marcado incremento de los costos sanitarios.\n",
      "\n",
      "Que muchos de los procedimientos mØdicos modernos dependen de la efectividad de los antibióticos, como la quimioterapia para tratar el cÆncer, las cirugías complejas, la diÆlisis renal y el trasplante de órganos; y que a medida que aumenta la resistencia a los antimicrobianos, estos procedimientos se vuelven cada vez mÆs riesgosos.\n",
      "\n",
      "Que en relación al diagnóstico, los mecanismos de resistencia emergentes son tambiØn cada vez mÆs complejos y requieren de nuevos mØtodos para la detección temprana y confirmación de la resistencia antimicrobiana, a fin de poder administrar la terapia adecuada.\n",
      "\n",
      "Que aunque el desarrollo de resistencia ocurre naturalmente con el tiempo, una serie de hechos, tanto en medicina humana como en veterinaria, han acelerado este proceso. En salud humana, el uso indiscriminado de antibióticos en infecciones ambulatorias que no los requieren, o la utilización excesiva de antimicrobianos de amplio espectro en el Æmbito hospitalario, sumado a la automedicación, al incumplimiento de la posología, la inadecuada composición de las presentaciones que elabora la industria farmacØutica, la no aplicación de las restricciones de venta bajo receta archivada en las farmacias, la insuficiente inversión en innovación observada en las œltimas dØcadas para estos productos y las dificultades para el diagnóstico oportuno de las infecciones causadas por microorganismos\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "https://www.boletinoficial.gob.ar/pdf/linkQR/YzB6b2o4Qy9ZRDFycmZ0RFhoUThyQT09\n",
      "\n",
      "resistentes, son las principales causas del crecimiento exponencial de la resistencia antimicrobiana.\n",
      "\n",
      "Que el problema de la resistencia antimicrobiana en salud humana tiene un fuerte correlato con la sanidad animal, ya que las enfermedades transmitidas por alimentos de origen animal son causa importante de morbimortalidad en todo el mundo.\n",
      "\n",
      "Que la distribución de alimentos contaminados y la migración de los animales han contribuido a la diseminación de microorganismos resistentes, encontrÆndose claramente documentada la relación entre animales de consumo y emergencia de la resistencia antimicrobiana en salud humana.\n",
      "\n",
      "Que en el Æmbito de la producción animal se utilizan antimicrobianos tanto para el tratamiento de las infecciones de forma individual o colectiva como en calidad de agentes promotores del crecimiento, los cuales se aæaden al pienso de los animales con el fin de acelerar su crecimiento y con ello el rendimiento de la producción.\n",
      "\n",
      "Que algunos de los antibióticos utilizados en la producción ganadera son de importancia crítica para la salud humana.\n",
      "\n",
      "Que pese a los esfuerzos en la investigación y el desarrollo, la ralentización en el descubrimiento de nuevas familias de antimicrobianos, sumada al mayor conocimiento en los mecanismos y la ecología de la resistencia antimicrobiana, han puesto de relieve la magnitud del problema.\n",
      "\n",
      "Que hoy en día, debemos considerar la sensibilidad a los antibióticos como un recurso limitado y no renovable, de muy lenta recuperación cuando se ha perdido.\n",
      "\n",
      "Que este problema, de origen multifactorial y alcance global, trasciende fronteras y estructuras de gobierno, y requiere acciones inmediatas, integradas y multisectoriales.\n",
      "\n",
      "Que los organismos internacionales dedicados a salud (Organización Mundial de la Salud - OMS y Organización Mundial de Sanidad Animal - OIE) han instado, recientemente, a los países a elaborar planes y a adoptar medidas para enfrentarlo, bajo el concepto de 'Una Salud', con una visión integral de la sanidad animal y la salud pœblica a escala mundial.\n",
      "\n",
      "Que entre los objetivos del MINISTERIO DE SALUD se encuentran los de formular, programar y coordinar las acciones vinculadas al sistema de vigilancia epidemiológica; coordinar las acciones vinculadas a la prevención y control de las enfermedades; entender, a partir de los registros específicos, en los estudios de recursos disponibles, oferta, demanda y necesidad, así como el diagnóstico de situación necesaria para la planificación estratØgica de la prevención y el control en el sector salud y formular, dirigir y coordinar las campaæas nacionales de promoción y protección de la salud.\n",
      "\n",
      "Que entre los objetivos del MINISTERIO DE AGRICULTURA GANADERIA Y PESCA se encuentran los de elaborar y ejecutar planes, programas y políticas de producción, comercialización, tecnología, calidad y sanidad en materia agropecuaria, pesquera, forestal, agroindustrial y agroenergØtica, coordinando y conciliando los intereses del Gobierno Nacional, las provincias y los diferentes subsectores; entender en el diseæo y ejecución de las políticas de desarrollo, promoción, calidad; bioseguridad y sanidad de productos, industrializados o no, para consumo alimentario de origen animal o vegetal, promoviendo los estÆndares de comercialización respectivos e intervenir en todos los acuerdos, convenios y/o actos de\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "https://www.boletinoficial.gob.ar/pdf/linkQR/YzB6b2o4Qy9ZRDFycmZ0RFhoUThyQT09\n",
      "\n",
      "naturaleza similar que se suscriban entre las distintas Æreas integrantes del Ministerio y los Organismos y Autoridades de los distintos poderes del Estado en el Æmbito Nacional, Provincial o Municipal, Entes Regionales e Instituciones intermedias, coordinando la actualización permanente de aquellos que se encontraran en ejecución.\n",
      "\n",
      "Que resulta necesario aprobar una Estrategia Nacional para el Control de la Resistencia Antimicrobiana a fin de garantizar un uso responsable de los mismos, a travØs de un balance entre minimizar su utilización innecesaria sin comprometer la salud de las personas.\n",
      "\n",
      "Que la mencionada Estrategia apunta a retrasar o impedir la emergencia y diseminación de bacterias resistentes a travØs del fortalecimiento de la vigilancia clínica, microbiológica y farmacØutica, la regulación y fiscalización de la comercialización de antimicrobianos, de la promoción del consumo racional y prudente y de la detección precoz y el control de las infecciones en hospitales y en establecimientos agropecuarios.\n",
      "\n",
      "Que serÆ objetivo tambiØn de la citada Estrategia promover la innovación en antimicrobianos, en promotores del crecimiento no antibióticos y en pruebas diagnósticas para la identificación y caracterización de bacterias resistentes.\n",
      "\n",
      "Que se considera oportuno, a fin de coordinar las acciones de esta Estrategia Nacional, la creación en el Æmbito de la SECRETAR\"A DE PROMOCIÓN Y PROGRAMAS SANITARIOS del MINISTERIO DE SALUD, de la Comisión Nacional para el Control de la Resistencia Antimicrobiana.\n",
      "\n",
      "Que la DIRECCIÓN GENERAL DE ASUNTOS JUR\"DICOS del MINISTERIO DE SALUD y la DIRECCIÓN GENERAL DE ASUNTOS JUR\"DICOS del MINISTERIO DE AGRICULTURA, GANADERIA Y PESCA han tomado la intervención de su competencia.\n",
      "\n",
      "Que la presente medida se dicta en ejercicio de las facultades conferidas por la Ley de Ministerios - T.O. 1992, modificada por su similar Ley N° 26.338, y por el Artículo 2° del 'Reglamento de Procedimientos Administrativos, Decreto 1759/72 t.o. 1991'.\n",
      "\n",
      "Por ello,\n",
      "\n",
      "EL MINISTRO DE SALUD Y EL MINISTRO DE AGRICULTURA, GANADERIA Y PESCA RESUELVEN:\n",
      "\n",
      "ARTICULO 1° - ApruØbase la Estrategia Argentina para el Control de la Resistencia Antimicrobiana, de acuerdo a los objetivos detallados en el ANEXO I que forma parte integrante del presente.\n",
      "\n",
      "ARTICULO 2° - CrØase en el Æmbito de la SECRETAR\"A DE PROMOCIÓN Y PROGRAMAS SANITARIOS del MINISTERIO DE SALUD, una Comisión Nacional para el Control de la Resistencia\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "https://www.boletinoficial.gob.ar/pdf/linkQR/YzB6b2o4Qy9ZRDFycmZ0RFhoUThyQT09\n",
      "\n",
      "Antimicrobiana, con la misión de verificar el cumplimiento de la Estrategia aprobada en el artículo 1° de la presente Resolución, la que se conformarÆ y funcionarÆ de acuerdo a lo estipulado por el ANEXO II que forma parte integrante de la presente.\n",
      "\n",
      "ARTICULO 3° - Comuníquese, publíquese, dØse a la Dirección Nacional de Registro Oficial y archívese. - Dr. DANIEL GUSTAVO GOLLAN, Ministro de Salud. - Ing. Agr. CARLOS HORACIO CASAMIQUELA, Ministro de Agricultura, Ganadería y Pesca.\n",
      "\n",
      "## ANEXO N° I\n",
      "\n",
      "ESTRATEGIA ARGENTINA PARA EL CONTROL DE LA RESISTENCIA ANTIMICROBIANA \"NDICE\n",
      "\n",
      "- 1. Introducción\n",
      "- 2. Vigilancia de la resistencia antimicrobiana en salud humana\n",
      "- 3. Vigilancia de la resistencia antimicrobiana en salud animal y producción agroalimentaria\n",
      "- 4. Vigilancia del uso de antimicrobianos\n",
      "- 5. Regulación del uso de antimicrobianos en salud humana\n",
      "- 6. Regulación del uso de antimicrobianos en salud animal y producción agroalimentaria\n",
      "- 7. Uso responsable de antimicrobianos en salud humana\n",
      "- 8. Uso responsable de antimicrobianos en salud animal y producción agroalimentaria\n",
      "- 9. Prevención y control de infecciones asociadas al cuidado de la salud humana\n",
      "- 10. Prevención y control de infecciones en salud animal y producción agroalimentaria Bibliografía de Referencia\n",
      "\n",
      "| SIGLAS    |                                                                        |\n",
      "|-----------|------------------------------------------------------------------------|\n",
      "| ADECI     | Asociación Argentina de Enfermeros en Control de Infecciones           |\n",
      "| AFACIMERA | Asociación de Facultades de Ciencias MØdicas de la Repœblica Argentina |\n",
      "| ANLIS     | Administración Nacional de Laboratorios e Institutos de Salud          |\n",
      "| ANMAT     | Administración Nacional de Medicamentos, Alimentos y Tecnología MØdica |\n",
      "| CLSI      | Clinical Laboratory Standard Institute                                 |\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "https://www.boletinoficial.gob.ar/pdf/linkQR/YzB6b2o4Qy9ZRDFycmZ0RFhoUThyQT09\n",
      "\n",
      "| ENPIHA   | Encuesta Nacional de Prevalencia de Infecciones Hospitalarias de Argentina   |\n",
      "|----------|------------------------------------------------------------------------------|\n",
      "| INE      | Instituto Nacional de Epidemiología                                          |\n",
      "| INEI     | Instituto Nacional de Enfermedades Infecciosas Agudas                        |\n",
      "| INTA     | Instituto Nacional de Tecnología Agropecuaria                                |\n",
      "| LNR      | Laboratorio Nacional de Referencia                                           |\n",
      "| OIE      | Organización Mundial de Sanidad Animal                                       |\n",
      "| OMS      | Organización Mundial de la Salud                                             |\n",
      "| OPS      | Organización Panamericana de la Salud                                        |\n",
      "| RAM      | Resistencia Antimicrobiana                                                   |\n",
      "| SADI     | Sociedad Argentina de Infectología                                           |\n",
      "| SATI     | Sociedad Argentina de Terapia Intensiva                                      |\n",
      "| SENASA   | Servicio Nacional de Sanidad y Calidad Agro- alimentaria                     |\n",
      "| VIHDA    | Vigilancia de Infecciones Hospitalarias de Argentina                         |\n",
      "\n",
      "## 1. INTRODUCCIÓN\n",
      "\n",
      "Los antimicrobianos son medicamentos esenciales para la salud humana y animal. Desde su descubrimiento, y a medida que se fueron incorporando nuevos principios activos, millones de vidas se han salvado gracias a ellos. Sin embargo, su uso masivo ha generado la aparición y el veloz desarrollo del fenómeno de la resistencia antimicrobiana (RAM). La RAM es uno de los mecanismos que tienen los microorganismos para defenderse en un medio desfavorable, como lo es la presencia de los antibióticos. En otras palabras, la RAM es la capacidad de un microorganismo de resistir al efecto de estos medicamentos. Si bien toda clase de microbio puede desarrollar resistencia, el mayor impacto sobre las posibilidades\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "https://www.boletinoficial.gob.ar/pdf/linkQR/YzB6b2o4Qy9ZRDFycmZ0RFhoUThyQT09\n",
      "\n",
      "terapØuticas actuales ocurre especialmente en las bacterias.\n",
      "\n",
      "Aunque el desarrollo de resistencia ocurre naturalmente con el tiempo, el exceso de uso o el uso inadecuado de los antimicrobianos han acelerado notablemente este proceso. En salud humana, el uso indiscriminado de antibióticos en el Æmbito hospitalario o su administración en infecciones ambulatorias que en realidad no los requieren, sumado a la automedicación, al incumplimiento de la posología, la inadecuada composición de las presentaciones que se fabrican, la no aplicación de las restricciones de venta bajo receta archivada en las farmacias, la insuficiente inversión en innovación para estos productos observada en los œltimos aæos, y las dificultades en el diagnóstico oportuno de las infecciones causadas por microorganismos resistentes, son las principales causas del crecimiento exponencial de este fenómeno.\n",
      "\n",
      "Diversos gØrmenes resistentes a mÆs de 3 antimicrobianos (multirresistencia), a la mayoría de ellos (resistencia extrema) o a todos los antimicrobianos existentes (panresistencia) estÆn emergiendo como agentes patógenos relevantes, como es el caso de Staphylococcus aureus, Enterococcus faecium, Acinetobacter, Pseudomonas aeruginosa y Klebsiella pneumoniae. Es cada vez mayor la evidencia que demuestra que la multirresistencia constituye un factor de mal pronóstico (mayor mortalidad) por fracaso terapØutico, y produce un marcado aumento de los costos de atención. AdemÆs, muchos de los procedimientos mØdicos modernos, tales como los tratamientos oncológicos, las cirugías complejas y la diÆlisis renal, dependen de la efectividad de los antibióticos; y a medida que se incrementa la RAM, estos procedimientos se vuelven cada vez mÆs riesgosos.\n",
      "\n",
      "La urgencia del problema aumenta por el reconocimiento de grupos de bacterias (llamados clones exitosos) responsables de la diseminación global de bacterias multirresistentes. El caso mÆs emblemÆtico en el mundo es la emergencia y diseminación exponencial desde 2010 de Klebsiella pneumoniae productora de carbapenemasas tipo KPC, para el que se han agotado las opciones terapØuticas actuales y se debe recurrir a antiguos antibióticos sobre los que no hay evidencia de eficacia clínica y/o estÆn asociados con toxicidad significativa. Muchos de estos clones resistentes han mostrado la capacidad de subsistir y de diseminarse por fuera de las instituciones de salud, extendiØndose a la comunidad general y haciendo difusos los límites de tØrminos tales como 'infecciones hospitalarias o asociadas al cuidado de la salud' e 'infecciones adquiridas en la comunidad'. Prueba de ello es el ejemplo del Staphylococcus aureus meticilino-resistente de la comunidad, el cual ya ha alcanzado niveles de prevalencia superiores a los observados en los hospitales. El problema de la RAM en salud humana tiene un fuerte correlato con la sanidad animal. Las enfermedades transmitidas por alimentos de origen animal son causa importante de morbimortalidad en todo el mundo. La distribución de alimentos contaminados y la migración de los animales han contribuido a la diseminación de microorganismos resistentes. La relación entre animales de consumo y emergencia de RAM en salud humana ha sido documentada claramente en bacterias zoonóticas como Salmonella spp y Campylobacter spp. La RAM ha aparecido tambiØn en bacterias comensales presentes en el tracto intestinal de los animales, tales como Enterococcus y Escherichia coli, las que pueden ser transmitidas por los alimentos y actuar como reservorios de genes de resistencia, transfiriØndolos a bacterias patógenas o zoonóticas de importancia para la salud pœblica.\n",
      "\n",
      "En el Æmbito de la producción animal, se utilizan antimicrobianos para el tratamiento de las infecciones en animales de forma individual o colectiva. Los tratamientos son de tres tipos: a) profilÆctico, con la intención de proteger a animales sanos que se consideran expuestos a un microorganismo; b) metafilÆctico, para evitar la propagación de infecciones de animales enfermos a sanos en una misma unidad de producción; y c)\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "https://www.boletinoficial.gob.ar/pdf/linkQR/YzB6b2o4Qy9ZRDFycmZ0RFhoUThyQT09\n",
      "\n",
      "terapØuticos, cuando la infección ya estÆ instaurada. Adicionalmente, en las producciones intensivas de bovinos, cerdos, aves y en acuicultura, se emplean bajas dosis de antimicrobianos como agentes promotores del crecimiento. Estos se aæaden al pienso de los animales con el fin de acelerar su crecimiento y con ello el rendimiento de la producción. Los antibióticos actuarían a travØs de la reducción tanto de la microbiota que compite con el huØsped por los nutrientes, como de las bacterias patógenas, las cuales pueden afectar el rendimiento al producir enfermedad subclínica. Por otro lado, se sabe que la exposición prolongada a dosis bajas de antibióticos se relaciona de manera directa con una mayor probabilidad de generar RAM.\n",
      "\n",
      "Algunos de los antibióticos utilizados en la producción ganadera son de importancia crítica para la salud humana. Por ejemplo, los macrólidos y tetraciclinas que se usan a menudo en la alimentación de los animales para estimular su crecimiento o prevenir infecciones, y las fluorquinolonas y cefalosporinas que se utilizan frecuentemente para tratar y/o prevenir las infecciones en sanidad animal.\n",
      "\n",
      "En relación al diagnóstico, los mecanismos de resistencia emergentes son tambiØn cada vez mÆs complejos y requieren de nuevos mØtodos para la detección temprana y confirmación de RAM a fin de poder administrar la terapia adecuada.\n",
      "\n",
      "Pese a los esfuerzos en la investigación y el desarrollo, la ralentización en el descubrimiento de nuevas familias de antimicrobianos, sumada al mayor conocimiento en los mecanismos y la ecología de la RAM, han puesto de relieve la magnitud del problema. Hoy en día, debemos considerar la sensibilidad a los antibióticos como un recurso limitado y no renovable, de muy lenta recuperación cuando se ha perdido.\n",
      "\n",
      "Este problema, de origen multifactorial y alcance global, trasciende fronteras y estructuras de gobierno, y requiere acciones inmediatas, integradas y multisectoriales. Los organismos internacionales dedicados a salud (Organización Mundial de la Salud - OMS y Organización Mundial de Sanidad Animal - OIE) han instado recientemente a los países a elaborar planes y a adoptar medidas para enfrentarlo, bajo el concepto de 'Una Salud', con una visión integral de la sanidad animal y la salud pœblica a escala mundial.\n",
      "\n",
      "Por todas estas razones, es de gran importancia encontrar maneras de garantizar un uso responsable de los antimicrobianos, a travØs de un balance entre minimizar su utilización innecesaria pero sin comprometer la salud de las personas. En marzo de 2014, el Ministerio de Salud de la Nación convocó a diversas entidades involucradas en la problemÆtica, con el propósito de elaborar la presente Estrategia para el Control de la RAM.\n",
      "\n",
      "Los objetivos de esta Estrategia son los siguientes:\n",
      "\n",
      "- 1. Retrasar o impedir la emergencia y diseminación de bacterias resistentes a travØs de la regulación y fiscalización de la comercialización de antimicrobianos, de la promoción del consumo racional y prudente, y de la detección precoz y el control de las infecciones en hospitales y establecimientos agropecuarios.\n",
      "- 2. Fortalecer la vigilancia de la RAM y del uso de antimicrobianos tomando como modelo la estrategia 'Una Salud'.\n",
      "- 3. Promover la innovación en antimicrobianos, promotores del crecimiento no-antibióticos y pruebas diagnósticas para la identificación y la caracterización de bacterias resistentes.\n",
      "- La Estrategia fue elaborada bajo la coordinación de la Secretaría de Promoción y Programas Sanitarios del Ministerio de Salud, y con la participación de las siguientes entidades:\n",
      "- - Ministerio de Salud: Administración Nacional de Laboratorios e Institutos de Salud (ANLIS), Administración Nacional de Medicamentos, Alimentos y Tecnología MØdica (ANMAT) y el Programa REMEDIAR.\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "https://www.boletinoficial.gob.ar/pdf/linkQR/YzB6b2o4Qy9ZRDFycmZ0RFhoUThyQT09\n",
      "\n",
      "- - Ministerio de Agricultura, Ganadería y Pesca: Servicio Nacional de Sanidad y Calidad Agro-alimentaria (SENASA) e Instituto Nacional de Tecnología Agropecuaria (INTA).\n",
      "- - Universidades Nacionales de La Plata y del Centro de la Provincia de Buenos Aires.\n",
      "- - Representación para las AmØricas de la Organización Mundial de Sanidad Animal (OIE).\n",
      "- - Sociedad Argentina de Infectología (SADI) y Sociedad Argentina de Terapia Intensiva (SATI)\n",
      "\n",
      "Nota: Las acciones propuestas en este documento poseen una perspectiva de viabilidad y de priorización, y no pretenden ser ni exhaustivas ni excluyentes. Otras acciones que concurran a cumplir los objetivos generales del mismo podrían llevarse a cabo simultÆneamente.\n",
      "\n",
      "- 2. VIGILANCIA DE LA RESISTENCIA ANTIMICROBIANA EN SALUD HUMANA\n",
      "- 2.1. Definición y relación con el problema de la RAM\n",
      "\n",
      "El diagnóstico y monitoreo de un problema de salud son la base de la planificación sanitaria. La vigilancia de la RAM en salud humana consiste en recoger, procesar, analizar, interpretar y difundir de manera sistemÆtica y continua datos comparables y validados de la resistencia antimicrobiana. La vigilancia permite:\n",
      "\n",
      "- - Determinar y analizar las fuentes y las tendencias temporales y espaciales y de la RAM en las bacterias;\n",
      "- - Detectar la aparición de nuevos mecanismos de resistencia;\n",
      "- - Orientar las decisiones terapØuticas;\n",
      "- - Evaluar las prÆcticas de prescripción de agentes antimicrobianos y recomendaciones de uso prudente;\n",
      "- - Llevar a cabo anÆlisis de riesgos orientados a la protección de salud de los seres humanos y la sanidad de los animales;\n",
      "- - Proporcionar una base para formular recomendaciones sobre políticas de salud pœblica y sanidad animal y evaluar el impacto de las acciones destinadas a contener la resistencia;\n",
      "- - Crear conciencia entre las partes interesadas.\n",
      "- 2.2. Situación actual de la vigilancia de la RAM en salud humana\n",
      "- 2.2.1. Sistemas de vigilancia en funcionamiento\n",
      "\n",
      "En Argentina funcionan tres redes vinculadas al problema de la RAM: WHONET-Argentina, SIREVAArgentina y PROVSAG.\n",
      "\n",
      "La Red WHONET se encuentra dedicada específicamente a recoger datos clínicos de rutina de sensibilidad a los antibióticos y funciona desde 1989 bajo la coordinación del Servicio de Antimicrobianos del Instituto Nacional de Enfermedades Infecciosas (INEI-ANLIS). Esta Red estÆ integrada actualmente por 96 hospitales de todas las jurisdicciones del país (Figura 1). Para garantizar la calidad de los resultados de la vigilancia, los laboratorios participantes cuentan con procedimientos estandarizados de laboratorio, manuales de control de calidad interno, programas de control de calidad externo y de capacitación del personal, y provisión continua de actualizaciones bibliogrÆficas y de cepas de referencia. Para el manejo de datos se utiliza el programa WHONET desarrollado por la OMS. Cada laboratorio participante envía mensualmente al laboratorio coordinador los resultados de todas las pruebas de sensibilidad a antimicrobianos que realiza, bajo las recomendaciones del Clinical Laboratory Standard Institute (CLSI) para las pruebas de difusión en agar y de concentración inhibitoria mínima.\n",
      "\n",
      "- El laboratorio coordinador cumple las siguientes funciones:\n",
      "- - Analiza periódicamente los resultados recibidos, devuelve los comentarios pertinentes, indicando aquellos que requieren ser verificados, y analiza las pruebas realizadas como control de calidad interno;\n",
      "- - Recibe las bacterias con perfiles de resistencia inusuales y aplica tØcnicas cuantitativas y moleculares de\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "https://www.boletinoficial.gob.ar/pdf/linkQR/YzB6b2o4Qy9ZRDFycmZ0RFhoUThyQT09\n",
      "\n",
      "referencia para la detección y caracterización de los mecanismos de RAM y clones circulantes;\n",
      "\n",
      "- - Elabora normativas para los procedimientos microbiológicos y recomendaciones para la detección de bacterias con resistencias extremas y/o inusuales;\n",
      "- - Desarrolla mØtodos diagnósticos para la detección precoz de mecanismos de RAM;\n",
      "- - Coordina el Programa Nacional de Control de Calidad en Bacteriología con participación obligatoria de todos los laboratorios de la Red;\n",
      "- - Analiza y confecciona un informe anual con los datos relevantes de la vigilancia, el cual se difunde a los laboratorios participantes de la Red, a todos los efectores de salud del país y a la Organización Panamericana de la Salud/Organización Mundial de la Salud; y se publica con acceso libre en el sitio\n",
      "\n",
      "www.antimicrobianos.com.ar; y\n",
      "\n",
      "- - Emite alertas por correo electrónico de la emergencia nacional y regional de mecanismos de resistencia potencialmente pandØmicos.\n",
      "\n",
      "La Red SIREVA-Argentina lleva a cabo la vigilancia de los agentes bacterianos causantes de neumonía y de meningitis: Streptococcus pneumoniae, Neisseria meningitidis y Haemophilus influenzae. Esta red, coordinada en forma conjunta por los servicios de Bacteriología Clínica y de Antimicrobianos del INEI-ANLIS, provee información epidemiológica de la distribución de serotipos y sensibilidad a los antimicrobianos en aislamientos de infecciones invasivas en la población general. Esta información contribuye a la evaluación de la cobertura de vacunas y a la elección de la terapia antimicrobiana mÆs apropiada para estas infecciones.\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "La Red PROVSAG (Programa de Vigilancia de la Sensibilidad Antimicrobiana de Gonococo de la Red de Infecciones de Transmisión Sexual) vigila la sensibilidad a los antimicrobianos de uso habitual en el manejo de la gonorrea, detecta en forma precoz y oportuna la emergencia de perfiles de sensibilidad inusuales de Neisseria gonorrhoeae y caracteriza los mecanismos de resistencia y clones circulantes en el país. El Servicio Enfermedades de Transmisión Sexual del INEI-ANLIS coordina esta Red y actœa como Laboratorio Nacional de Referencia (LNR).\n",
      "\n",
      "- 2.3. Líneas estratØgicas para la vigilancia de la RAM en salud humana\n",
      "- a) Fortalecimiento y capacitación continua de los laboratorios coordinadores de las Redes y de los laboratorios participantes de la vigilancia de la RAM;\n",
      "- b) Fortalecimiento de las acciones de comunicación y difusión oportuna de la información de la RAM;\n",
      "- c) Promoción del desarrollo e implementación de nuevos mØtodos de diagnóstico rÆpido para la detección\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "https://www.boletinoficial.gob.ar/pdf/linkQR/YzB6b2o4Qy9ZRDFycmZ0RFhoUThyQT09\n",
      "\n",
      "precoz de microorganismos con resistencia mœltiple; y\n",
      "\n",
      "- d) Armonización de estrategias de vigilancia de RAM en salud humana, animal y ambiental.\n",
      "- 2.4. Acciones específicas para la vigilancia de la RAM en salud humana\n",
      "- 2.4.1. Capacitación y Control de Calidad\n",
      "- a) Continuar realizando el Curso de Actualización en Antimicrobianos 'Dra. Alicia Rossi' con cupo para 110 profesionales y el Curso anual de Epidemiología Molecular con cupo de 18 profesionales;\n",
      "- b) Participar en los congresos internacionales de las Sociedades Europea y Americana de Microbiología, y en otros eventos científicos nacionales e internacionales;\n",
      "- c) Efectuar una pasantía anual de un profesional en centros de referencia del exterior;\n",
      "- d) Suscribirse a revistas científicas y acceder a bibliotecas digitales temÆticas (ASM, Elsevier, Oxford Press);\n",
      "- e) Participar en eventos científicos organizados por entidades nacionales e internacionales;\n",
      "- f) Incorporar los cursos a la plataforma virtual de ANLIS para capacitación on line en gran escala e implementar tecnología para videoconferencias;\n",
      "- g) Proveer insumos para el Programa Nacional de Control de Calidad en Bacteriología con asignación presupuestaria específica;\n",
      "- h) Distribuir las cepas de referencia para pruebas de sensibilidad y cepas estÆndares para diagnóstico de mecanismos de resistencia circulantes en el país;\n",
      "\n",
      "## 2.4.2. Comunicación\n",
      "\n",
      "- i) Elaborar y comunicar el Boletín Informativo y los Alertas Digitales de la emergencia de mecanismos de resistencia potencialmente pandØmicos en el país y la región;\n",
      "- j) Elaborar e incorporar al Boletín un resumen ejecutivo con indicadores seleccionados de la RAM, integrando la información proveniente de la vigilancia armonizada entre salud humana y animal;\n",
      "- k) Aumentar la frecuencia de publicación del Boletín a semestral en lugar de anual;\n",
      "- I) Incorporar referentes de nuevas entidades como SENASA, INTA, SADI y SATI a la lista de destinatarios de comunicaciones;\n",
      "- m) Actualizar y difundir algoritmos de trabajo para armonizar procedimientos de bœsqueda de mecanismos de resistencia entre todos los laboratorios del país;\n",
      "- n) Mantener la plataforma web del LNR para difusión de la información de la vigilancia y de los trabajos científicos publicados o presentados en congresos;\n",
      "- o) Desarrollar e implementar una herramienta digital on line para anÆlisis personalizados;\n",
      "- p) Incluir links a la web del LNR en sitios web de otras instituciones o sociedades científicas como SADI y SATI;\n",
      "- q) Establecer alianzas con otras entidades para la difusión de los resultados de la vigilancia a todos los efectores de salud;\n",
      "- 2.4.3. Armonización de las estrategias de vigilancia\n",
      "- r) Elaborar y actualizar procedimientos de estudio de la RAM en cooperación entre ANLIS, SENASA, INTA y las universidades nacionales;\n",
      "- s) Realizar reuniones periódicas o segœn necesidad con los actores involucrados;\n",
      "- t) Elaborar y difundir un reporte anual conjunto con los perfiles de resistencia de bacterias zoonóticas e indicadoras de origen animal y los mismos gØrmenes de origen humano;\n",
      "- 2.4.4. Desarrollo e implementación de nuevos mØtodos de diagnóstico\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "https://www.boletinoficial.gob.ar/pdf/linkQR/YzB6b2o4Qy9ZRDFycmZ0RFhoUThyQT09\n",
      "\n",
      "- u) Proveer insumos para el desarrollo de nuevas metodologías diagnósticas para gØrmenes multirresistentes con asignación presupuestaria específica;\n",
      "- v) Establecer alianzas con otras entidades pœblicas o privadas para el desarrollo de nuevas metodologías diagnósticas; y\n",
      "- w) Registrar la propiedad intelectual y/o patentes de nuevos desarrollos institucionales.\n",
      "- 3. VIGILANCIA DE LA RESISTENCIA ANTIMICROBIANA EN SALUD ANIMAL Y PRODUCCIÓN AGROALIMENTARIA\n",
      "- 3.1. Definición y relación con el problema de la RAM\n",
      "- La vigilancia de la RAM es el seguimiento activo y sostenido en el tiempo de la prevalencia de la resistencia de las bacterias en los animales, los alimentos y el ambiente; y constituye una faceta crítica de la estrategia de sanidad animal y seguridad alimentaria destinada a limitar su propagación y a optimizar la elección de antimicrobianos con fines terapØuticos.\n",
      "- 3.2. Situación actual de la vigilancia de la RAM en salud animal y producción agroalimentaria Argentina no cuenta aœn con un programa de vigilancia permanente de RAM en animales de producción. La vigilancia es necesaria en 3 grupos de bacterias en bovinos, porcinos y aves: a) bacterias 'indicadoras', b) bacterias zoonóticas, y c) bacterias patógenas. Las bacterias indicadoras son parte de la microbiota intestinal de seres humanos, otros mamíferos, aves e insectos y su importancia radica en su capacidad de adquirir y diseminar genes de resistencia que pueden ser transferidos a las bacterias patógenas o zoonóticas.\n",
      "\n",
      "El SENASA, con la cooperación de ANLIS, INTA y facultades de veterinaria de universidades nacionales, liderarÆ la implementación de un programa de vigilancia de la RAM en animales de consumo. Para este programa, se obtendrÆn muestras en establecimientos frigoríficos, y el aislamiento bacteriano y las pruebas de sensibilidad antimicrobiana se centralizarÆn en la Dirección de Laboratorios y Control TØcnico del SENASA y/o en el o los laboratorios que el Ministerio de Agricultura, Ganadería y Pesca defina. La metodología de trabajo se presenta en la sección 3.5. El registro, almacenamiento e interpretación de la información se realizarÆ mediante el sistema de software WHONET. Por su parte, el INTA aportarÆ a la investigación y desarrollo de principios activos alternativos a los antibióticos como factores de crecimiento y agentes terapØuticos.\n",
      "\n",
      "- 3.3. Líneas estratØgicas para la vigilancia de la RAM en salud animal y producción agroalimentaria a) Desarrollo e implementación del programa nacional de vigilancia de la RAM en animales de consumo para determinar la presencia de resistencia a diferentes antimicrobianos en por lo menos 2 bacterias comensales: Escherichia coli y Enterococcus spp, y 2 zoonóticas: Campylobacter spp y Salmonella spp;\n",
      "- b) Armonización de las estrategias de vigilancia de RAM en salud humana y animal; y\n",
      "- c) Desarrollo de herramientas de comunicación y difusión oportuna de la información.\n",
      "- 3.4. Acciones específicas para la vigilancia de la RAM en salud animal y producción agroalimentaria\n",
      "- a) Aislar bacterias comensales y zoonóticas de ganado bovino, porcino y aves destinadas a consumo humano, y determinar su perfil de sensibilidad a diferentes antimicrobianos;\n",
      "- b) Comparar los resultados con datos obtenidos en estudios previos, cuando sea posible;\n",
      "- c) Determinar la prevalencia de RAM por especie animal y por región geogrÆfica;\n",
      "- d) Correlacionar el consumo de antimicrobianos con la RAM;\n",
      "- e) Caracterizar y correlacionar los mecanismos de resistencia entre bacterias obtenidas de muestras animales y humanas;\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "https://www.boletinoficial.gob.ar/pdf/linkQR/YzB6b2o4Qy9ZRDFycmZ0RFhoUThyQT09\n",
      "\n",
      "- f) Realizar estudios específicos sobre el comportamiento de antimicrobianos vehiculizados en diferentes matrices biológicas (agua o alimento, pre-mezcla o nœcleo concentrado) y sobre el impacto de su uso en el medio ambiente de los sistemas de producción;\n",
      "- g) Evaluar terapias alternativas al uso de antibióticos como factores de crecimiento en las producciones intensivas; y\n",
      "- h) Evaluar el impacto de la administración en diferentes matrices biológicas sobre el nivel de resistencia observado en la población bacteriana ambiental.\n",
      "- Y7\n",
      "- 1es,\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "## 4. VIGILANCIA DEL USO DE ANTIMICROBIANOS\n",
      "\n",
      "- 4.1. Definición y relación con el problema de la RAM\n",
      "\n",
      "El objetivo de la vigilancia del uso de antimicrobianos comprende dos dimensiones bÆsicas de la política de medicamentos: a) el acceso a ellos y b) su uso adecuado. Esta información permitirÆ identificar las jurisdicciones y/o los establecimientos que no los utilizan de modo apropiado y focalizar las acciones dónde mÆs se necesiten.\n",
      "\n",
      "- 4.2. Situación actual de la vigilancia del uso de antimicrobianos\n",
      "\n",
      "No existe en la actualidad un programa de vigilancia del uso de antimicrobianos que integre las distintas fuentes de información existentes, tanto pœblicas como privadas. En el Æmbito pœblico, los programas nacionales, tales como Remediar, Tuberculosis y Lepra, y la Dirección de VIH/SIDA, disponen de información sobre la provisión y utilización de los antimicrobianos que cada uno gestiona. A partir de esos datos, relacionados con el individuo, tiempo, lugar, diagnóstico o indicación y características del tratamiento (ambulatorio/internado), se podrÆ realizar estudios epidemiológicos de esos medicamentos. En los Æmbitos privado y de obras sociales, existen relevamientos de la dimensión industrial y comercial de los medicamentos (por ejemplo, IMS Health). Por œltimo, un tercer recurso lo constituyen los grupos científicos que producen información vinculada a la utilización de medicamentos en general. Por otra parte, los programas de trazabilidad de medicamentos de ANMAT (Resolución 435 de 2011 del Ministerio de Salud de la Nación) y de productos fitosanitarios y veterinarios de SENASA (Resolución SENASA 369/2013), proveerÆn datos sobre la comercialización y distribución de los antimicrobianos en salud humana y en producción agroalimentaria.\n",
      "\n",
      "4.3. Líneas estratØgicas para la vigilancia del uso de antimicrobianos\n",
      "\n",
      "- a) Diseæo e implementación de la vigilancia del acceso a los antimicrobianos\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "https://www.boletinoficial.gob.ar/pdf/linkQR/YzB6b2o4Qy9ZRDFycmZ0RFhoUThyQT09\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "https://www.boletinoficial.gob.ar/pdf/linkQR/YzB6b2o4Qy9ZRDFycmZ0RFhoUThyQT09\n",
      "\n",
      "El acceso se refiere a la utilización efectiva de antimicrobianos en salud humana, incluyendo la prescripción profesional y el consumo por parte del usuario final. Sin embargo, debido a limitaciones en la disponibilidad de datos exhaustivos, el acceso tambiØn puede ser indicado por la disponibilidad de antimicrobianos en la comunidad, entendida como la suma de la distribución pœblica y la comercialización privada de medicamentos.\n",
      "\n",
      "El monitoreo de la disponibilidad de antimicrobianos en la comunidad supone un abordaje de tipo exploratorio descriptivo, transversal y longitudinal, y permitirÆ conocer tendencias, niveles críticos o de alerta y definir y evaluar medidas de restricción aplicables a su uso. En el mismo sentido, permitirÆ indagar asociaciones espaciales y temporales entre los niveles de disponibilidad, características geogrÆficas (industrias, residuos, clima) y RAM.\n",
      "\n",
      "- b) Diseæo e implementación de la vigilancia del uso adecuado\n",
      "\n",
      "El uso adecuado refiere a la calidad tanto de la prescripción como de la provisión del servicio farmacØutico, en tØrminos de uso de la medicación apropiada a la necesidad clínica, en las dosis correspondientes a los requerimientos individuales de cada paciente, por el período adecuado de tiempo. La vigilancia permitirÆ establecer el grado de adecuación del uso de antimicrobianos a protocolos, guías, pautas o esquemas terapØuticos definidos.\n",
      "\n",
      "- 4.4. Acciones específicas para la vigilancia del uso de antimicrobianos\n",
      "\n",
      "Vigilancia del acceso. El abordaje del acceso se basa en (a) datos disponibles en el Ministerio de Salud de la Nación y los ministerios de salud provinciales, sobre disponibilidad y uso de medicamentos en los niveles ambulatorio (Centros de Atención Primaria de la Salud - CAPS) y hospitalario; y en (b) datos del mercado farmacØutico privado sobre la comercialización de antimicrobianos en la red de farmacias comunitarias. La vigilancia del acceso permitirÆ:\n",
      "\n",
      "- a) Comparar tendencias y diferencias en la tasa de uso de antibióticos entre provincias, en base a series temporales;\n",
      "- b) Identificar establecimientos, Æreas o zonas de mayor utilización de antimicrobianos, en base a tØcnicas de anÆlisis geoespacial;\n",
      "- c) Caracterizar los perfiles de CAPS o establecimientos hospitalarios con mayores/menores tasas de uso de antimicrobianos; y\n",
      "- d) Realizar investigaciones en unidades de terapia intensiva del país sobre la prescripción y consumo de antimicrobianos: Programa VIHDA en conjunto con SADI y SATI.\n",
      "\n",
      "Los principales indicadores utilizados serÆn: Dosis Diarias Definidas (DDD, o unidad similar) de antimicrobianos por habitante; tasa de uso de antimicrobianos cada 100 consultas; % de prescripciones de antimicrobianos sobre el total de prescripciones; % de pacientes con al menos una prescripción de antimicrobianos sobre el total de pacientes.\n",
      "\n",
      "Vigilancia del uso adecuado. Establecer el uso adecuado requiere disponibilidad de datos que contengan información de la indicación mØdica (morbilidad), prescripción farmacológica e identificación del paciente (en especial, edad), disponibles para un conjunto de programas pœblicos desarrollados en el nivel ambulatorio (REMEDIAR, Salud Sexual, Tuberculosis, entre otros) y hospitalario (VIH, etc.). Respecto al Æmbito de la seguridad social o privado, así como tambiØn a información de uso en internación, los datos requeridos pueden obtenerse por muestreo, por ejemplo, a travØs de la encuesta de prevalencia de infecciones hospitalarias (ENPIHA) que realiza anualmente el INE, o mediante estudios transversales en la comunidad,\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "https://www.boletinoficial.gob.ar/pdf/linkQR/YzB6b2o4Qy9ZRDFycmZ0RFhoUThyQT09\n",
      "\n",
      "por ejemplo, de auto-prescripción o consumo no controlado. La vigilancia del uso adecuado permitirÆ:\n",
      "\n",
      "- a) Determinar el grado de adecuación de la utilización de antimicrobianos en la prÆctica terapØutica habitual (estudios de tipo indicación-prescripción y prescripción-consumo);\n",
      "- b) Identificar geogrÆficamente establecimientos, Æreas o zonas de mayor uso inapropiado de antimicrobianos (mapas); e\n",
      "- c) Identificar perfiles de profesionales, CAPS o establecimientos hospitalarios con mayores o menores tasas de uso inapropiado de antimicrobianos.\n",
      "\n",
      "Los principales indicadores serÆn: nivel de adecuación de prescripciones de antimicrobianos a recomendaciones sanitarias; % de usuarios que recibieron servicios farmacØuticos sobre el total de prescripciones y/o pacientes; % de usuarios que registren adherencia al tratamiento indicado; % de usuarios de antimicrobianos sin prescripción profesional.\n",
      "\n",
      "El monitoreo del uso adecuado permitirÆ determinar la calidad de provisión de los servicios sanitarios vinculados con los antimicrobianos e identificar necesidades de capacitación de los equipos de salud, así como tambiØn diseæar acciones específicas segœn Æreas geogrÆficas o de conocimiento, incluyendo la revisión y eventual adecuación de las recomendaciones de utilización.\n",
      "\n",
      "SerÆ responsabilidad del Programa REMEDIAR del Ministerio de Salud de la Nación:\n",
      "\n",
      "- a) Desarrollar la vigilancia del uso de antimicrobianos y consolidar información proveniente de los usos humano, animal y agropecuario;\n",
      "- b) Relevar, con la cooperación de la Dirección de Calidad de Servicios de Salud, las Guías de Diagnóstico y Tratamiento existentes, que permitan considerar adecuada la prescripción, conforme la relación diagnóstico (indicación) y tratamiento (prescripción), identificando medicamento, dosificación y tiempo de tratamiento;\n",
      "- c) Consolidar y difundir un banco de datos con los criterios para clasificar una indicación como adecuada o\n",
      "\n",
      "prudente;\n",
      "\n",
      "- d) Obtener datos de distintas fuentes para realizar la vigilancia del uso de antimicrobianos en los tØrminos descriptos en este documento; y\n",
      "- e) Desarrollar herramientas de comunicación y difusión oportuna de la información con los principales resultados, conclusiones y recomendaciones, destinada a los distintos actores involucrados en la utilización de antimicrobianos y a la comunidad en general.\n",
      "- La Dirección Nacional de Agroquímicos, Productos Veterinarios y Alimentos del SENASA serÆ responsable de:\n",
      "- a) Realizar un seguimiento anual del volumen de venta de antibióticos, con la colaboración de las cÆmaras industriales de productos veterinarios y los colegios profesionales; y\n",
      "- b) Proveer los datos que se obtengan del sistema de trazabilidad de productos fitosanitarios y veterinarios en cuanto Øste se encuentre en funcionamiento pleno.\n",
      "- 5. REGULACIÓN DEL USO DE ANTIMICROBIANOS EN SALUD HUMANA\n",
      "- 5.1. Definición y relación con el problema de la RAM\n",
      "- El objetivo de la regulación farmacØutica es garantizar la eficacia, seguridad y calidad de los productos farmacØuticos que utiliza la población.\n",
      "\n",
      "La regulación del uso de antimicrobianos tiene impacto en los siguientes aspectos:\n",
      "\n",
      "- - Eficacia e indicaciones terapØuticas debidamente demostradas;\n",
      "- - Restricciones apropiadas aplicando criterios científicos de seguridad al acceso libre a los productos\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "https://www.boletinoficial.gob.ar/pdf/linkQR/YzB6b2o4Qy9ZRDFycmZ0RFhoUThyQT09\n",
      "\n",
      "antibióticos de uso sistØmico (oral u parenteral) a travØs de la determinación de la condición de dispensa al pœblico como 'venta bajo receta archivada'; y\n",
      "\n",
      "- - Adecuación del nœmero de unidades disponibles en las presentaciones de venta segœn la concentración y vía de administración y a criterios mØdico-científicos sustentados en las guías de tratamiento de entidades mØdicas reconocidas.\n",
      "- 5.2. Situación actual de la regulación del uso de antimicrobianos en salud humana\n",
      "\n",
      "La autoridad reguladora nacional es la Administración Nacional de Medicamentos, Alimentos y Tecnología MØdica (ANMAT), y su Æmbito de aplicación es la importación/exportación y el trÆnsito federal de los medicamentos. Sin embargo, en la organización federal del país, las provincias conservan el poder de regulación y fiscalización dentro de sus jurisdicciones. Esto motivó la necesidad de crear un espacio de coordinación denominado ANMAT FEDERAL. El objetivo del Plan ANMAT FEDERAL es fortalecer las capacidades nacionales y provinciales de regulación, fiscalización y vigilancia de los productos para la salud (medicamentos, alimentos y tecnología), a travØs de la conformación de una red con referentes en cada jurisdicción.\n",
      "\n",
      "La Resolución 3835/69 (modificada luego por Resolución 378/70) del entonces Ministerio de Bienestar Social, estableció que los medicamentos cuyos ingredientes farmacØuticos activos (IFAs) tuvieran actividad antibiótica de uso sistØmico deberÆn ser dispensados de acuerdo a su condición de inscripción con Venta Bajo Receta Archivada a partir del 1 de enero de 1970, y ambas se encuentran aœn vigentes. Las recetas deben ser archivadas por fecha correlativa y conservadas por un lapso de dos aæos, vencido el cual la farmacia puede proceder a su destrucción. Por otra parte, el Art. 36 del Decreto 7123/68, reglamentario de la Ley 17.565, definió que: 'La adquisición y venta que realicen las droguerías de productos de venta bajo receta archivada deberÆ hacerse por factura y/o remito separado..., debiendo conservarse la documentación archivada en forma ordenada, y ser exhibida y puesta a disposición de los inspectores de la Secretaría de Estado de Salud Pœblica, a su requerimiento.'.\n",
      "\n",
      "En la prÆctica, se reconoce el incumplimiento de la dispensa con estas exigencias por parte de los establecimientos farmacØuticos por lo que se abren dos campos de responsabilidad. Un primer campo corresponde a la responsabilidad administrativa del control del ejercicio profesional farmacØutico. Este control corresponde a las autoridades sanitarias locales. En el Æmbito de CABA actualmente es la Dirección de Registro Fiscalización y Sanidad de Fronteras del Ministerio de Salud de Nación, la cual al constatar las transgresiones a la normativa debe iniciar las actuaciones sumariales correspondientes, pudiendo concluir con las sanciones que establece el art. 45 de la Ley 17.565 de Ejercicio de la Actividad de Farmacia: apercibimiento, multa, clausura del establecimiento, suspensión de la matrícula y/o inhabilitación. Un segundo campo de responsabilidad se abrió con la Ley 26.524 (2009) del Código Penal, la cual estableció que la dispensa de cualquier tipo de especialidad medicinal sin cumplimiento de las condiciones legales de expendio configura un tipo penal el cual puede sancionarse con una pena de prisión de hasta TRES aæos.\n",
      "\n",
      "En relación a la publicidad de los antimicrobianos, Østa se encuentra prohibida desde 1964 a partir del Art. 19 de la Ley Nacional de Medicamentos N' 16.463, que establece que 'Queda prohibido: (inciso d) Toda forma de anuncio al pœblico de los productos cuyo expendio sólo haya sido autorizado bajo receta'. 5.3. Líneas estratØgicas para la regulación del uso de antimicrobianos en salud humana a) Implementación de medidas que promuevan el uso adecuado de antimicrobianos segœn preceptos\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "https://www.boletinoficial.gob.ar/pdf/linkQR/YzB6b2o4Qy9ZRDFycmZ0RFhoUThyQT09\n",
      "\n",
      "## científico-tØcnicos;\n",
      "\n",
      "- b) Capacitación para el cumplimiento de las Resoluciones 3835/69 y 378/70 sobre la venta de antimicrobianos bajo receta archivada a travØs de su verificación en las inspecciones a las farmacias; y\n",
      "- c) Desarrollo de un procedimiento de evaluación preferencial de nuevos antimicrobianos o nuevas formulaciones y mØtodos rÆpidos de diagnóstico para infecciones resistentes.\n",
      "- 5.4. Acciones específicas para la regulación del uso de antimicrobianos en salud humana\n",
      "- a) Verificar y adecuar la condición de expendio autorizada oportunamente en el registro de cada uno de los medicamentos con acción antibiótica de uso sistØmico;\n",
      "- b) Sensibilizar y capacitar a los integrantes de la Red de ANMAT FEDERAL sobre la efectiva dispensa bajo receta archivada de los medicamentos antibióticos de uso sistØmico;\n",
      "- c) Generar instrumentos reguladores que faciliten las actividades de control, por ejemplo, ampliando a los antimicrobianos lo establecido por la Disposición 38/90 de la entonces Subsecretaría de Administración de Servicios y Programas de Salud para los sicotrópicos y estupefacientes (Leyes 17.818 y 19.303), por la cual se exige que la venta que realicen los Laboratorios a las Droguerías y Østas a las Farmacias, debe ser facturada (con factura y remito) en forma separada de cualquier otro medicamento, consignando los nœmeros de partida y de serie de fabricación;\n",
      "- d) Revisar, con la cooperación de las sociedades profesionales relacionadas con la temÆtica, la adecuación de las presentaciones comerciales de antimicrobianos a la duración y dosis recomendada de tratamientos, con el objeto de evitar el incumplimiento del mismo por parte de los pacientes toda vez que la presentación comercial no alcance para completar el tratamiento indicado o sobren unidades al finalizar el mismo; e e) Implementar un procedimiento Ægil de revisión de nuevos mØtodos diagnósticos para la detección precoz de RAM y de nuevos principios activos o nuevas formulaciones de los existentes para tratamiento de las infecciones, con la cooperación de ANLIS y SADI.\n",
      "- 6. REGULACIÓN DEL USO DE ANTIMICROBIANOS EN SALUD ANIMAL Y PRODUCCIÓN AGROALIMENTARIA\n",
      "- 6.1. Definición y relación con el problema de la RAM\n",
      "- El objetivo de la regulación de los alimentos de origen animal es garantizar la seguridad de este tipo de alimentos para la población. En Argentina, la autoridad reguladora es el Servicio Nacional de Sanidad y Calidad Agroalimentaria (SENASA).\n",
      "- La regulación tiene impacto en la vigilancia del uso de agentes antimicrobianos y en su uso racional y prudente en sanidad animal y producción agroalimentaria, mediante mecanismos de registro de productos, regulación de su uso y en el control de residuos o contaminantes en los alimentos de ese origen.\n",
      "- 6.2. Situación actual de la regulación del uso de antimicrobianos en salud animal y producción agroalimentaria\n",
      "\n",
      "Desde hace mÆs de diez aæos, el SENASA lleva adelante un Programa de Control de Residuos, Contaminantes e Higiene de Alimentos de origen animal. Este programa busca detectar la presencia de residuos químicos y contaminantes en alimentos de origen animal que puedan afectar la salud de los consumidores. Entre los residuos bajo control se encuentran diversos agentes antimicrobianos, los cuales pueden generar resistencia antimicrobiana cuando se encuentran presentes en los alimentos.\n",
      "\n",
      "En cuanto a la regulación aplicable, en 2007, la Resolución SENASA 609 estableció que todos los productos veterinarios con acción antimicrobiana se encuentran en la categoría de venta bajo receta. En 2011, la\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "https://www.boletinoficial.gob.ar/pdf/linkQR/YzB6b2o4Qy9ZRDFycmZ0RFhoUThyQT09\n",
      "\n",
      "Resolución 666 determinó que los establecimientos de producción de animales para consumo humano deben llevar un libro de registro de tratamientos sujeto a inspección por el SENASA en el que se deberÆ consignar toda administración de productos veterinarios sobre los animales de producción.\n",
      "\n",
      "Por œltimo, en 2013 el SENASA instituyó el Sistema Nacional de Trazabilidad de Productos Fitosanitarios y Veterinarios, el cual permitirÆ conocer el volumen y tipo de antimicrobianos que se comercializa en el marco de la comercialización de los productos veterinarios. Este sistema on line se basa en las declaraciones juradas de venta de productos veterinarios que involucra a todos los eslabones de la cadena comercial, desde el elaborador o el importador del producto hasta el veterinario que indica y vende el producto. De esta manera, toda vez que se realiza una venta, el vendedor debe declarar quØ vendió, y el comprador que aceptó la venta y que asume la responsabilidad por la tenencia de los productos adquiridos.\n",
      "\n",
      "- 6.3. Líneas estratØgicas para la regulación del uso de antimicrobianos en salud animal y producción agroalimentaria\n",
      "- a) Desarrollo o actualización de regulaciones sobre el uso de antimicrobianos, destinadas a preservar la sensibilidad bacteriana como recurso no renovable; y\n",
      "- b) Participación en instancias internacionales de discusión sobre las prÆcticas reguladoras para la sanidad animal.\n",
      "- 6.4. Acciones específicas para la regulación del uso de antimicrobianos en salud animal y producción agroalimentaria\n",
      "- a) Recopilar y analizar resultados de los sistemas de vigilancia y trazabilidad de productos veterinarios para la realización de anÆlisis de riesgos y creación de perfiles de riesgo;\n",
      "- b) Fortalecer los controles de venta indiscriminada y uso de antibióticos;\n",
      "- c) Establecer que toda comercialización de antibióticos se realice a cargo de un profesional matriculado; y\n",
      "- d) Crear una instancia de discusión sobre el uso de antimicrobianos con las cÆmaras de la industria de productos veterinarios, los colegios de profesionales, las universidades y el Ministerio de Salud.\n",
      "- 7. USO RESPONSABLE DE ANTIMICROBIANOS EN SALUD HUMANA\n",
      "- 7.1. Definición y relación con el problema de la RAM\n",
      "- La OMS define como uso adecuado de los antimicrobianos el uso eficaz en relación con el costo de los antimicrobianos con el cual se obtiene el mÆximo efecto clínico-terapØutico y simultÆneamente se minimiza la toxicidad del medicamento y el desarrollo de RAM.\n",
      "\n",
      "Los principios generales que se aplican al uso adecuado de los antimicrobianos son iguales a los de otros productos medicinales, pero con una particularidad: el tratamiento individual tiene repercusión en la salud de la sociedad como resultado de la inducción de generación de resistencia y la presión selectiva ejercida sobre los microorganismos sensibles. AdemÆs, la falla terapØutica debida a agentes patógenos resistentes a los fÆrmacos o a superinfecciones aumenta su potencial de diseminación en todo el hospital y/o en la comunidad. A pesar de que este es un efecto esperable aœn cuando se usan de manera correcta, el uso\n",
      "\n",
      "inapropiado acelera notablemente este fenómeno.\n",
      "\n",
      "La elección del tratamiento antimicrobiano apropiado puede ser sencilla en caso de agentes causales conocidos o que pueden deducirse con bastante certeza de la presentación clínica del paciente. Sin embargo, cuando se carece de un diagnóstico microbiológico confiable o la infección es pluricausal, el tratamiento empírico es la prÆctica habitual, y a menudo incluye antimicrobianos de espectro amplio. En condiciones ideales, la elección del medicamento debería hacerse con base en la información local,\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "https://www.boletinoficial.gob.ar/pdf/linkQR/YzB6b2o4Qy9ZRDFycmZ0RFhoUThyQT09\n",
      "\n",
      "institucional y/o regional de la vigilancia de la resistencia y siguiendo las normas de tratamiento propuestas por sociedades científicas.\n",
      "\n",
      "- 7.2. Situación actual del uso responsable de antimicrobianos en salud humana\n",
      "\n",
      "La mayor parte de los antimicrobianos usados en salud humana se destina al tratamiento de infecciones ambulatorias, aœn cuando muchas de ellas son de etiología viral y no requieren antibióticos. Por otra parte, los antimicrobianos se encuentran entre los medicamentos de mayor uso en los hospitales: se estima que entre el 25 y el 41% de los pacientes internados recibe antibióticos, habitualmente de amplio espectro, y aproximadamente el 60% recibe al menos una dosis durante su ingreso. Por otra parte, ha sido ya demostrado en numerosos estudios que la utilización de antimicrobianos en el medio hospitalario se puede optimizar en el 30-50% de los casos.\n",
      "\n",
      "Por estos motivos se generaron hace tiempo los programas institucionales de salvaguarda de los antimicrobianos (conocidos en inglØs como 'Antimicrobial Stewardship Programs'). Estos programas buscan mejorar la utilización de estos medicamentos en los hospitales a travØs de tres acciones: a) optimizar los resultados clínicos; b) reducir los efectos adversos, incluyendo la resistencia, y c) garantizar una terapia costo-efectiva.\n",
      "\n",
      "Finalmente, en el Æmbito de la comunidad se observa una excesiva confianza por parte de la población en el efecto de los antimicrobianos, lo que conduce al uso de ellos sin prescripción mØdica y a la inadecuada adherencia a los tratamientos (tanto los auto-instituidos como los indicados por profesionales), en el marco de un desconocimiento de sus efectos negativos.\n",
      "\n",
      "- 7.3. Líneas estratØgicas para el uso responsable de antimicrobianos en salud humana\n",
      "- a) Cooperación entre el Ministerio de Salud de la Nación (Servicio de Antimicrobianos INEI-ANLIS, Programa VIHDA INE-ANLIS, Programa REMEDIAR, ANMAT), SADI y SATI;\n",
      "- b) Capacitación y promoción del uso racional y prudente de los antimicrobianos destinada a los profesionales de salud en los Æmbitos ambulatorio y hospitalario; y\n",
      "- c) Difusión en la comunidad de la importancia del uso de antimicrobianos con prescripción mØdica y la adherencia al tratamiento indicado.\n",
      "- 7.4. Acciones específicas para el uso responsable de antimicrobianos en salud humana\n",
      "\n",
      "## 7.4.1. Equipos de salud\n",
      "\n",
      "- a) Implementar un curso virtual de actualización en uso responsable de antimicrobianos en el Æmbito ambulatorio y hospitalario, dirigido a mØdicos (especialmente generalistas, de familia, pediatras, internistas e intensivistas), enfermeros, farmacØuticos, odontólogos, bioquímicos y a estudiantes avanzados de estas carreras. Se dictarÆ en conjunto entre SADI, SATI, ADECI y el Programa VIHDA, utilizando la plataforma de Educación a Distancia del INE-ANLIS;\n",
      "\n",
      "b) Realizar talleres regionales, entre el Programa VIHDA, SADI, SATI y los referentes locales sobre el uso responsable de antimicrobianos para difundir la problemÆtica, los datos de la vigilancia y las guías y recomendaciones de tratamiento. Las sedes serían: Resistencia, TucumÆn, Córdoba, Rosario, Mendoza, Bariloche, Puerto Madryn y Ushuaia;\n",
      "\n",
      "- c) Incorporar la temÆtica de la RAM en la currícula de las carreras de ciencias de la Salud, en trabajo conjunto con AFACIMERA;\n",
      "- d) Promover la cooperación entre sociedades científicas y de profesionales de la salud para llevar a cabo cursos virtuales sobre infecciones prevalentes segœn las especialidades, y la inclusión del tema de la RAM\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "https://www.boletinoficial.gob.ar/pdf/linkQR/YzB6b2o4Qy9ZRDFycmZ0RFhoUThyQT09\n",
      "\n",
      "## en la agenda de sus respectivos congresos; y\n",
      "\n",
      "- e) Continuar los cursos sobre Terapia Racional del programa REMEDIAR, la cooperación con SADI para la elaboración de contenidos y el dictado con las universidades participantes.\n",
      "\n",
      "## 7.4.2. Comunidad\n",
      "\n",
      "- a) Elaborar materiales de difusión (folletos, afiches, artículos, etc.) y realizar campaæas en medios de comunicación;\n",
      "- b) Concientizar a la población y a los profesionales mØdicos y farmacØuticos involucrados acerca de la exigencia de la venta bajo receta archivada de los antimicrobianos; e\n",
      "- c) Implementar el Día Nacional del Uso Responsable de Antibióticos para realizar acciones que promuevan\n",
      "- el reconocimiento del problema y su prevención. Debido a que el mayor uso de antimicrobianos se registra en invierno, la fecha propuesta es el 21 de junio.\n",
      "- 8. USO RESPONSABLE DE ANTIMICROBIANOS EN SALUD ANIMAL Y PRODUCCIÓN AGROALIMENTARIA\n",
      "- 8.1. Definición y relación con el problema de la RAM\n",
      "- El uso responsable de antimicrobianos en salud animal y producción agroalimentaria refiere a la implementación de medidas y recomendaciones prÆcticas para mejorar la sanidad y el bienestar animal y, al mismo tiempo, prevenir y/o reducir la emergencia y propagación de bacterias resistentes a los\n",
      "\n",
      "antimicrobianos en animales y en humanos. Estas medidas tienen los siguientes objetivos: a) garantizar el uso racional de los agentes antimicrobianos en los animales, con vistas a optimizar su\n",
      "\n",
      "- eficacia y su inocuidad;\n",
      "- b) cumplir con la obligación Øtica y la necesidad económica de mantener a los animales en buen estado de salud;\n",
      "- c) prevenir o reducir la transferencia de microorganismos resistentes o determinantes de resistencia en el seno de las poblaciones animales, su entorno y entre los animales y los seres humanos;\n",
      "- d) contribuir a mantener la eficacia y la utilidad de los agentes antimicrobianos utilizados en medicina humana y veterinaria;\n",
      "- e) proteger la salud del consumidor garantizando la inocuidad de los alimentos de origen animal en relación con los residuos de agentes antimicrobianos.\n",
      "\n",
      "Las medidas incluyen acciones a nivel de todas las etapas y los actores que intervienen en el ciclo de uso de los antimicrobianos, desde su registro en el SENASA hasta su prescripción, comercialización y consumo.\n",
      "\n",
      "- 8.2. Situación actual del uso responsable de antimicrobianos en salud animal y producción agroalimentaria No existen datos nacionales sobre la cantidad de antimicrobianos utilizados en las diferentes especies animales. A nivel mundial, se estima que la mitad de los antibióticos producidos se destina a uso veterinaria, de lo cual el 80% corresponde a producciones intensivas de cerdos, aves y bovinos, un 10% a mascotas (perros y gatos) y el 5% restante a piscicultura. A su vez, un porcentaje importante del uso en producción intensiva no cumple con un fin terapØutico, sino que se utiliza como aditivo promotor del crecimiento.\n",
      "\n",
      "Tampoco existen en el país reglamentaciones que establezcan prÆcticas específicas para el uso responsable de antimicrobianos. A nivel mundial, el Código Sanitario para los Animales Terrestres (OIE) especifica los criterios y las medidas para lograr el uso responsable de los antimicrobianos, y actœa como una norma internacional para sus países miembros. Algunas de las acciones detalladas en esta norma global se encuentran reglamentadas y se aplican en nuestro país, tales como la exigencia de requisitos para la\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "https://www.boletinoficial.gob.ar/pdf/linkQR/YzB6b2o4Qy9ZRDFycmZ0RFhoUThyQT09\n",
      "\n",
      "autorización de comercialización y controles de calidad por parte de los fabricantes, y la definición y control del cumplimiento de los períodos de restricción pre-faena y pre-ordeæe. Asimismo, las regulaciones generadas por el SENASA en los œltimos aæos, y destinadas a la trazabilidad de productos y a registros de tratamientos se adecuan tambiØn al Código de la OIE.\n",
      "\n",
      "Por otra parte, existen Æmbitos que requieren de mayores acciones, tales como los sistemas de contralor de las prescripciones y su trazabilidad, actualmente en desarrollo. Asimismo, se debe tener en cuenta que no se han realizado aœn campaæas sistematizadas a nivel nacional para a la difusión de buenas prÆcticas de uso.\n",
      "\n",
      "- 8.3. Líneas estratØgicas para el uso responsable de antimicrobianos en salud animal y producción agroalimentaria\n",
      "- a) Desarrollo de conocimiento, formación e información a profesionales veterinarios sobre el uso prudente y responsable de antibióticos, sustentado sobre bases farmacocinØticas, farmacodinÆmicas y toxicológicas;\n",
      "- b) Intensificación de los controles de comercialización de formulaciones antimicrobianas;\n",
      "- c) Regulación del uso de antimicrobianos en función de la información que se obtenga del programa de vigilancia, y el correspondiente anÆlisis de riesgos;\n",
      "- d) Incremento del conocimiento farmacológico y farmacotØcnico sobre el comportamiento de las formulaciones antibióticas, vehiculizadas en matrices biológicas y en los animales, considerando el impacto en el medio ambiente;\n",
      "- e) Control de la evolución de resistencia bacteriana a antibióticos en la clínica de pequeæos animales y producciones intensivas; y\n",
      "- f) Promoción del uso responsable de antimicrobianos, incluyendo su correcta prescripción y administración por parte de los veterinarios.\n",
      "- 8.4 Acciones específicas para el uso responsable de antimicrobianos en salud animal y producción agroalimentaria\n",
      "- a) Elaborar una guía de buena prÆctica para la prescripción y uso de antimicrobianos y otros productos veterinarios, en línea con las referencias internacionales;\n",
      "- b) Organizar cursos y talleres de capacitación para veterinarios de prÆctica libre y aquellos que actœan en la cadena de comercialización o estÆn a cargo de explotaciones pecuarias y de plantas productoras de alimentos balanceados, en conjunto con las universidades, los colegios profesionales y grupos tØcnicos de intercambio de las diferentes actividades productivas (cerdos, aves, bovinos, etc.);\n",
      "- c) Incorporar la temÆtica de la RAM en la currícula de las carreras de veterinaria, en trabajo conjunto con el Consejo Nacional de Decanos de Ciencias Veterinarias; y\n",
      "- d) Sostener y potenciar el contralor en todas las etapas del proceso de distribución y uso de antimicrobianos, ampliando al resto de los medicamentos veterinarios con impacto en la salud humana.\n",
      "- 9. PREVENCIÓN Y CONTROL DE INFECCIONES ASOCIADAS AL CUIDADO DE LA SALUD HUMANA\n",
      "- 9.1. Definición y relación con el problema de la RAM\n",
      "\n",
      "Infección Hospitalaria (IH) o Infección asociada al cuidado de la salud (IACS) es toda afección localizada o sistØmica producida como consecuencia de una reacción adversa a la presencia de uno o mÆs agentes infecciosos o sus toxinas, que se presenta en un paciente asistido en una institución de salud y no estuviese presente o incubÆndose al momento de la admisión del paciente, salvo que se relacione con una admisión previa en la misma institución.\n",
      "\n",
      "Los pacientes internados constituyen uno de los principales reservorios de microorganismos resistentes a los\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "https://www.boletinoficial.gob.ar/pdf/linkQR/YzB6b2o4Qy9ZRDFycmZ0RFhoUThyQT09\n",
      "\n",
      "antimicrobianos y actœan como fuente de infección en las instituciones y en la comunidad. A su vez, los enfermos crónicos que requieren de frecuentes hospitalizaciones corren mayor riesgo de contraer infecciones por gØrmenes resistentes.\n",
      "\n",
      "El control deficiente de infecciones en cualquier entorno incrementa enormemente el riesgo de propagación de infecciones multirresistentes, especialmente durante los brotes. Por esta razón, las medidas de prevención y control de infecciones son fundamentales para contener la propagación de la RAM.\n",
      "\n",
      "- 9.2. Situación actual de la prevención y control de infecciones en salud humana\n",
      "\n",
      "El Programa Nacional de Epidemiología y Control de Infecciones Hospitalarias tiene sede en el Instituto Nacional de Epidemiología (INE-ANLIS), y fue creado por Resolución 2885/83 del entonces Ministerio de Acción Social, con el propósito de 'contribuir a la reducción de la morbimortalidad por IACS y a mejorar la calidad de atención en los hospitales del país'. El Programa trabaja sistemÆtica e ininterrumpidamente en 6 ejes interconectados: Docencia, Investigación, Normatización, Vigilancia, Asesoramiento y Educación para la salud.\n",
      "\n",
      "En referencia a la vigilancia, en 1995 se implementó a modo piloto el Sistema Intensificado de Vigilancia Epidemiológica Nacional de Infecciones Hospitalarias (SIVENIH) que involucró a 25 hospitales pœblicos y privados del país, voluntariamente adheridos, quienes recolectaron y analizaron datos de vigilancia durante 2 aæos. El anÆlisis de la experiencia piloto permitió detectar las fortalezas, debilidades y necesidades del sistema y, en 2004, se creó el Programa Nacional de Vigilancia de Infecciones Hospitalarias de Argentina (VIHDA) para el seguimiento de IACS en los hospitales adheridos. Este programa es de carÆcter voluntario y los hospitales deben cumplir una serie de requisitos para ser admitidos en Øl.\n",
      "\n",
      "El Programa VIHDA actualmente integra a diversas instituciones de salud del país en una red dedicada a la prevención, vigilancia y control continuo y sistematizado de las IACS, lo que le permite a cada institución disponer de sus propios indicadores de manera instantÆnea para actuar inmediatamente al respecto. Estas instituciones reportan al Programa la información relevante de la vigilancia a travØs de un sistema informÆtico especialmente diseæado, el cual puede generar reportes automÆticos e inmediatos de indicadores propios. La información es tambiØn consolidada a nivel nacional, con elaboración de indicadores nacionales.\n",
      "\n",
      "La estrategia de vigilancia del Programa VIHDA posee los siguientes componentes:\n",
      "\n",
      "- a) Vigilancia intensificada en Æreas críticas y quirœrgicas, a travØs del Software VIHDA; y\n",
      "- b) Estudios periódicos de Prevalencia de Infecciones Hospitalarias de Argentina (ENPIHA), a travØs del software SisWEP.\n",
      "\n",
      "AdemÆs de un programa nacional de vigilancia de las IACS, el otro elemento esencial para la reducción de la morbi-mortalidad ocasionada por ellas es la constitución en hospitales de un ComitØ de Control y Prevención de Infecciones, conformado por un equipo de profesionales que realizan actividades de detección, prevención, control, vigilancia, capacitación, docencia e investigación, para la detección, manejo y control de las IACS. En nuestro país, la mayoría de los hospitales de mayor complejidad ya lo han constituido. La estructura bÆsica de un ComitØ de Control de Infecciones comprende dos comisiones: una ejecutiva y otra ampliada. La primera debe estar integrada por un mØdico infectólogo, una enfermera responsable de control de infecciones (ECI) y un representante del Laboratorio de Microbiología. La segunda debe conformarse con representantes de los distintos servicios del hospital (enfermería, jefe de cirugía, UCIA/UCIP, esterilización, farmacia, administración, lavadero, compras, etc.), a fin de intermediar entre la comisión ejecutiva y los servicios.\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "https://www.boletinoficial.gob.ar/pdf/linkQR/YzB6b2o4Qy9ZRDFycmZ0RFhoUThyQT09\n",
      "\n",
      "- 9.3. Líneas estratØgicas para la prevención y control de infecciones en salud humana\n",
      "- 9.3.1. Fortalecimiento de los programas de prevención y control de infecciones en servicios asistenciales con internación, con los siguientes elementos:\n",
      "- a) Estructura orgÆnica para facilitar la formulación y la gestión de políticas y estrategias de prevención y control de infecciones;\n",
      "- b) Elaboración, implementación y actualización de directrices de prevención y control de infecciones, incluyendo el control de la resistencia a los antimicrobianos;\n",
      "- c) Capacitación de los equipos de salud en los principios y prÆcticas de prevención y control de infecciones;\n",
      "- d) Ambientes apropiados (infraestructura y equipamiento) para la aplicación adecuada de los principios y prÆcticas de prevención y control de infecciones;\n",
      "- e) Servicios de laboratorio y de diagnóstico que permitan la detección exacta y oportuna de microorganismos resistentes para fundamentar la prescripción de antimicrobianos;\n",
      "- f) Estrategia de vigilancia para posibilitar la detección y contención precoces de infecciones por microorganismos multirresistentes emergentes;\n",
      "- g) Monitoreo y evaluación del programa para adaptar la estrategia segœn necesidad;\n",
      "- h) Inclusión del cargo de Enfermero en Control de Infecciones en el escalafón y requisitos para la función en proporción a la cantidad de camas de las instituciones; y\n",
      "- i) Comunicación con las autoridades y todos los servicios del establecimiento.\n",
      "- 9.3.2. Promoción de la aplicación de las normas de prevención y control de infecciones en establecimientos de salud (higiene de manos, precauciones de barrera, asepsia, desinfección y esterilización, higiene ambiental y manejo de residuos), y capacitación sobre el control y la prevención de infecciones en entornos comunitarios.\n",
      "- 9.3.3. Fortalecimiento de los programas provinciales de prevención y control de infecciones.\n",
      "- 9.4. Acciones específicas para la prevención y control de infecciones en salud humana\n",
      "- a) Implementar un curso sobre control y prevención de IACS en forma conjunta entre el Programa VIHDA, SADI, SATI y ADECI, en la plataforma de educación a distancia de ANLIS.\n",
      "- b) Actualizar el Consenso INE-SADI 2011 'La multirresistencia: un problema a abordar en forma interdisciplinaria e interinstitucional'. Este Consenso incluye la siguiente temÆtica: manejo adecuado de antibióticos; optimización de los procesos de prevención de IACS; y uso de antimicrobianos en grandes animales y en alimentos de origen agropecuario, y su implicancia en la salud humana;\n",
      "- c) Incentivar la incorporación de mÆs hospitales al programa VIHDA y optimizar la base de datos para facilitar su carga;\n",
      "- d) Supervisar y asesorar a los establecimientos de salud de referencia en cada provincia, a cargo del Programa VIHDA;\n",
      "- e) Asesorar en forma directa a profesionales de la salud desde el Programa VIHDA;\n",
      "- f) Implementar el Programa de Autoevaluación para los programas de prevención y control de IACS en establecimientos de salud de referencia;\n",
      "- g) Promover el reconocimiento de las tareas de enfermería en control de infecciones en los hospitales del país; y\n",
      "- h) Estimular la mejora continua de la infraestructura, personal e instrumental para lograr una adecuada prevención y control de las infecciones intrahospitalarias.\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "https://www.boletinoficial.gob.ar/pdf/linkQR/YzB6b2o4Qy9ZRDFycmZ0RFhoUThyQT09\n",
      "\n",
      "## 10. PREVENCIÓN Y CONTROL DE INFECCIONES EN SALUD ANIMAL Y PRODUCCIÓN AGROALIMENTARIA\n",
      "\n",
      "## 10.1. Definición y relación con el problema de la RAM\n",
      "\n",
      "La ganadería desempeæa un importante papel para la seguridad e inocuidad alimentaria y la nutrición de los seres humanos. El desarrollo de los sistemas productivos ha derivado en una creciente demanda de alternativas profilÆcticas y terapØuticas, y los antimicrobianos se han transformado en herramientas esenciales para el tratamiento y control de las enfermedades infecciosas de los animales.\n",
      "\n",
      "La tecnificación en el proceso de producción de proteínas de origen animal no ha quedado exenta de resultar en una mayor presión de selección de cepas resistentes, considerÆndose que la producción de alimentos de origen animal constituye un factor importante de riesgo de selección y propagación a los seres humanos de los microorganismos resistentes a los antimicrobianos, así como de sus determinantes de resistencia, principalmente a travØs del consumo de alimentos.\n",
      "\n",
      "El tratamiento de los animales enfermos en medicina veterinaria representa un verdadero desafío, debido a que la medicina individual ha evolucionado hacia una medicina de tipo colectivo despuØs de la generalización de las producciones intensivas, donde ya no se habla de un animal enfermo sino de un conjunto de animales enfermos que deben ser atendidos. En estos casos, es difícil suponer que todos los animales tratados a un mismo tiempo con una dosis adecuada incorporada en el agua de bebida, en los alimentos o por vía parenteral, tengan una misma respuesta terapØutica, lo que predispone a que algunos de ellos sean sub dosificados y a que persista la presión de infección dentro del grupo tratado. Esto aumenta enormemente el riesgo de propagación de la infección atentando contra el bienestar animal y predisponiendo al desarrollo de infecciones multirresistentes.\n",
      "\n",
      "La sub dosificación, el uso profilÆctico y la aplicación de antimicrobianos como promotores del crecimiento facilitan al desarrollo de infecciones asociadas con RAM, lo que representa un problema real para la salud pœblica por tratarse en muchas casos de enfermedades de carÆcter zoonótico -salmonelosis, campilobacteriosis, Escherichia coli enterohemorrÆgica.\n",
      "\n",
      "10.2. Situación actual de la prevención y control de infecciones en salud animal\n",
      "\n",
      "Existen actualmente normas internacionales dedicadas al tema, destacÆndose los Capítulos 6.7 al 6.10 del Código Sanitario para los Animales Terrestres de la OIE, que abarcan desde la armonización de los programas nacionales de vigilancia de la RAM, hasta las metodologías para el seguimiento de las cantidades de antimicrobianos utilizadas y sus patrones de uso, los criterios para su uso prudente y responsable, y la metodología de aplicación de anÆlisis de riesgos derivados del uso de antimicrobianos en animales en toda la cadena alimentaria. Por otra parte, la atención de la prevención y control de infecciones en medicina veterinaria se suele dedicar en mayor medida a enfermedades sujetas a notificación obligatoria, tales como fiebre aftosa, tuberculosis, brucelosis, leptospirosis, hidatidosis, rabia o triquinelosis; y en menor medida a las infecciones causadas por bacterias resistentes a los antibióticos.\n",
      "\n",
      "En relación a la vigilancia, el Sistema Mundial de Información Sanitaria Animal que mantiene la OlE concentra la información que proveen los países e incluye los eventos epidemiológicos importantes, así como el seguimiento anual de ciertas enfermedades en animales terrestres y acuÆticos, incluyendo a los animales silvestres.\n",
      "\n",
      "10.3. Líneas estratØgicas para la prevención y control de infecciones en salud animal\n",
      "\n",
      "a) Desarrollo de programas de gestión, prevención y control de enfermedades infecciosas asociadas con\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "https://www.boletinoficial.gob.ar/pdf/linkQR/YzB6b2o4Qy9ZRDFycmZ0RFhoUThyQT09\n",
      "\n",
      "resistencia a los antimicrobianos en medicina veterinaria, contemplando la bioseguridad de establecimientos de producción intensiva en cuanto a infraestructura y equipamiento adecuado para las prÆcticas de prevención y control de infecciones;\n",
      "\n",
      "- b) Capacitación del personal tØcnico destinado a producciones animales intensivas para la prevención y control de enfermedades infecciosas en los entornos productivos; e\n",
      "- c) Implementación de laboratorios de diagnóstico en red que permitan la identificación de microorganismos resistentes a antimicrobianos y el monitoreo de las infecciones.\n",
      "- 10.4. Acciones específicas para la prevención y control de infecciones en salud animal\n",
      "- a) Desarrollar normativas para llevar adelante los programas de prevención y control de infecciones entre el Ministerio de Agricultura, Ganadería y Pesca, el Ministerio de Salud, las universidades y los colegios profesionales;\n",
      "- b) Realizar cursos de capacitación a profesionales veterinarios dictados en forma conjunta entre el Ministerio de Agricultura, Ganadería y Pesca, el Ministerio de Salud, los colegios profesionales y las universidades;\n",
      "- c) Propiciar el cumplimiento de normas bÆsicas de bioseguridad, higiene y desinfección del personal, equipamiento y ambiente productivo afectados a las producciones intensivas;\n",
      "- d) Generar laboratorios con diagnósticos protocolizados y trabajo en red para determinar el nivel de resistencia de bacterias aisladas de animales de consumo y la emergencia de mecanismos de resistencia a antimicrobianos críticos en la salud humana y animal, como así tambiØn el uso adecuado de antimicrobianos;\n",
      "\n",
      "y\n",
      "\n",
      "- e) Desarrollar un programa de monitoreo y evaluación para adoptar estrategias conjuntas entre los Æmbitos veterinario y humano.\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "## BIBLIOGRAFIA DE REFERENCIA\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "https://www.boletinoficial.gob.ar/pdf/linkQR/YzB6b2o4Qy9ZRDFycmZ0RFhoUThyQT09\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "pub'\n",
      "\n",
      "## ANEXO II\n",
      "\n",
      "Comisión Nacional para el Control de la Resistencia Antimicrobiana\n",
      "\n",
      "Artículo 1°: La Comisión Nacional para el Control de la Resistencia Antimicrobiana serÆ presidida por el titular de la Secretaría de Promoción y Programas Sanitarios quien cursarÆ las invitaciones a las reuniones ordinarias y/o extraordinarias de la misma.\n",
      "\n",
      "Artículo 2°: La Comisión Nacional para el Control de la Resistencia Antimicrobiana serÆ integrada por la mÆxima autoridad, o por un representante por ella designada, de cada uno de los siguientes:\n",
      "\n",
      "La Dirección Nacional de Prevención de Enfermedades y Riesgos;\n",
      "\n",
      "La Administración Nacional de Medicamentos, Alimentos y Tecnología MØdica (ANMAT);\n",
      "\n",
      "El Instituto Nacional de Enfermedades Infecciosas Agudas (INEI) dependiente de la Administración Nacional de Laboratorios e Institutos de Salud (ANLIS);\n",
      "\n",
      "El Instituto Nacional de Epidemiología (INE) dependiente de la Administración Nacional de Laboratorios e Institutos de Salud (ANLIS);\n",
      "\n",
      "El Instituto Nacional de Tecnología Agropecuaria (INTA);\n",
      "\n",
      "El Servicio Nacional de Sanidad y Calidad Agro-alimentaria (SENASA);\n",
      "\n",
      "El REMEDIAR + Redes; y\n",
      "\n",
      "La Dirección de Economía de la Salud.\n",
      "\n",
      "Artículo 3°: Invitase a las siguientes entidades a participar de la Comisión Nacional para el Control de la Resistencia Antimicrobiana en calidad de Miembro Invitado, a travØs de su mÆxima autoridad o de un\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "https://www.boletinoficial.gob.ar/pdf/linkQR/YzB6b2o4Qy9ZRDFycmZ0RFhoUThyQT09\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "<!-- image -->\n",
      "\n",
      "https://www.boletinoficial.gob.ar/pdf/linkQR/YzB6b2o4Qy9ZRDFycmZ0RFhoUThyQT09\n",
      "\n",
      "representante por ella designado:\n",
      "\n",
      "Asociación Argentina de Enfermeros en Control de infecciones (ADECI);\n",
      "\n",
      "Sociedad Argentina de Infectología (SADI);\n",
      "\n",
      "Sociedad Argentina de Terapia Intensiva (SATI);\n",
      "\n",
      "Organización Mundial de Sanidad Animal (OIE);\n",
      "\n",
      "y\n",
      "\n",
      "Organización Panamericana de la Salud (OPS).\n",
      "\n",
      "Artículo 4': Los integrantes de la Comisión Nacional para el Control de la Resistencia Antimicrobiana designados en los artículos 3° y 4° desarrollarÆn sus funciones en carÆcter ad-honorem y sin perjuicio de sus funciones específicas.\n",
      "\n",
      "Artículo 5': Facultase a la Comisión Nacional para el Control de la Resistencia Antimicrobiana a convocar a otros organismos estatales, sociedades científicas, entidades de la sociedad civil, acadØmicos, funcionarios y/o expertos en la materia cuando así lo estime oportuno y conveniente en pos de cumplir con sus objetivos.\n",
      "\n",
      "Artículo 6°: La Comisión Nacional para el Control de la Resistencia Antimicrobiana se reunirÆ una vez cada tres (3) meses, o cuando el Presidente de la Comisión lo considere necesario. Todas las decisiones de la Comisión Nacional para el Control de la Resistencia Antimicrobiana se adoptarÆn por mayoría simple de los miembros presentes.\n",
      "\n",
      "Artículo 7°: Las reuniones y resoluciones adoptadas por la Comisión Nacional para el Control de la Resistencia Antimicrobiana se registrarÆn en un libro de actas. Previo al inicio de cada reunión se designarÆ entre los presentes un secretario de actas a fin de cumplir esta labor. Una vez finalizada los presentes refrendarÆn la misma.\n",
      "\n",
      "e. 29/06/2015 N° 113788/15 v. 29/06/2015\n",
      "\n",
      "Fecha de publicacion:\n",
      "\n",
      "29/06/2015\n",
      "\n",
      "<!-- image -->\n"
     ]
    }
   ],
   "source": [
    "print(result.document.export_to_markdown())"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Spanish scanned document (Ecudaor)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Converting document:   0%|          | 0/100 [01:53<?, ?it/s]\n"
     ]
    },
    {
     "ename": "KeyboardInterrupt",
     "evalue": "",
     "output_type": "error",
     "traceback": [
      "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[0;31mKeyboardInterrupt\u001b[0m                         Traceback (most recent call last)",
      "Cell \u001b[0;32mIn[11], line 7\u001b[0m\n\u001b[1;32m      5\u001b[0m \u001b[38;5;66;03m# this one is less structured\u001b[39;00m\n\u001b[1;32m      6\u001b[0m \u001b[38;5;28;01mwith\u001b[39;00m tqdm(total\u001b[38;5;241m=\u001b[39m\u001b[38;5;241m100\u001b[39m, desc\u001b[38;5;241m=\u001b[39m\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mConverting document\u001b[39m\u001b[38;5;124m\"\u001b[39m) \u001b[38;5;28;01mas\u001b[39;00m pbar:\n\u001b[0;32m----> 7\u001b[0m     result \u001b[38;5;241m=\u001b[39m \u001b[43mconverter\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mconvert\u001b[49m\u001b[43m(\u001b[49m\u001b[43mecuador_link\u001b[49m\u001b[43m)\u001b[49m\n\u001b[1;32m      8\u001b[0m     pbar\u001b[38;5;241m.\u001b[39mupdate(\u001b[38;5;241m100\u001b[39m)\n",
      "File \u001b[0;32m~/Library/Python/3.9/lib/python/site-packages/pydantic/_internal/_validate_call.py:38\u001b[0m, in \u001b[0;36mupdate_wrapper_attributes.<locals>.wrapper_function\u001b[0;34m(*args, **kwargs)\u001b[0m\n\u001b[1;32m     36\u001b[0m \u001b[38;5;129m@functools\u001b[39m\u001b[38;5;241m.\u001b[39mwraps(wrapped)\n\u001b[1;32m     37\u001b[0m \u001b[38;5;28;01mdef\u001b[39;00m \u001b[38;5;21mwrapper_function\u001b[39m(\u001b[38;5;241m*\u001b[39margs, \u001b[38;5;241m*\u001b[39m\u001b[38;5;241m*\u001b[39mkwargs):\n\u001b[0;32m---> 38\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[43mwrapper\u001b[49m\u001b[43m(\u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43margs\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43mkwargs\u001b[49m\u001b[43m)\u001b[49m\n",
      "File \u001b[0;32m~/Library/Python/3.9/lib/python/site-packages/pydantic/_internal/_validate_call.py:111\u001b[0m, in \u001b[0;36mValidateCallWrapper.__call__\u001b[0;34m(self, *args, **kwargs)\u001b[0m\n\u001b[1;32m    110\u001b[0m \u001b[38;5;28;01mdef\u001b[39;00m \u001b[38;5;21m__call__\u001b[39m(\u001b[38;5;28mself\u001b[39m, \u001b[38;5;241m*\u001b[39margs: Any, \u001b[38;5;241m*\u001b[39m\u001b[38;5;241m*\u001b[39mkwargs: Any) \u001b[38;5;241m-\u001b[39m\u001b[38;5;241m>\u001b[39m Any:\n\u001b[0;32m--> 111\u001b[0m     res \u001b[38;5;241m=\u001b[39m \u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43m__pydantic_validator__\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mvalidate_python\u001b[49m\u001b[43m(\u001b[49m\u001b[43mpydantic_core\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mArgsKwargs\u001b[49m\u001b[43m(\u001b[49m\u001b[43margs\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mkwargs\u001b[49m\u001b[43m)\u001b[49m\u001b[43m)\u001b[49m\n\u001b[1;32m    112\u001b[0m     \u001b[38;5;28;01mif\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m__return_pydantic_validator__:\n\u001b[1;32m    113\u001b[0m         \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m__return_pydantic_validator__(res)\n",
      "File \u001b[0;32m~/Library/Python/3.9/lib/python/site-packages/docling/document_converter.py:195\u001b[0m, in \u001b[0;36mDocumentConverter.convert\u001b[0;34m(self, source, headers, raises_on_error, max_num_pages, max_file_size)\u001b[0m\n\u001b[1;32m    179\u001b[0m \u001b[38;5;129m@validate_call\u001b[39m(config\u001b[38;5;241m=\u001b[39mConfigDict(strict\u001b[38;5;241m=\u001b[39m\u001b[38;5;28;01mTrue\u001b[39;00m))\n\u001b[1;32m    180\u001b[0m \u001b[38;5;28;01mdef\u001b[39;00m \u001b[38;5;21mconvert\u001b[39m(\n\u001b[1;32m    181\u001b[0m     \u001b[38;5;28mself\u001b[39m,\n\u001b[0;32m   (...)\u001b[0m\n\u001b[1;32m    186\u001b[0m     max_file_size: \u001b[38;5;28mint\u001b[39m \u001b[38;5;241m=\u001b[39m sys\u001b[38;5;241m.\u001b[39mmaxsize,\n\u001b[1;32m    187\u001b[0m ) \u001b[38;5;241m-\u001b[39m\u001b[38;5;241m>\u001b[39m ConversionResult:\n\u001b[1;32m    188\u001b[0m     all_res \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39mconvert_all(\n\u001b[1;32m    189\u001b[0m         source\u001b[38;5;241m=\u001b[39m[source],\n\u001b[1;32m    190\u001b[0m         raises_on_error\u001b[38;5;241m=\u001b[39mraises_on_error,\n\u001b[0;32m   (...)\u001b[0m\n\u001b[1;32m    193\u001b[0m         headers\u001b[38;5;241m=\u001b[39mheaders,\n\u001b[1;32m    194\u001b[0m     )\n\u001b[0;32m--> 195\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28;43mnext\u001b[39;49m\u001b[43m(\u001b[49m\u001b[43mall_res\u001b[49m\u001b[43m)\u001b[49m\n",
      "File \u001b[0;32m~/Library/Python/3.9/lib/python/site-packages/docling/document_converter.py:216\u001b[0m, in \u001b[0;36mDocumentConverter.convert_all\u001b[0;34m(self, source, headers, raises_on_error, max_num_pages, max_file_size)\u001b[0m\n\u001b[1;32m    213\u001b[0m conv_res_iter \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_convert(conv_input, raises_on_error\u001b[38;5;241m=\u001b[39mraises_on_error)\n\u001b[1;32m    215\u001b[0m had_result \u001b[38;5;241m=\u001b[39m \u001b[38;5;28;01mFalse\u001b[39;00m\n\u001b[0;32m--> 216\u001b[0m \u001b[38;5;28;01mfor\u001b[39;00m conv_res \u001b[38;5;129;01min\u001b[39;00m conv_res_iter:\n\u001b[1;32m    217\u001b[0m     had_result \u001b[38;5;241m=\u001b[39m \u001b[38;5;28;01mTrue\u001b[39;00m\n\u001b[1;32m    218\u001b[0m     \u001b[38;5;28;01mif\u001b[39;00m raises_on_error \u001b[38;5;129;01mand\u001b[39;00m conv_res\u001b[38;5;241m.\u001b[39mstatus \u001b[38;5;129;01mnot\u001b[39;00m \u001b[38;5;129;01min\u001b[39;00m {\n\u001b[1;32m    219\u001b[0m         ConversionStatus\u001b[38;5;241m.\u001b[39mSUCCESS,\n\u001b[1;32m    220\u001b[0m         ConversionStatus\u001b[38;5;241m.\u001b[39mPARTIAL_SUCCESS,\n\u001b[1;32m    221\u001b[0m     }:\n",
      "File \u001b[0;32m~/Library/Python/3.9/lib/python/site-packages/docling/document_converter.py:251\u001b[0m, in \u001b[0;36mDocumentConverter._convert\u001b[0;34m(self, conv_input, raises_on_error)\u001b[0m\n\u001b[1;32m    242\u001b[0m _log\u001b[38;5;241m.\u001b[39minfo(\u001b[38;5;124mf\u001b[39m\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mGoing to convert document batch...\u001b[39m\u001b[38;5;124m\"\u001b[39m)\n\u001b[1;32m    244\u001b[0m \u001b[38;5;66;03m# parallel processing only within input_batch\u001b[39;00m\n\u001b[1;32m    245\u001b[0m \u001b[38;5;66;03m# with ThreadPoolExecutor(\u001b[39;00m\n\u001b[1;32m    246\u001b[0m \u001b[38;5;66;03m#    max_workers=settings.perf.doc_batch_concurrency\u001b[39;00m\n\u001b[1;32m    247\u001b[0m \u001b[38;5;66;03m# ) as pool:\u001b[39;00m\n\u001b[1;32m    248\u001b[0m \u001b[38;5;66;03m#   yield from pool.map(self.process_document, input_batch)\u001b[39;00m\n\u001b[1;32m    249\u001b[0m \u001b[38;5;66;03m# Note: PDF backends are not thread-safe, thread pool usage was disabled.\u001b[39;00m\n\u001b[0;32m--> 251\u001b[0m \u001b[38;5;28;01mfor\u001b[39;00m item \u001b[38;5;129;01min\u001b[39;00m \u001b[38;5;28mmap\u001b[39m(\n\u001b[1;32m    252\u001b[0m     partial(\u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_process_document, raises_on_error\u001b[38;5;241m=\u001b[39mraises_on_error),\n\u001b[1;32m    253\u001b[0m     input_batch,\n\u001b[1;32m    254\u001b[0m ):\n\u001b[1;32m    255\u001b[0m     elapsed \u001b[38;5;241m=\u001b[39m time\u001b[38;5;241m.\u001b[39mmonotonic() \u001b[38;5;241m-\u001b[39m start_time\n\u001b[1;32m    256\u001b[0m     start_time \u001b[38;5;241m=\u001b[39m time\u001b[38;5;241m.\u001b[39mmonotonic()\n",
      "File \u001b[0;32m~/Library/Python/3.9/lib/python/site-packages/docling/document_converter.py:292\u001b[0m, in \u001b[0;36mDocumentConverter._process_document\u001b[0;34m(self, in_doc, raises_on_error)\u001b[0m\n\u001b[1;32m    288\u001b[0m valid \u001b[38;5;241m=\u001b[39m (\n\u001b[1;32m    289\u001b[0m     \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39mallowed_formats \u001b[38;5;129;01mis\u001b[39;00m \u001b[38;5;129;01mnot\u001b[39;00m \u001b[38;5;28;01mNone\u001b[39;00m \u001b[38;5;129;01mand\u001b[39;00m in_doc\u001b[38;5;241m.\u001b[39mformat \u001b[38;5;129;01min\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39mallowed_formats\n\u001b[1;32m    290\u001b[0m )\n\u001b[1;32m    291\u001b[0m \u001b[38;5;28;01mif\u001b[39;00m valid:\n\u001b[0;32m--> 292\u001b[0m     conv_res \u001b[38;5;241m=\u001b[39m \u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43m_execute_pipeline\u001b[49m\u001b[43m(\u001b[49m\u001b[43min_doc\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mraises_on_error\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mraises_on_error\u001b[49m\u001b[43m)\u001b[49m\n\u001b[1;32m    293\u001b[0m \u001b[38;5;28;01melse\u001b[39;00m:\n\u001b[1;32m    294\u001b[0m     error_message \u001b[38;5;241m=\u001b[39m \u001b[38;5;124mf\u001b[39m\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mFile format not allowed: \u001b[39m\u001b[38;5;132;01m{\u001b[39;00min_doc\u001b[38;5;241m.\u001b[39mfile\u001b[38;5;132;01m}\u001b[39;00m\u001b[38;5;124m\"\u001b[39m\n",
      "File \u001b[0;32m~/Library/Python/3.9/lib/python/site-packages/docling/document_converter.py:315\u001b[0m, in \u001b[0;36mDocumentConverter._execute_pipeline\u001b[0;34m(self, in_doc, raises_on_error)\u001b[0m\n\u001b[1;32m    313\u001b[0m pipeline \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_get_pipeline(in_doc\u001b[38;5;241m.\u001b[39mformat)\n\u001b[1;32m    314\u001b[0m \u001b[38;5;28;01mif\u001b[39;00m pipeline \u001b[38;5;129;01mis\u001b[39;00m \u001b[38;5;129;01mnot\u001b[39;00m \u001b[38;5;28;01mNone\u001b[39;00m:\n\u001b[0;32m--> 315\u001b[0m     conv_res \u001b[38;5;241m=\u001b[39m \u001b[43mpipeline\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mexecute\u001b[49m\u001b[43m(\u001b[49m\u001b[43min_doc\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mraises_on_error\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mraises_on_error\u001b[49m\u001b[43m)\u001b[49m\n\u001b[1;32m    316\u001b[0m \u001b[38;5;28;01melse\u001b[39;00m:\n\u001b[1;32m    317\u001b[0m     \u001b[38;5;28;01mif\u001b[39;00m raises_on_error:\n",
      "File \u001b[0;32m~/Library/Python/3.9/lib/python/site-packages/docling/pipeline/base_pipeline.py:45\u001b[0m, in \u001b[0;36mBasePipeline.execute\u001b[0;34m(self, in_doc, raises_on_error)\u001b[0m\n\u001b[1;32m     39\u001b[0m \u001b[38;5;28;01mtry\u001b[39;00m:\n\u001b[1;32m     40\u001b[0m     \u001b[38;5;28;01mwith\u001b[39;00m TimeRecorder(\n\u001b[1;32m     41\u001b[0m         conv_res, \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mpipeline_total\u001b[39m\u001b[38;5;124m\"\u001b[39m, scope\u001b[38;5;241m=\u001b[39mProfilingScope\u001b[38;5;241m.\u001b[39mDOCUMENT\n\u001b[1;32m     42\u001b[0m     ):\n\u001b[1;32m     43\u001b[0m         \u001b[38;5;66;03m# These steps are building and assembling the structure of the\u001b[39;00m\n\u001b[1;32m     44\u001b[0m         \u001b[38;5;66;03m# output DoclingDocument.\u001b[39;00m\n\u001b[0;32m---> 45\u001b[0m         conv_res \u001b[38;5;241m=\u001b[39m \u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43m_build_document\u001b[49m\u001b[43m(\u001b[49m\u001b[43mconv_res\u001b[49m\u001b[43m)\u001b[49m\n\u001b[1;32m     46\u001b[0m         conv_res \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_assemble_document(conv_res)\n\u001b[1;32m     47\u001b[0m         \u001b[38;5;66;03m# From this stage, all operations should rely only on conv_res.output\u001b[39;00m\n",
      "File \u001b[0;32m~/Library/Python/3.9/lib/python/site-packages/docling/pipeline/base_pipeline.py:161\u001b[0m, in \u001b[0;36mPaginatedPipeline._build_document\u001b[0;34m(self, conv_res)\u001b[0m\n\u001b[1;32m    158\u001b[0m \u001b[38;5;66;03m# 2. Run pipeline stages\u001b[39;00m\n\u001b[1;32m    159\u001b[0m pipeline_pages \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_apply_on_pages(conv_res, init_pages)\n\u001b[0;32m--> 161\u001b[0m \u001b[38;5;28;01mfor\u001b[39;00m p \u001b[38;5;129;01min\u001b[39;00m pipeline_pages:  \u001b[38;5;66;03m# Must exhaust!\u001b[39;00m\n\u001b[1;32m    162\u001b[0m \n\u001b[1;32m    163\u001b[0m     \u001b[38;5;66;03m# Cleanup cached images\u001b[39;00m\n\u001b[1;32m    164\u001b[0m     \u001b[38;5;28;01mif\u001b[39;00m \u001b[38;5;129;01mnot\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39mkeep_images:\n\u001b[1;32m    165\u001b[0m         p\u001b[38;5;241m.\u001b[39m_image_cache \u001b[38;5;241m=\u001b[39m {}\n",
      "File \u001b[0;32m~/Library/Python/3.9/lib/python/site-packages/docling/pipeline/base_pipeline.py:127\u001b[0m, in \u001b[0;36mPaginatedPipeline._apply_on_pages\u001b[0;34m(self, conv_res, page_batch)\u001b[0m\n\u001b[1;32m    124\u001b[0m \u001b[38;5;28;01mfor\u001b[39;00m model \u001b[38;5;129;01min\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39mbuild_pipe:\n\u001b[1;32m    125\u001b[0m     page_batch \u001b[38;5;241m=\u001b[39m model(conv_res, page_batch)\n\u001b[0;32m--> 127\u001b[0m \u001b[38;5;28;01myield from\u001b[39;00m page_batch\n",
      "File \u001b[0;32m~/Library/Python/3.9/lib/python/site-packages/docling/models/page_assemble_model.py:60\u001b[0m, in \u001b[0;36mPageAssembleModel.__call__\u001b[0;34m(self, conv_res, page_batch)\u001b[0m\n\u001b[1;32m     57\u001b[0m \u001b[38;5;28;01mdef\u001b[39;00m \u001b[38;5;21m__call__\u001b[39m(\n\u001b[1;32m     58\u001b[0m     \u001b[38;5;28mself\u001b[39m, conv_res: ConversionResult, page_batch: Iterable[Page]\n\u001b[1;32m     59\u001b[0m ) \u001b[38;5;241m-\u001b[39m\u001b[38;5;241m>\u001b[39m Iterable[Page]:\n\u001b[0;32m---> 60\u001b[0m     \u001b[38;5;28;01mfor\u001b[39;00m page \u001b[38;5;129;01min\u001b[39;00m page_batch:\n\u001b[1;32m     61\u001b[0m         \u001b[38;5;28;01massert\u001b[39;00m page\u001b[38;5;241m.\u001b[39m_backend \u001b[38;5;129;01mis\u001b[39;00m \u001b[38;5;129;01mnot\u001b[39;00m \u001b[38;5;28;01mNone\u001b[39;00m\n\u001b[1;32m     62\u001b[0m         \u001b[38;5;28;01mif\u001b[39;00m \u001b[38;5;129;01mnot\u001b[39;00m page\u001b[38;5;241m.\u001b[39m_backend\u001b[38;5;241m.\u001b[39mis_valid():\n",
      "File \u001b[0;32m~/Library/Python/3.9/lib/python/site-packages/docling/models/table_structure_model.py:136\u001b[0m, in \u001b[0;36mTableStructureModel.__call__\u001b[0;34m(self, conv_res, page_batch)\u001b[0m\n\u001b[1;32m    133\u001b[0m     \u001b[38;5;28;01myield from\u001b[39;00m page_batch\n\u001b[1;32m    134\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m\n\u001b[0;32m--> 136\u001b[0m \u001b[38;5;28;01mfor\u001b[39;00m page \u001b[38;5;129;01min\u001b[39;00m page_batch:\n\u001b[1;32m    137\u001b[0m     \u001b[38;5;28;01massert\u001b[39;00m page\u001b[38;5;241m.\u001b[39m_backend \u001b[38;5;129;01mis\u001b[39;00m \u001b[38;5;129;01mnot\u001b[39;00m \u001b[38;5;28;01mNone\u001b[39;00m\n\u001b[1;32m    138\u001b[0m     \u001b[38;5;28;01mif\u001b[39;00m \u001b[38;5;129;01mnot\u001b[39;00m page\u001b[38;5;241m.\u001b[39m_backend\u001b[38;5;241m.\u001b[39mis_valid():\n",
      "File \u001b[0;32m~/Library/Python/3.9/lib/python/site-packages/docling/models/layout_model.py:102\u001b[0m, in \u001b[0;36mLayoutModel.__call__\u001b[0;34m(self, conv_res, page_batch)\u001b[0m\n\u001b[1;32m     98\u001b[0m \u001b[38;5;28;01mdef\u001b[39;00m \u001b[38;5;21m__call__\u001b[39m(\n\u001b[1;32m     99\u001b[0m     \u001b[38;5;28mself\u001b[39m, conv_res: ConversionResult, page_batch: Iterable[Page]\n\u001b[1;32m    100\u001b[0m ) \u001b[38;5;241m-\u001b[39m\u001b[38;5;241m>\u001b[39m Iterable[Page]:\n\u001b[0;32m--> 102\u001b[0m     \u001b[38;5;28;01mfor\u001b[39;00m page \u001b[38;5;129;01min\u001b[39;00m page_batch:\n\u001b[1;32m    103\u001b[0m         \u001b[38;5;28;01massert\u001b[39;00m page\u001b[38;5;241m.\u001b[39m_backend \u001b[38;5;129;01mis\u001b[39;00m \u001b[38;5;129;01mnot\u001b[39;00m \u001b[38;5;28;01mNone\u001b[39;00m\n\u001b[1;32m    104\u001b[0m         \u001b[38;5;28;01mif\u001b[39;00m \u001b[38;5;129;01mnot\u001b[39;00m page\u001b[38;5;241m.\u001b[39m_backend\u001b[38;5;241m.\u001b[39mis_valid():\n",
      "File \u001b[0;32m~/Library/Python/3.9/lib/python/site-packages/docling/models/easyocr_model.py:100\u001b[0m, in \u001b[0;36mEasyOcrModel.__call__\u001b[0;34m(self, conv_res, page_batch)\u001b[0m\n\u001b[1;32m     96\u001b[0m high_res_image \u001b[38;5;241m=\u001b[39m page\u001b[38;5;241m.\u001b[39m_backend\u001b[38;5;241m.\u001b[39mget_page_image(\n\u001b[1;32m     97\u001b[0m     scale\u001b[38;5;241m=\u001b[39m\u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39mscale, cropbox\u001b[38;5;241m=\u001b[39mocr_rect\n\u001b[1;32m     98\u001b[0m )\n\u001b[1;32m     99\u001b[0m im \u001b[38;5;241m=\u001b[39m numpy\u001b[38;5;241m.\u001b[39marray(high_res_image)\n\u001b[0;32m--> 100\u001b[0m result \u001b[38;5;241m=\u001b[39m \u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mreader\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mreadtext\u001b[49m\u001b[43m(\u001b[49m\u001b[43mim\u001b[49m\u001b[43m)\u001b[49m\n\u001b[1;32m    102\u001b[0m \u001b[38;5;28;01mdel\u001b[39;00m high_res_image\n\u001b[1;32m    103\u001b[0m \u001b[38;5;28;01mdel\u001b[39;00m im\n",
      "File \u001b[0;32m~/Library/Python/3.9/lib/python/site-packages/easyocr/easyocr.py:456\u001b[0m, in \u001b[0;36mReader.readtext\u001b[0;34m(self, image, decoder, beamWidth, batch_size, workers, allowlist, blocklist, detail, rotation_info, paragraph, min_size, contrast_ths, adjust_contrast, filter_ths, text_threshold, low_text, link_threshold, canvas_size, mag_ratio, slope_ths, ycenter_ths, height_ths, width_ths, y_ths, x_ths, add_margin, threshold, bbox_min_score, bbox_min_size, max_candidates, output_format)\u001b[0m\n\u001b[1;32m    450\u001b[0m \u001b[38;5;250m\u001b[39m\u001b[38;5;124;03m'''\u001b[39;00m\n\u001b[1;32m    451\u001b[0m \u001b[38;5;124;03mParameters:\u001b[39;00m\n\u001b[1;32m    452\u001b[0m \u001b[38;5;124;03mimage: file path or numpy-array or a byte stream object\u001b[39;00m\n\u001b[1;32m    453\u001b[0m \u001b[38;5;124;03m'''\u001b[39;00m\n\u001b[1;32m    454\u001b[0m img, img_cv_grey \u001b[38;5;241m=\u001b[39m reformat_input(image)\n\u001b[0;32m--> 456\u001b[0m horizontal_list, free_list \u001b[38;5;241m=\u001b[39m \u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mdetect\u001b[49m\u001b[43m(\u001b[49m\u001b[43mimg\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\n\u001b[1;32m    457\u001b[0m \u001b[43m                                         \u001b[49m\u001b[43mmin_size\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43m \u001b[49m\u001b[43mmin_size\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mtext_threshold\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43m \u001b[49m\u001b[43mtext_threshold\u001b[49m\u001b[43m,\u001b[49m\u001b[43m\\\u001b[49m\n\u001b[1;32m    458\u001b[0m \u001b[43m                                         \u001b[49m\u001b[43mlow_text\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43m \u001b[49m\u001b[43mlow_text\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mlink_threshold\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43m \u001b[49m\u001b[43mlink_threshold\u001b[49m\u001b[43m,\u001b[49m\u001b[43m\\\u001b[49m\n\u001b[1;32m    459\u001b[0m \u001b[43m                                         \u001b[49m\u001b[43mcanvas_size\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43m \u001b[49m\u001b[43mcanvas_size\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mmag_ratio\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43m \u001b[49m\u001b[43mmag_ratio\u001b[49m\u001b[43m,\u001b[49m\u001b[43m\\\u001b[49m\n\u001b[1;32m    460\u001b[0m \u001b[43m                                         \u001b[49m\u001b[43mslope_ths\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43m \u001b[49m\u001b[43mslope_ths\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mycenter_ths\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43m \u001b[49m\u001b[43mycenter_ths\u001b[49m\u001b[43m,\u001b[49m\u001b[43m\\\u001b[49m\n\u001b[1;32m    461\u001b[0m \u001b[43m                                         \u001b[49m\u001b[43mheight_ths\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43m \u001b[49m\u001b[43mheight_ths\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mwidth_ths\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43m \u001b[49m\u001b[43mwidth_ths\u001b[49m\u001b[43m,\u001b[49m\u001b[43m\\\u001b[49m\n\u001b[1;32m    462\u001b[0m \u001b[43m                                         \u001b[49m\u001b[43madd_margin\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43m \u001b[49m\u001b[43madd_margin\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mreformat\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43m \u001b[49m\u001b[38;5;28;43;01mFalse\u001b[39;49;00m\u001b[43m,\u001b[49m\u001b[43m\\\u001b[49m\n\u001b[1;32m    463\u001b[0m \u001b[43m                                         \u001b[49m\u001b[43mthreshold\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43m \u001b[49m\u001b[43mthreshold\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mbbox_min_score\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43m \u001b[49m\u001b[43mbbox_min_score\u001b[49m\u001b[43m,\u001b[49m\u001b[43m\\\u001b[49m\n\u001b[1;32m    464\u001b[0m \u001b[43m                                         \u001b[49m\u001b[43mbbox_min_size\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43m \u001b[49m\u001b[43mbbox_min_size\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mmax_candidates\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43m \u001b[49m\u001b[43mmax_candidates\u001b[49m\n\u001b[1;32m    465\u001b[0m \u001b[43m                                         \u001b[49m\u001b[43m)\u001b[49m\n\u001b[1;32m    466\u001b[0m \u001b[38;5;66;03m# get the 1st result from hor & free list as self.detect returns a list of depth 3\u001b[39;00m\n\u001b[1;32m    467\u001b[0m horizontal_list, free_list \u001b[38;5;241m=\u001b[39m horizontal_list[\u001b[38;5;241m0\u001b[39m], free_list[\u001b[38;5;241m0\u001b[39m]\n",
      "File \u001b[0;32m~/Library/Python/3.9/lib/python/site-packages/easyocr/easyocr.py:321\u001b[0m, in \u001b[0;36mReader.detect\u001b[0;34m(self, img, min_size, text_threshold, low_text, link_threshold, canvas_size, mag_ratio, slope_ths, ycenter_ths, height_ths, width_ths, add_margin, reformat, optimal_num_chars, threshold, bbox_min_score, bbox_min_size, max_candidates)\u001b[0m\n\u001b[1;32m    318\u001b[0m \u001b[38;5;28;01mif\u001b[39;00m reformat:\n\u001b[1;32m    319\u001b[0m     img, img_cv_grey \u001b[38;5;241m=\u001b[39m reformat_input(img)\n\u001b[0;32m--> 321\u001b[0m text_box_list \u001b[38;5;241m=\u001b[39m \u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mget_textbox\u001b[49m\u001b[43m(\u001b[49m\u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mdetector\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\n\u001b[1;32m    322\u001b[0m \u001b[43m                            \u001b[49m\u001b[43mimg\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\n\u001b[1;32m    323\u001b[0m \u001b[43m                            \u001b[49m\u001b[43mcanvas_size\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43m \u001b[49m\u001b[43mcanvas_size\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\n\u001b[1;32m    324\u001b[0m \u001b[43m                            \u001b[49m\u001b[43mmag_ratio\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43m \u001b[49m\u001b[43mmag_ratio\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    325\u001b[0m \u001b[43m                            \u001b[49m\u001b[43mtext_threshold\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43m \u001b[49m\u001b[43mtext_threshold\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\n\u001b[1;32m    326\u001b[0m \u001b[43m                            \u001b[49m\u001b[43mlink_threshold\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43m \u001b[49m\u001b[43mlink_threshold\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\n\u001b[1;32m    327\u001b[0m \u001b[43m                            \u001b[49m\u001b[43mlow_text\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43m \u001b[49m\u001b[43mlow_text\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    328\u001b[0m \u001b[43m                            \u001b[49m\u001b[43mpoly\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43m \u001b[49m\u001b[38;5;28;43;01mFalse\u001b[39;49;00m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\n\u001b[1;32m    329\u001b[0m \u001b[43m                            \u001b[49m\u001b[43mdevice\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43m \u001b[49m\u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mdevice\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\n\u001b[1;32m    330\u001b[0m \u001b[43m                            \u001b[49m\u001b[43moptimal_num_chars\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43m \u001b[49m\u001b[43moptimal_num_chars\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    331\u001b[0m \u001b[43m                            \u001b[49m\u001b[43mthreshold\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43m \u001b[49m\u001b[43mthreshold\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\n\u001b[1;32m    332\u001b[0m \u001b[43m                            \u001b[49m\u001b[43mbbox_min_score\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43m \u001b[49m\u001b[43mbbox_min_score\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\n\u001b[1;32m    333\u001b[0m \u001b[43m                            \u001b[49m\u001b[43mbbox_min_size\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43m \u001b[49m\u001b[43mbbox_min_size\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\n\u001b[1;32m    334\u001b[0m \u001b[43m                            \u001b[49m\u001b[43mmax_candidates\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43m \u001b[49m\u001b[43mmax_candidates\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    335\u001b[0m \u001b[43m                            \u001b[49m\u001b[43m)\u001b[49m\n\u001b[1;32m    337\u001b[0m horizontal_list_agg, free_list_agg \u001b[38;5;241m=\u001b[39m [], []\n\u001b[1;32m    338\u001b[0m \u001b[38;5;28;01mfor\u001b[39;00m text_box \u001b[38;5;129;01min\u001b[39;00m text_box_list:\n",
      "File \u001b[0;32m~/Library/Python/3.9/lib/python/site-packages/easyocr/detection.py:95\u001b[0m, in \u001b[0;36mget_textbox\u001b[0;34m(detector, image, canvas_size, mag_ratio, text_threshold, link_threshold, low_text, poly, device, optimal_num_chars, **kwargs)\u001b[0m\n\u001b[1;32m     93\u001b[0m result \u001b[38;5;241m=\u001b[39m []\n\u001b[1;32m     94\u001b[0m estimate_num_chars \u001b[38;5;241m=\u001b[39m optimal_num_chars \u001b[38;5;129;01mis\u001b[39;00m \u001b[38;5;129;01mnot\u001b[39;00m \u001b[38;5;28;01mNone\u001b[39;00m\n\u001b[0;32m---> 95\u001b[0m bboxes_list, polys_list \u001b[38;5;241m=\u001b[39m \u001b[43mtest_net\u001b[49m\u001b[43m(\u001b[49m\u001b[43mcanvas_size\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mmag_ratio\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mdetector\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m     96\u001b[0m \u001b[43m                                   \u001b[49m\u001b[43mimage\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mtext_threshold\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m     97\u001b[0m \u001b[43m                                   \u001b[49m\u001b[43mlink_threshold\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mlow_text\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mpoly\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m     98\u001b[0m \u001b[43m                                   \u001b[49m\u001b[43mdevice\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mestimate_num_chars\u001b[49m\u001b[43m)\u001b[49m\n\u001b[1;32m     99\u001b[0m \u001b[38;5;28;01mif\u001b[39;00m estimate_num_chars:\n\u001b[1;32m    100\u001b[0m     polys_list \u001b[38;5;241m=\u001b[39m [[p \u001b[38;5;28;01mfor\u001b[39;00m p, _ \u001b[38;5;129;01min\u001b[39;00m \u001b[38;5;28msorted\u001b[39m(polys, key\u001b[38;5;241m=\u001b[39m\u001b[38;5;28;01mlambda\u001b[39;00m x: \u001b[38;5;28mabs\u001b[39m(optimal_num_chars \u001b[38;5;241m-\u001b[39m x[\u001b[38;5;241m1\u001b[39m]))]\n\u001b[1;32m    101\u001b[0m                   \u001b[38;5;28;01mfor\u001b[39;00m polys \u001b[38;5;129;01min\u001b[39;00m polys_list]\n",
      "File \u001b[0;32m~/Library/Python/3.9/lib/python/site-packages/easyocr/detection.py:46\u001b[0m, in \u001b[0;36mtest_net\u001b[0;34m(canvas_size, mag_ratio, net, image, text_threshold, link_threshold, low_text, poly, device, estimate_num_chars)\u001b[0m\n\u001b[1;32m     44\u001b[0m \u001b[38;5;66;03m# forward pass\u001b[39;00m\n\u001b[1;32m     45\u001b[0m \u001b[38;5;28;01mwith\u001b[39;00m torch\u001b[38;5;241m.\u001b[39mno_grad():\n\u001b[0;32m---> 46\u001b[0m     y, feature \u001b[38;5;241m=\u001b[39m \u001b[43mnet\u001b[49m\u001b[43m(\u001b[49m\u001b[43mx\u001b[49m\u001b[43m)\u001b[49m\n\u001b[1;32m     48\u001b[0m boxes_list, polys_list \u001b[38;5;241m=\u001b[39m [], []\n\u001b[1;32m     49\u001b[0m \u001b[38;5;28;01mfor\u001b[39;00m out \u001b[38;5;129;01min\u001b[39;00m y:\n\u001b[1;32m     50\u001b[0m     \u001b[38;5;66;03m# make score and link map\u001b[39;00m\n",
      "File \u001b[0;32m~/Library/Python/3.9/lib/python/site-packages/torch/nn/modules/module.py:1511\u001b[0m, in \u001b[0;36mModule._wrapped_call_impl\u001b[0;34m(self, *args, **kwargs)\u001b[0m\n\u001b[1;32m   1509\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_compiled_call_impl(\u001b[38;5;241m*\u001b[39margs, \u001b[38;5;241m*\u001b[39m\u001b[38;5;241m*\u001b[39mkwargs)  \u001b[38;5;66;03m# type: ignore[misc]\u001b[39;00m\n\u001b[1;32m   1510\u001b[0m \u001b[38;5;28;01melse\u001b[39;00m:\n\u001b[0;32m-> 1511\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43m_call_impl\u001b[49m\u001b[43m(\u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43margs\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43mkwargs\u001b[49m\u001b[43m)\u001b[49m\n",
      "File \u001b[0;32m~/Library/Python/3.9/lib/python/site-packages/torch/nn/modules/module.py:1520\u001b[0m, in \u001b[0;36mModule._call_impl\u001b[0;34m(self, *args, **kwargs)\u001b[0m\n\u001b[1;32m   1515\u001b[0m \u001b[38;5;66;03m# If we don't have any hooks, we want to skip the rest of the logic in\u001b[39;00m\n\u001b[1;32m   1516\u001b[0m \u001b[38;5;66;03m# this function, and just call forward.\u001b[39;00m\n\u001b[1;32m   1517\u001b[0m \u001b[38;5;28;01mif\u001b[39;00m \u001b[38;5;129;01mnot\u001b[39;00m (\u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_backward_hooks \u001b[38;5;129;01mor\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_backward_pre_hooks \u001b[38;5;129;01mor\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_forward_hooks \u001b[38;5;129;01mor\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_forward_pre_hooks\n\u001b[1;32m   1518\u001b[0m         \u001b[38;5;129;01mor\u001b[39;00m _global_backward_pre_hooks \u001b[38;5;129;01mor\u001b[39;00m _global_backward_hooks\n\u001b[1;32m   1519\u001b[0m         \u001b[38;5;129;01mor\u001b[39;00m _global_forward_hooks \u001b[38;5;129;01mor\u001b[39;00m _global_forward_pre_hooks):\n\u001b[0;32m-> 1520\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[43mforward_call\u001b[49m\u001b[43m(\u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43margs\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43mkwargs\u001b[49m\u001b[43m)\u001b[49m\n\u001b[1;32m   1522\u001b[0m \u001b[38;5;28;01mtry\u001b[39;00m:\n\u001b[1;32m   1523\u001b[0m     result \u001b[38;5;241m=\u001b[39m \u001b[38;5;28;01mNone\u001b[39;00m\n",
      "File \u001b[0;32m~/Library/Python/3.9/lib/python/site-packages/easyocr/craft.py:60\u001b[0m, in \u001b[0;36mCRAFT.forward\u001b[0;34m(self, x)\u001b[0m\n\u001b[1;32m     58\u001b[0m \u001b[38;5;28;01mdef\u001b[39;00m \u001b[38;5;21mforward\u001b[39m(\u001b[38;5;28mself\u001b[39m, x):\n\u001b[1;32m     59\u001b[0m \u001b[38;5;250m    \u001b[39m\u001b[38;5;124;03m\"\"\" Base network \"\"\"\u001b[39;00m\n\u001b[0;32m---> 60\u001b[0m     sources \u001b[38;5;241m=\u001b[39m \u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mbasenet\u001b[49m\u001b[43m(\u001b[49m\u001b[43mx\u001b[49m\u001b[43m)\u001b[49m\n\u001b[1;32m     62\u001b[0m \u001b[38;5;250m    \u001b[39m\u001b[38;5;124;03m\"\"\" U network \"\"\"\u001b[39;00m\n\u001b[1;32m     63\u001b[0m     y \u001b[38;5;241m=\u001b[39m torch\u001b[38;5;241m.\u001b[39mcat([sources[\u001b[38;5;241m0\u001b[39m], sources[\u001b[38;5;241m1\u001b[39m]], dim\u001b[38;5;241m=\u001b[39m\u001b[38;5;241m1\u001b[39m)\n",
      "File \u001b[0;32m~/Library/Python/3.9/lib/python/site-packages/torch/nn/modules/module.py:1511\u001b[0m, in \u001b[0;36mModule._wrapped_call_impl\u001b[0;34m(self, *args, **kwargs)\u001b[0m\n\u001b[1;32m   1509\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_compiled_call_impl(\u001b[38;5;241m*\u001b[39margs, \u001b[38;5;241m*\u001b[39m\u001b[38;5;241m*\u001b[39mkwargs)  \u001b[38;5;66;03m# type: ignore[misc]\u001b[39;00m\n\u001b[1;32m   1510\u001b[0m \u001b[38;5;28;01melse\u001b[39;00m:\n\u001b[0;32m-> 1511\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43m_call_impl\u001b[49m\u001b[43m(\u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43margs\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43mkwargs\u001b[49m\u001b[43m)\u001b[49m\n",
      "File \u001b[0;32m~/Library/Python/3.9/lib/python/site-packages/torch/nn/modules/module.py:1520\u001b[0m, in \u001b[0;36mModule._call_impl\u001b[0;34m(self, *args, **kwargs)\u001b[0m\n\u001b[1;32m   1515\u001b[0m \u001b[38;5;66;03m# If we don't have any hooks, we want to skip the rest of the logic in\u001b[39;00m\n\u001b[1;32m   1516\u001b[0m \u001b[38;5;66;03m# this function, and just call forward.\u001b[39;00m\n\u001b[1;32m   1517\u001b[0m \u001b[38;5;28;01mif\u001b[39;00m \u001b[38;5;129;01mnot\u001b[39;00m (\u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_backward_hooks \u001b[38;5;129;01mor\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_backward_pre_hooks \u001b[38;5;129;01mor\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_forward_hooks \u001b[38;5;129;01mor\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_forward_pre_hooks\n\u001b[1;32m   1518\u001b[0m         \u001b[38;5;129;01mor\u001b[39;00m _global_backward_pre_hooks \u001b[38;5;129;01mor\u001b[39;00m _global_backward_hooks\n\u001b[1;32m   1519\u001b[0m         \u001b[38;5;129;01mor\u001b[39;00m _global_forward_hooks \u001b[38;5;129;01mor\u001b[39;00m _global_forward_pre_hooks):\n\u001b[0;32m-> 1520\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[43mforward_call\u001b[49m\u001b[43m(\u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43margs\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43mkwargs\u001b[49m\u001b[43m)\u001b[49m\n\u001b[1;32m   1522\u001b[0m \u001b[38;5;28;01mtry\u001b[39;00m:\n\u001b[1;32m   1523\u001b[0m     result \u001b[38;5;241m=\u001b[39m \u001b[38;5;28;01mNone\u001b[39;00m\n",
      "File \u001b[0;32m~/Library/Python/3.9/lib/python/site-packages/easyocr/model/modules.py:68\u001b[0m, in \u001b[0;36mvgg16_bn.forward\u001b[0;34m(self, X)\u001b[0m\n\u001b[1;32m     67\u001b[0m \u001b[38;5;28;01mdef\u001b[39;00m \u001b[38;5;21mforward\u001b[39m(\u001b[38;5;28mself\u001b[39m, X):\n\u001b[0;32m---> 68\u001b[0m     h \u001b[38;5;241m=\u001b[39m \u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mslice1\u001b[49m\u001b[43m(\u001b[49m\u001b[43mX\u001b[49m\u001b[43m)\u001b[49m\n\u001b[1;32m     69\u001b[0m     h_relu2_2 \u001b[38;5;241m=\u001b[39m h\n\u001b[1;32m     70\u001b[0m     h \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39mslice2(h)\n",
      "File \u001b[0;32m~/Library/Python/3.9/lib/python/site-packages/torch/nn/modules/module.py:1511\u001b[0m, in \u001b[0;36mModule._wrapped_call_impl\u001b[0;34m(self, *args, **kwargs)\u001b[0m\n\u001b[1;32m   1509\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_compiled_call_impl(\u001b[38;5;241m*\u001b[39margs, \u001b[38;5;241m*\u001b[39m\u001b[38;5;241m*\u001b[39mkwargs)  \u001b[38;5;66;03m# type: ignore[misc]\u001b[39;00m\n\u001b[1;32m   1510\u001b[0m \u001b[38;5;28;01melse\u001b[39;00m:\n\u001b[0;32m-> 1511\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43m_call_impl\u001b[49m\u001b[43m(\u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43margs\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43mkwargs\u001b[49m\u001b[43m)\u001b[49m\n",
      "File \u001b[0;32m~/Library/Python/3.9/lib/python/site-packages/torch/nn/modules/module.py:1520\u001b[0m, in \u001b[0;36mModule._call_impl\u001b[0;34m(self, *args, **kwargs)\u001b[0m\n\u001b[1;32m   1515\u001b[0m \u001b[38;5;66;03m# If we don't have any hooks, we want to skip the rest of the logic in\u001b[39;00m\n\u001b[1;32m   1516\u001b[0m \u001b[38;5;66;03m# this function, and just call forward.\u001b[39;00m\n\u001b[1;32m   1517\u001b[0m \u001b[38;5;28;01mif\u001b[39;00m \u001b[38;5;129;01mnot\u001b[39;00m (\u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_backward_hooks \u001b[38;5;129;01mor\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_backward_pre_hooks \u001b[38;5;129;01mor\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_forward_hooks \u001b[38;5;129;01mor\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_forward_pre_hooks\n\u001b[1;32m   1518\u001b[0m         \u001b[38;5;129;01mor\u001b[39;00m _global_backward_pre_hooks \u001b[38;5;129;01mor\u001b[39;00m _global_backward_hooks\n\u001b[1;32m   1519\u001b[0m         \u001b[38;5;129;01mor\u001b[39;00m _global_forward_hooks \u001b[38;5;129;01mor\u001b[39;00m _global_forward_pre_hooks):\n\u001b[0;32m-> 1520\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[43mforward_call\u001b[49m\u001b[43m(\u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43margs\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43mkwargs\u001b[49m\u001b[43m)\u001b[49m\n\u001b[1;32m   1522\u001b[0m \u001b[38;5;28;01mtry\u001b[39;00m:\n\u001b[1;32m   1523\u001b[0m     result \u001b[38;5;241m=\u001b[39m \u001b[38;5;28;01mNone\u001b[39;00m\n",
      "File \u001b[0;32m~/Library/Python/3.9/lib/python/site-packages/torch/nn/modules/container.py:217\u001b[0m, in \u001b[0;36mSequential.forward\u001b[0;34m(self, input)\u001b[0m\n\u001b[1;32m    215\u001b[0m \u001b[38;5;28;01mdef\u001b[39;00m \u001b[38;5;21mforward\u001b[39m(\u001b[38;5;28mself\u001b[39m, \u001b[38;5;28minput\u001b[39m):\n\u001b[1;32m    216\u001b[0m     \u001b[38;5;28;01mfor\u001b[39;00m module \u001b[38;5;129;01min\u001b[39;00m \u001b[38;5;28mself\u001b[39m:\n\u001b[0;32m--> 217\u001b[0m         \u001b[38;5;28minput\u001b[39m \u001b[38;5;241m=\u001b[39m \u001b[43mmodule\u001b[49m\u001b[43m(\u001b[49m\u001b[38;5;28;43minput\u001b[39;49m\u001b[43m)\u001b[49m\n\u001b[1;32m    218\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28minput\u001b[39m\n",
      "File \u001b[0;32m~/Library/Python/3.9/lib/python/site-packages/torch/nn/modules/module.py:1511\u001b[0m, in \u001b[0;36mModule._wrapped_call_impl\u001b[0;34m(self, *args, **kwargs)\u001b[0m\n\u001b[1;32m   1509\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_compiled_call_impl(\u001b[38;5;241m*\u001b[39margs, \u001b[38;5;241m*\u001b[39m\u001b[38;5;241m*\u001b[39mkwargs)  \u001b[38;5;66;03m# type: ignore[misc]\u001b[39;00m\n\u001b[1;32m   1510\u001b[0m \u001b[38;5;28;01melse\u001b[39;00m:\n\u001b[0;32m-> 1511\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43m_call_impl\u001b[49m\u001b[43m(\u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43margs\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43mkwargs\u001b[49m\u001b[43m)\u001b[49m\n",
      "File \u001b[0;32m~/Library/Python/3.9/lib/python/site-packages/torch/nn/modules/module.py:1520\u001b[0m, in \u001b[0;36mModule._call_impl\u001b[0;34m(self, *args, **kwargs)\u001b[0m\n\u001b[1;32m   1515\u001b[0m \u001b[38;5;66;03m# If we don't have any hooks, we want to skip the rest of the logic in\u001b[39;00m\n\u001b[1;32m   1516\u001b[0m \u001b[38;5;66;03m# this function, and just call forward.\u001b[39;00m\n\u001b[1;32m   1517\u001b[0m \u001b[38;5;28;01mif\u001b[39;00m \u001b[38;5;129;01mnot\u001b[39;00m (\u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_backward_hooks \u001b[38;5;129;01mor\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_backward_pre_hooks \u001b[38;5;129;01mor\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_forward_hooks \u001b[38;5;129;01mor\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_forward_pre_hooks\n\u001b[1;32m   1518\u001b[0m         \u001b[38;5;129;01mor\u001b[39;00m _global_backward_pre_hooks \u001b[38;5;129;01mor\u001b[39;00m _global_backward_hooks\n\u001b[1;32m   1519\u001b[0m         \u001b[38;5;129;01mor\u001b[39;00m _global_forward_hooks \u001b[38;5;129;01mor\u001b[39;00m _global_forward_pre_hooks):\n\u001b[0;32m-> 1520\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[43mforward_call\u001b[49m\u001b[43m(\u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43margs\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43mkwargs\u001b[49m\u001b[43m)\u001b[49m\n\u001b[1;32m   1522\u001b[0m \u001b[38;5;28;01mtry\u001b[39;00m:\n\u001b[1;32m   1523\u001b[0m     result \u001b[38;5;241m=\u001b[39m \u001b[38;5;28;01mNone\u001b[39;00m\n",
      "File \u001b[0;32m~/Library/Python/3.9/lib/python/site-packages/torch/nn/modules/conv.py:460\u001b[0m, in \u001b[0;36mConv2d.forward\u001b[0;34m(self, input)\u001b[0m\n\u001b[1;32m    459\u001b[0m \u001b[38;5;28;01mdef\u001b[39;00m \u001b[38;5;21mforward\u001b[39m(\u001b[38;5;28mself\u001b[39m, \u001b[38;5;28minput\u001b[39m: Tensor) \u001b[38;5;241m-\u001b[39m\u001b[38;5;241m>\u001b[39m Tensor:\n\u001b[0;32m--> 460\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43m_conv_forward\u001b[49m\u001b[43m(\u001b[49m\u001b[38;5;28;43minput\u001b[39;49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mweight\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mbias\u001b[49m\u001b[43m)\u001b[49m\n",
      "File \u001b[0;32m~/Library/Python/3.9/lib/python/site-packages/torch/nn/modules/conv.py:456\u001b[0m, in \u001b[0;36mConv2d._conv_forward\u001b[0;34m(self, input, weight, bias)\u001b[0m\n\u001b[1;32m    452\u001b[0m \u001b[38;5;28;01mif\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39mpadding_mode \u001b[38;5;241m!=\u001b[39m \u001b[38;5;124m'\u001b[39m\u001b[38;5;124mzeros\u001b[39m\u001b[38;5;124m'\u001b[39m:\n\u001b[1;32m    453\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m F\u001b[38;5;241m.\u001b[39mconv2d(F\u001b[38;5;241m.\u001b[39mpad(\u001b[38;5;28minput\u001b[39m, \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_reversed_padding_repeated_twice, mode\u001b[38;5;241m=\u001b[39m\u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39mpadding_mode),\n\u001b[1;32m    454\u001b[0m                     weight, bias, \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39mstride,\n\u001b[1;32m    455\u001b[0m                     _pair(\u001b[38;5;241m0\u001b[39m), \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39mdilation, \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39mgroups)\n\u001b[0;32m--> 456\u001b[0m \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[43mF\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mconv2d\u001b[49m\u001b[43m(\u001b[49m\u001b[38;5;28;43minput\u001b[39;49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mweight\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mbias\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mstride\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    457\u001b[0m \u001b[43m                \u001b[49m\u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mpadding\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mdilation\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mgroups\u001b[49m\u001b[43m)\u001b[49m\n",
      "\u001b[0;31mKeyboardInterrupt\u001b[0m: "
     ]
    }
   ],
   "source": [
    "from tqdm import tqdm\n",
    "\n",
    "ecuador_link = \"https://cdn.who.int/media/docs/default-source/antimicrobial-resistance/amr-spc-npm/nap-library/ecuador-nap-on-amr-2019-2023.pdf?sfvrsn=f6c54ad2_3&download=true\"\n",
    "\n",
    "# this one is less structured\n",
    "with tqdm(total=100, desc=\"Converting document\") as pbar:\n",
    "    result = converter.convert(ecuador_link)\n",
    "    pbar.update(100)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Use this one"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Defaulting to user installation because normal site-packages is not writeable\n",
      "Collecting pymupdf4llm\n",
      "  Downloading pymupdf4llm-0.0.17-py3-none-any.whl.metadata (4.1 kB)\n",
      "Collecting pymupdf>=1.24.10 (from pymupdf4llm)\n",
      "  Downloading pymupdf-1.25.2-cp39-abi3-macosx_10_9_x86_64.whl.metadata (3.4 kB)\n",
      "Downloading pymupdf4llm-0.0.17-py3-none-any.whl (26 kB)\n",
      "Downloading pymupdf-1.25.2-cp39-abi3-macosx_10_9_x86_64.whl (19.3 MB)\n",
      "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m19.3/19.3 MB\u001b[0m \u001b[31m2.6 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0ma \u001b[36m0:00:01\u001b[0m\n",
      "\u001b[?25hInstalling collected packages: pymupdf, pymupdf4llm\n",
      "Successfully installed pymupdf-1.25.2 pymupdf4llm-0.0.17\n",
      "Note: you may need to restart the kernel to use updated packages.\n"
     ]
    }
   ],
   "source": [
    "pip install pymupdf4llm"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pymupdf4llm"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [],
   "source": [
    "chile_pdf = \"chile_nap.pdf\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Processing chile_nap.pdf...\n",
      "[                                        ] (0/60[                                        ] ( 1/60[=                                       ] ( 2/60[==                                      ] ( 3/60[==                                      ] ( 4/60[===                                     ] ( 5/[====                                    ] ( 6/60[====                                    ] ( 7/60[=====                                   ] ( 8/[======                                  ] ( 9/60[======                                  ] (10/60[=======                                 ] (11/[========                                ] (12/60[========                                ] (13/60[=========                               ] (14/[==========                              ] (15/60[==========                              ] (16/60[===========                             ] (17/60[============                            ] (18/60[============                            ] (19/60[=============                           ] (20/60[==============                          ] (21/60[==============                          ] (22/60[===============                         ] (23/[================                        ] (24/60[================                        ] (25/60[=================                       ] (26/[==================                      ] (27/60[==================                      ] (28/60[===================                     ] (29/[====================                    ] (30/60[====================                    ] (31/60[=====================                   ] (32/60[======================                  ] (33/60[======================                  ] (34/60[=======================                 ] (35/[========================                ] (36/60[========================                ] (37/60[=========================               ] (38/[==========================              ] (39/60[==========================              ] (40/60[===========================             ] (41/[============================            ] (42/60[============================            ] (43/60[=============================           ] (44/[==============================          ] (45/60[==============================          ] (46/60[===============================         ] (47/[================================        ] (48/60[================================        ] (49/60[=================================       ] (50/[==================================      ] (51/60[==================================      ] (52/60[===================================     ] (53/[====================================    ] (54/60[====================================    ] (55/60[=====================================   ] (56/[======================================  ] (57/60[======================================  ] (58/60[======================================= ] (59/[========================================] (60/60]\n"
     ]
    }
   ],
   "source": [
    "chile_text = pymupdf4llm.to_markdown(chile_pdf)\n",
    "\n",
    "with open(\"chile_nap.md\", \"w\") as f:\n",
    "    f.write(chile_text)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [],
   "source": [
    "with open(\"chile_nap.txt\", \"w\") as f:\n",
    "    f.write(chile_text)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [],
   "source": [
    "arg_pdf = 'argentina_nap.pdf'"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Processing argentina_nap.pdf...\n",
      "[                                        ] (0/2[=                                       ] ( 1/2[==                                      ] ( 2/28=[====                                    ] ( 3/28[=====                                   ] ( 4/2=[=======                                 ] ( 5/2[========                                ] ( 6/28=[==========                              ] ( 7/28[===========                             ] ( 8/2[============                            ] ( 9/28=[==============                          ] (10/28[===============                         ] (11/2=[=================                       ] (12/2[==================                      ] (13/28=[====================                    ] (14/28[=====================                   ] (15/2[======================                  ] (16/28=[========================                ] (17/28[=========================               ] (18/2=[===========================             ] (19/2[============================            ] (20/28=[==============================          ] (21/28[===============================         ] (22/2[================================        ] (23/28=[==================================      ] (24/28[===================================     ] (25/2=[=====================================   ] (26/2[======================================  ] (27/28=[========================================] (28/28]\n"
     ]
    }
   ],
   "source": [
    "arg_text = pymupdf4llm.to_markdown(arg_pdf)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'str'>\n"
     ]
    }
   ],
   "source": [
    "# find the type of the object\n",
    "print(type(arg_text))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {},
   "outputs": [],
   "source": [
    "# turn arg_text into a txt file\n",
    "with open('argentina_nap.txt', 'w') as f:\n",
    "    f.write(arg_text)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Processing ethiopia_nap.pdf...\n",
      "[                                        ] (0/3[=                                       ] ( 1/3[==                                      ] ( 2/36[===                                     ] ( 3/3[====                                    ] ( 4/36[=====                                   ] ( 5/3[======                                  ] ( 6/36[=======                                 ] ( 7/3[========                                ] ( 8/36=[==========                              ] ( 9/36[===========                             ] (10/3[============                            ] (11/36[=============                           ] (12/3[==============                          ] (13/36[===============                         ] (14/3[================                        ] (15/36[=================                       ] (16/3[==================                      ] (17/36=[====================                    ] (18/36[=====================                   ] (19/3[======================                  ] (20/36[=======================                 ] (21/3[========================                ] (22/36[=========================               ] (23/3[==========================              ] (24/36[===========================             ] (25/3[============================            ] (26/36=[==============================          ] (27/36[===============================         ] (28/3[================================        ] (29/36[=================================       ] (30/3[==================================      ] (31/36[===================================     ] (32/3[====================================    ] (33/36[=====================================   ] (34/3[======================================  ] (35/36=[========================================] (36/36]\n"
     ]
    }
   ],
   "source": [
    "eth_pdf = 'ethiopia_nap.pdf'\n",
    "\n",
    "eth_text = pymupdf4llm.to_markdown(eth_pdf)\n",
    "\n",
    "with open('ethiopia_nap.txt', 'w') as f:\n",
    "    f.write(eth_text)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Processing ecuador_nap.pdf...\n",
      "[                                        ] (0/3[=                                       ] ( 1/3[==                                      ] ( 2/38[===                                     ] ( 3/3[====                                    ] ( 4/38[=====                                   ] ( 5/3[======                                  ] ( 6/38[=======                                 ] ( 7/3[========                                ] ( 8/38[=========                               ] ( 9/3[==========                              ] (10/38[===========                             ] (11/3[============                            ] (12/38[=============                           ] (13/3[==============                          ] (14/38[===============                         ] (15/3[================                        ] (16/38[=================                       ] (17/3[==================                      ] (18/38[====================                    ] (19/38=[=====================                   ] (20/3[======================                  ] (21/38[=======================                 ] (22/3[========================                ] (23/38[=========================               ] (24/3[==========================              ] (25/38[===========================             ] (26/3[============================            ] (27/38[=============================           ] (28/3[==============================          ] (29/38[===============================         ] (30/3[================================        ] (31/38[=================================       ] (32/3[==================================      ] (33/38[===================================     ] (34/3[====================================    ] (35/38[=====================================   ] (36/3[======================================  ] (37/38[========================================] (38/38]\n"
     ]
    }
   ],
   "source": [
    "ecu_pdf = 'ecuador_nap.pdf'\n",
    "\n",
    "ecu_text = pymupdf4llm.to_markdown(ecu_pdf)\n",
    "\n",
    "with open('ecuador_nap.txt', 'w') as f:\n",
    "    f.write(ecu_text)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.6"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
